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1. Introduction 
 
1.1. Formulation Challenges with Biologicals 
 
1.1.1. General Considerations 
 
Unlike small chemical drugs (or New Chemical Entities (NCEs)), biologicals and 
especially protein pharmaceuticals form higher ordered structures. For the maximum 
efficacy and safety of the drug product it is mandatory to preserve this fragile system 
of interactions and arrangements until the drug is applied in the patient‟s body and 
arrives at the site of action (Porter 2001; Rosenberg 2006). In general, proteins are 
forming small specific and less hydrophobic surfaces. Usually the more hydrophobic 
amino acids are buried in the protein‟s core to reduce the contact area to water to a 
minimum. The more polar amino acids are predominant on the surface of the protein. 
This leads to strong hydrophobic interactions in the inner parts of the molecule and to 
an increased hydration at the surface. Only the target sites of e.g. antibodies contain 
a higher hydrophobic part at the surface (Ptitsyn 1987).  
Proteins usually have only one specific target, e.g. receptors, antigens. This high 
specificity is their big advantage compared to NCEs, which often show side effects 
due to targeting multiple sites. NCEs act only partially specific. Opioids for example 
bind to several types of receptors. For some antipsychotic drugs their unspecifity 
makes them even more potent. But with more targets, the odds of a higher incidence 
of severe side effects are increasing. 
Only proteins that are in the native state are active against their target (Weir et al. 
2002). Furthermore, unfolded or aggregated protein molecules can in some cases 
lead to severe side effects. Different stresses can lead to chemical and physical 
denaturation of the protein. The next few examples should demonstrate the problems 
with handling pharmaceutical proteins as bulk substance or in the final dosage form. 
In the downstream process human Growth Hormone (hGH) aggregates can occur 
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within the filter during sterile filtration (Maa and Hsu 1998). During lyophilization 
various proteins form aggregates during the freezing process itself. E.g. Interleukin-1 
receptor antagonist or tumor necrosis factor binding protein aggregate at the ice-
liquid interface unless stabilized with surfactant (Chang et al. 1996b).  
The oxidation of recombinant human monoclonal antibody HER2 is strongly 
enhanced in the presence iron ions derived from corrosive material during fill & finish 
processes (Lam et al. 1997).  
Furthermore the storage and shipping temperature is an important factor for protein 
stability. Myofibrillar ATPase becomes more denatured at -5°C than at -20°C (Martino 
and Zaritzky 1989). This phenomenon is explained with recrystallization of the protein 
at higher temperatures in the frozen state (Williamson et al. 1999; Pham 2006; 
Fernandez et al. 2008).   
 
Protein stability is not only an issue for content loss and hence a less efficient 
manufacturing process but may also lead to immunogenic side effects (Porter 2001; 
Patten and Schellekens 2003; Rosenberg 2006). Immunogenicity is a major concern 
especially when proteins are administered as multiple doses over prolonged periods 
(Patten and Schellekens 2003). The most prominent example for the breakdown of 
immune tolerance against a naturally occurring protein is probably the “erythropoietin 
(Epo) case”. The formation of non native like structures is related to the breakdown of 
immune tolerance against both the synthetic substance and Epo derived from the 
human body. This can be explained by the fact that the aggregated protein molecules 
form haptenes for the immune system. The human body in turn is not able later on to 
differentiate the origin of the haptene that also lies somewhere on the protein surface. 
When the body tries to eliminate all Epo the consequence for the patient is a so 
called pure red cell aplasia (PRCA). The only therapeutic option for this adverse 
effect is a complete blood transfusion to remove antibodies from the patient 
(Casadevall et al. 2002; Rossert et al. 2005; Schellekens 2005; Schellekens and 
Jiskoot 2006). Thus, the formulator in pharmaceutical industry has to try to prevent 
the protein from all types of chemical and physical degradation, which are explained 
in this chapter. 
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1.1.2. Physical Instability 
 
Physical denaturation describes the unfolding of the native protein structure. One can 
differentiate between partial and complete denaturation (Figure 1). A frequent 
consequence of denaturation is unfolding. But also native proteins can form 
associates (Brange 2000). 
 
 
Figure 1: Simplified model of proposed protein aggregation and association 
mechanism (Mahler et al. 2005) 
 
In Figure 1 N is the native state protein that can unfold to the denatured state D or 
form small associates As. As are oligomers and multimers whose monomer subunits 
have a preserved native structure. D or As can form aggregates Ag based on 
unfolded monomers. As can grow and build up large soluble Ass or when solubility 
limits are exceeded can form insoluble associates Asi. From smaller aggregates 
larger soluble Ags and insoluble aggregates AgI can be generated (Mahler et al. 
2005). 
As indicated by the dotted lines, the reaction back to a more native like state typically 
only occurs under special conditions like high pressure for the refolding of human 
Growth Hormone (St. John et al. 2001). 
An important aspect of physical instability is the size of the associates or aggregates. 
Proteins can arrange in small units like dimers, trimers or tetramers, but also in larger 
oligomers or aggregate to large multimers. Although some protein pharmaceuticals 
have a native state that comprises monomers, dimers and hexamers, e.g. insulin 
(Manallack et al. 1985; Bhattacharyya and Das 1999) or glycogen phosphorylase 
(Paladini et al. 1994) that show enhanced stability or activity in an oligomeric state, 
for most pharmaceutically applied proteins the monomer is the only acceptable, 
stable, and active state. 
D Ag Ags Agi
AsiAssAsN
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The problem with bigger oligomers is that they can act as epitopes for the patient‟s 
immune system. This recognition can lead to acute immunogenicity or breakdown of 
the immune tolerance (see above) to exogenous substances (Schellekens 2005; 
Rosenberg 2006).  
Often the first transition from N to D is going through a slightly unfolded state, the so-
called molten globule state (Figure 2) (Ptitsyn 1987; Kumar et al. 1995; Bam et al. 
1996). These intermediates are less compact than the native state, but show similar 
Stokes radii. The molten globule state is usually thermodynamically unstable and 
transforms into completely unfolded protein. But in some cases this partially unfolded 
protein can be preserved and can fold back to the native state by high pressure as 
applied for different proteins (Zhang et al. 1995; Bam et al. 1996).  
 
Figure 2: Proteins are folded via an Intermediate State (I), the molten globule 
state (N), into the native form. I is usually slightly bigger than N (from (Ptitsyn 
1987)). 
 
1.1.3. Chemical Instability: 
 
Chemical degradation of protein comprises a number of different processes. 
 
Deamidation is the most prominent degradation pathway for proteins (Robinson and 
Robinson 2001) for example insulin is deamidated at Asn21 under acid and at AsnB3 
under neutral pH conditions (Brange et al. 1992). For deamidation one of the two 
amino acids with amid functions, asparagine (Asn) or glutamine (Gln), must be 
present in the protein (Brange et al. 1992; Sasaoki et al. 1992; Shire 1996). Asn is 
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much more susceptible to deamidation than Gln. For both amino acids the 
mechanism leads via cyclic imide products to the oxidized acid, aparagic acid or 
glutamic acid or their respective iso-form (Robinson and Robinson 2001; Robinson 
and Robinson 2004).  
The amino acids most likely to undergo oxidation are methionine, cysteine and 
histidine (Gu et al. 1991; Stadtman 1993; Nabuchi et al. 1995; Fransson et al. 1996; 
Li et al. 1996a; Zhao et al. 1997). Methionine can react to its sulfoxide or under 
stronger conditions to its sulfone (Manning et al. 1989). Oxidized cystein is forming 
inter- and intramolecular disulfide bridges, under stronger conditions reactions to its 
sulfenic, sulfinic and finally sulfonic acids are possible, too (Florence 1980; Stadtman 
1993). In this work Interleukin-11 and hGH are applied. Both proteins are susceptible 
to methionine oxidation (Pikal et al. 1991; Yokota et al. 2000).  
When aspartic acid (Asp) is present in the protein, peptide bonds are eager to 
hydrolize at the N-terminal and C-terminal adjacent to an Asp residue. This 
behaviour is favoured when the following amino acid is proline and glycine. In some 
cases hydrolysis of Asn is following the deamidation of Asp to Asn (Manning et al. 
1989; Brange et al. 1992; Li et al. 1995; Reubsaet et al. 1998).  RhIL11 is also 
cleaved by hydrolytic mechanisms between Asp133 and Pro134 under acidic 
conditions (Kenley and Warne 1994).  
The potential for racemization is present in all amino acids but Gly. Asp and Glu 
racemize via cyclic imide intermediate formation. The rate of racemization is strongly 
structure dependent (Stephenson and Clarke 1989; Kimber and Hare 1992; Ritz and 
Schutz 1993; Luthra et al. 1994; Shahrokh et al. 1994). Shifts in pH and high 
temperatures are the cause of this degradation mechanism.  
Cys, Ser, Phe, Thr and Lys are prone to β-elimination. This is a special pathway of 
racemisation, where the intermediate product is cleaved after conversion. The 
products, originating from elimination mechanisms will contribute to physical 
instability such as aggregation, adsorption or precipitation. For example recombinant 
human Macrophage colony stimulating factor is supposed to be β-eliminated under 
alkaline conditions (Nashef et al. 1977; Schrier et al. 1993). Insulin shows β-
elimination after thiol-induced interchange (Costantino et al. 1994). 
A consequence of β-elimination can be disulfide scrambling. Free thiol groups can 
be oxidized forming disulfide bridges. Insulin shows disulfide scrambling in the dried 
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state. This is even more pronounced when the lyophilizatates showed higher residual 
moisture (Costantino et al. 1994; Kuwata et al. 1994; Shahrokh et al. 1994). 
The formation of anhydrids from Asp and Glu is another possible degradation 
pathway where intramolecular bonds are formed. These reaction are strongly 
dependent on pH and are sometimes proposed to occur in the presence of 
formaldehyde, e.g. for vaccines (Schrier et al. 1993; Prestrelski et al. 1995; 
Schwendeman et al. 1995). Non-disulfide cross-linking (also called non-reducible 
cross-linking) is also a degradation pathway of Interleukin-2, that is increased by the 
presence of polysorbate 80 in the liquid protein formulation (Wang et al. 2008). This 
degradation mechanism, usually oxidative, can e.g. be thioether formation and is 
detectable via SDS-Page (Wang 1999). 
A big number of therapeutic proteins, especially monoclonal antibodies show a 
specific level of glycosilation (Wang et al. 2005). Deglycosilation can impact thermal 
stability and function of the protein as shown for human Interferon-β and phytase. 
Furthermore, the isoelectric point can be shifted due to this degradation and impair 
physical stability of a formulation (Runkel et al. 1998; Bagger et al. 2007a). 
Deglycosilation can occur pH triggered and lead to thermally unstable proteins that 
are prone to intracellular degradation (Wang et al. 1996; Dobson 2003). 
In the presence of reducing sugars, such as glucose and fructose, proteins can 
undergo a degradation pathway called the Maillard reaction. This type of reaction is 
well known from food browning during baking. Products are usually yellowish to 
brownish and heterogenous. A free amino group of an amino acid and a hemiacetal 
in the sugar are essential for this kind of reaction (Reyes et al. 1982). E.g. for human 
relaxin in the lyophilized state it is important to refuse reducing sugars from the 
formulation as they significantly react with the protein (Li et al. 1996b). 
 
Physical and chemical instability are usually affecting each other. On the one hand 
side aggregation can occur due to covalent linkage of two unfolded monomers 
(Muhammad et al. 2009) and on the other hand chemical reactions may be enhanced 
in the unfolded state (Kendrick et al. 1997). 
1.2. Stabilizing Additives in Pharmaceutical Protein Formulation 
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There are several types of excipients applied to prevent physical degradation of 
pharmaceutical proteins. Surfactants are applied to prevent surface induced 
unfolding, as artificial chaperones to reverse unfolding and in some cases to prevent 
chemical denaturation. This group of excipients is discussed in detail in the 
paragraphs below. Other applied excipients are sugars and polyols, amino acids, 
buffer salts, polyethylene glycols (PEG), other polymers, metal ions. 
 
1.2.1. Other Excipients than Surfactants 
 
Sugars and polyols act through the preferential exclusion mechanism, introduced 
by Timasheff et al. into the pharmaceutical field (Timasheff 1993). Preferential 
exclusion of the excipient from the protein leads to a stronger hydration of the 
protein, which in turn leads to a denser packing of the protein molecules to minimize 
exposure of hydrophobic protein parts at the surface. Furthermore, reduced protein 
surface due to preferential exclusion reduces the chemical potential and is thus less 
prone to oxidative processes (Kendrick et al. 1997). Sugars are also able to remove 
metal salts from the solution and may prevent metal ion catalyzed chemical 
degradation or act in other ways as antioxidant (Lam et al. 1997). In freeze-dried 
formulation, sugars are acting as water replacement by providing hydroxyl functions 
to the protein (Crowe et al. 1993a; Crowe et al. 1993b; Schuele et al. 2008). The 
tendency of in particular sucrose and trehalose to form amorphous cakes makes 
them ideal bulking agents in dried protein formulations (Arakawa et al. 1993; Chang 
et al. 1996a). Furthermore these disaccharides lead in many cases to solid systems 
with a glass transition temperature and relaxation rates high enough for effective 
storage stability. In numerous cases trehalose stabilizes slightly better than sucrose 
(Tanaka et al. 1991; Hora et al. 1992; te Booy et al. 1992; Pikal and Rigsbee 1997; 
Cleland et al. 2001; Maury et al. 2005). Reducing sugars should not be applied, as 
they have the tendency to react to Maillard-products with terminal amino groups as 
shown for human relaxin (Li et al. 1996b). The use of the sugar alcohol mannitol 
usually yields crystalline solid formulations (Akers 2002). Shorter polyols like glycerol 
can be added to freeze-dried formulations for the suppression of local, nanosecond 
relaxations and frequency shifting of collective vibrations that occur upon addition of 
diluents. Therefore, they increase protein stability although the glass transition 
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temperature is decreased (Cicerone et al. 2005).  
Amino acids most probably stabilize due to preferential exclusion as shown for pig 
heart mitochondrial malate dehydrogenase similar to carbohydrates (Jensen et al. 
1996). Furthermore, for some amino acid / protein systems the amino acids protect 
the protein from oxidation, e.g. histidine is preventing oxidation of papain (Kanazawa 
et al. 1994). Cysteine and (partially) methionine stabilize recombinant human Ciliary 
Neurotrophic Factor, and recombinant human Nerve Growth Factor (Knepp et al. 
1996). 
Buffer salts on the one hand are mandatory to provide and stabilize the pH-value 
that shows the best retention of the native state of the protein, but also the choice of 
buffer affects the stability of the formulation. For example, in the typical pH range 
phosphate buffer in freeze-dried formulations tends to solidify in two different salts 
which differ in their solubility. Thus the pH during freezing can change dramatically. If 
one takes a closer look on the phosphate buffer system during freezing, one can 
detect up to 13 eutectic temperatures with decreasing pH with decreasing 
temperature and thus changing the surface charge of the protein (van den Berg and 
Rose 1959; Orii and Morita 1977; Franks 1993; Gomez et al. 2001; Pikal-Cleland et 
al. 2002). For some buffer systems the position in the Hofmeister series or their 
tendency to salt out/salt in proteins influence the stability of liquid formulations 
(Bagger et al. 2007b; Le Brun et al. 2009). Especially for highly concentrated protein 
formulations the addition of the right type of buffer salt and the correct pH are of 
importance (Shire et al. 2004; Salinas et al. 2010). The desired pH value should be 
well away from the isoelectric point of the protein to keep the net surface charge of 
the protein high and thus reduce intermolecular attraction forces (Yang and Honig 
1993; Le Brun et al. 2009; Salinas et al. 2010). Not only the salting out effects and 
the pH must be observed, but ionic strength plays a major role in protein stabilization, 
too. Not only the type of buffer salt must be correct, but also the salt concentration 
(Giancola et al. 1997; Hawe and Friess 2008; Salinas et al. 2010).  
In the past human serum albumin (HSA) have been an alternative for non-ionic 
surfactants. When added in high amounts, the surfaces of container systems are 
covered with e.g. HSA. But due to problems arising from blood borne pathogens 
such as prionic agents, bovine and human Serum Albumins are not the excipients of 
choice anymore. Also compared to recombinant HSA non-ionic surfactants are a 
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safer alternative as HSA may lead to immunogenic reactions (Braun et al. 1997) 
Polyethylene glycol (PEG) is used to precipitate or crystallize proteins (Prestrelski 
et al. 1993; Izutsu et al. 1995; Alden and Magnusson 1997). The phenomenon of 
precipitation of proteins in the presence of PEGs may be explained with the 
preferential hydration of PEGs (Timasheff 1992) or by the coverage of hydrophobic 
surfaces, but the problem finally remains not completely solved.  
 
1.2.2. Surface Active Agents (Surfactants) in Parenteral Formulations of 
Protein Pharmaceuticals: 
 
Surfactants are commonly used in pharmaceutical protein formulations to compete 
for interfaces that might cause unfolding and aggregation of the API. These interfaces 
are mostly between the aqueous protein solution on the one side and on the other 
side container walls, stoppers (coated and uncoated), the ice-crystals (during 
freezing in lyophilization processes or while storing), filter materials, tubes and 
coatings of e.g. pumps, and of course mostly the air-water interface. Especially when 
these interfaces are rapidly changing, e.g. due to shaking and stirring, surfactants 
showed their stabilizing abilities (Mahler et al. 2005). In 16 out of 23 approved 
monoclonal antibody formulations in 2006 surfactants are added as excipients (Wang 
et al. 2006). In most cases polysorbates and poloxamers are the excipients of choice. 
The concentration range of the applied surfactants is usually between 0.01 and 3 
mg/ml (Hawe et al.). Monoclonal antibodies are not the only proteins that can be 
stabilized by the addition of surfactants. The application of non-ionic surfactants is 
found ubiquitary in protein formulations and well described in literature. Enzymes and 
cytokines (Chang et al. 1996b), vaccines (Lang et al. 2007), fusion proteins (Chou et 
al. 2005), etc. can be stabilized with the addition of surface active substances. 
 
1.2.2.1. Physicochemical Aspects of Surfactants in Protein 
Formulations: 
 
There are several theories concerning the stabilizing effect of non-ionic surfactants in 
protein formulations. Postulated theories are surface competition on the one hand. 
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On the other hand stabilization of the native state due to preferential exclusion, 
formation of mixed micelles with native structured protein, as well as direct 
interactions with hydrophobic amino acids on the surface of the proteins are named 
as stabilizing mechanisms (Chang et al. 1996b; Bam et al. 1998). Surfactants are 
even proposed to act as artificial chaperones and to help to refold proteins that are 
already denatured (Bam et al. 1996). For some proteins complexes between 
hydrophobic cavities and the alkyl chains of the surfactants should be formed that are 
even more stable than the native protein (Giancola et al. 1997). Furthermore, it is 
described that with the use of higher molecular weight surfactants like poloxamers 
additional thermal stability is achieved by increasing the viscosity and hence 
molecular flexibility of the protein. The addition of 10 % poloxamer stabilized urease 
and IL-2 against shaking. This is way more than good applicable. The authors 
describe the stabilizing mechanism to increasing of the viscosity of the system (Wang 
and Johnston 1993). Preferential exclusion has also been discussed as potential 
mode of stabilization (Randolph and Jones 2002). But systems that show preferential 
exclusion typically increase the surface tension and especially for some proteins 
even preferential interaction demonstrated, e.g. fusion proteins and membrane 
proteins (Sukow et al. 1980; Takakuwa et al. 1999; Chou et al. 2005; Garidel et al. 
2009). The theories of surface competition and the surfactant-protein interaction are 
further explained below. 
 
1.2.2.2. Surface competition 
 
Proteins as well as surfactants are surface active. The drawback of proteins in the 
presence of hydrophobic interfaces is their tendency to expose hydrophobic parts to 
this side through unfolding (Chang et al. 1996b; Baszkin et al. 2001; Kiese et al. 
2008; McAuley et al. 2009). Nonionic surfactants have a higher surface pressure and 
are thus able to reduce the contact time of proteins to interfaces. Different 
approaches have been utilized to prove this competition directly, e.g. overflowing 
cylinder method (Eastoe and Dalton 2000; Bain 2008), atomic force microscopy 
(Mackie et al. 2001; Gunning et al. 2004; Woodward et al. 2009), equilibrium surface 
tension measurements or rheology measurements in a Langmuir trough (Pearson 
and Alexander 1968; Wu et al. 2006) or surface tension measurements using a 
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pressure-controlled pendant-drop surface balance (Wege et al. 2004). The 
mechanism is not always proposed to be the same. Some authors add direct 
interaction through charge changes, when ionic surfactants are applied to the 
interaction mechanisms. But the generally published opinion on the interfacial 
interaction is that the stronger surface active surfactant molecules displace protein 
molecules from the air-water interface (Wilde et al. 2002). 
In many studies the impact of surfactants on aggregation of pharmaceutical proteins 
has been discussed. HGH stressed by agitation, which creates an artificial increase 
and renewal of the air-water interface, could be stabilized by surfactants (Katakam et 
al. 1995; Katakam and Banga 1997; Maa and Hsu 1997; Bam et al. 1998). Other 
examples include the stabilization of Interleukin 2 by polysorbates during shaking 
(Wang et al. 2008) Monoclonal antibodies are stabilized by surfactants (Levine et al. 
1991; Mahler et al. 2005; Mahler et al. 2009) and stabilization of recombinant human 
Factor XIII is by the addition of PS 20 (Kreilgaard et al. 1998). Charman et al. used 
different approaches to induce unfolding (Charman et al. 1993). In all cases PS 20 
acted as a moderate to strong stabilizer. 
Further interfacial stress methods are related to the solid state. Repetitive freezing 
and thawing as a method of stress testing was published already in 1961 in a short 
Nature article on the stability of catalase (Shikama and Yamazaki 1961). During 
spray-drying interfaces change dramatically and here, too, surfactants proved their 
stabilizing ability at the interface. E.g. Maa et al. spray-dried hGH with and without 
surfactant (Maa et al. 1998). The amount of insoluble aggregates is dramatically 
decreased from 30 % to <1 % after the addition of 0.05 % PS 20. 
 
 
1.2.2.3. Molecular interactions between proteins and surfactants 
 
The most prominent interaction between proteins and surfactants is possibly the 
application of sodium dodecyl sulphate as denaturant in electrophoresis. In the SDS-
PAGE sodium dodecyl sulphate is applied to completely unfold the protein. In this 
case the charged hydrophilic head of the surfactant is attached at first to the 
positively charged amino acids and then to the protein peptide backbone. This leads 
to a complete linearization of the protein. In a polyacrylamid gel this protein-
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surfactant complexes can be separated by size as the net charge is mainly size 
dependent (Shapiro et al. 1967). With this technique separation of proteins only 
depending on the molecular weight of the protein is possible. Understandably this 
interaction has nothing to do with protein stabilization. 
Furthermore, in structural analysis of proteins, detergents form mixed micelles 
together with membrane proteins. In this application the surfactants act as membrane 
replacement (Prive 2007; Lopez et al. 2009). At first the original cell membrane is 
disrupted by the addition of surfactants and mixed micelles result. After dialysis 
against surfactant solutions the phospholipids will be removed stepwise and the 
proteins are stabilized only due to the presence of surfactant micelles. 
Another aspect of direct protein surfactant interaction is the fact that proteins which 
are present in the molten globule or unfolded state can be refolded easier when 
surfactants are added to the solution. In literature this mechanism is described for 
hGH and non-ionic surfactants (Bam et al. 1996; Bhattacharyya and Das 1999) 
whereas ionic surfactants would not assist refolding in the case of rhodanese 
(Tandon and Horowitz 1987). The terminology for substances that show this 
behaviour is artificial chaperone. Bam et al. found a ratio of less than 4 molecules 
polysorbate per molecule human Growth hormone as the best stabilizing ratio for 
protection against unfolding after interfacial stress. They explained this by coverage 
of the hydrophobic patches on the protein‟s surface by the surfactant‟s fatty acid 
chains (Bam et al. 1995; Bam et al. 1998) and hence a site specific interaction 
between the protein molecule and surfactant molecules. 
  
1.2.2.4. Surfactants in pharmaceutical products 
 
In  
Table 1 a selected list of marketed formulations is given. The most frequently used 
surfactants are Polsorbate 20, Polysorbate 80 and Poloxamer 188 in a concentration 
range between 0.001% and 0.1%.  
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Product name API Manufacturer Surfactant Concentration 
Aranesp Darbepoetin 
alpha 
Amgen PS 80 0.005 
Gonal-f Follitropin 
alpha 
EMD Serono Poloxamer 188 0.01% 
Herceptin Trastazumab Genentech PS 20 0.06% 
Humira Adalimumab Abbott PS 80 0.1% 
Lantus Insulin glargin Sanofi-Aventis PS 20 0.02% 
Lucentis Ranibizumab Genentech PS 20 0.01% 
Mircera Methoxy-PEG-
Epoetin beta 
Roche Poloxamer 188 0.01% 
Neulasta PEG-
Filgastrim 
Amgen PS 20 0.0012% 
Norditropin Somatropin NovoNordisk Poloxamer 188 0.03% 
Nutropin Somatropin Genentech PS 20 0.02 
Raptiva Efalizumab Genentech PS 20 0.16% 
Rebif Interferon beta EMD Serono Poloxamer 188 0.012% 
Reopro Abciximab Eli Lilly PS 80 0.001% 
Rituxan Rituximab Genentech PS 80 0.07 
 
Table 1: List of selected pharmaceutical drug products and their surfactant 
content [respective full prescribing information] 
 
1.2.2.5. Problems with Surfactants in Protein Formulation 
 
The number of approved surfactants in pharmaceutical formulations is limited. Most 
of the substances are non-ionic as their haemolytic activity is lower and cell rupture is 
less likely compared to ionic surfactants (Bonsall and Hunt 1971). Typically these 
non-ionic surfactants are based on PEG as their hydrophilic moiety. Autoxidation of 
the PEG residues is described for PS 20, PS 40 and PS 60 from Donbrow et al. 
(Donbrow et al. 1978) and similarly for PS 80 (Ha et al. 2002). Wang et al. also 
demonstrated a consequently negative impact on protein stability. Sorensen et al. 
mention that this problem generally occurs in biotechnology and bioanalytics (Jaeger 
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et al. 1994). They observed autoxidation in PS 20 and Triton-X (Jaeger et al. 1994). 
Ashani et al. found peroxide equivalents in Brij-35 and Triton-X (Ashani and Catravas 
1980).  
Apparently, this has also implication on protein stability and protein formulation. 
Recombinant human ciliary neurotrophic factor and recombinant human nerve 
growth factor are oxidized to a higher extend in the presence of PS 80 (Knepp et al. 
1996). Recombinant human Granulocyte Colony Stimulating Factor is formulated 
with a very small content of PS 80 due to oxidation problems (Herman et al. 1996). 
Furthermore, it could be demonstrated that the occurrence of peroxide equivalents 
from the manufacturing process is related to a reduced long term stability of a 
monoclonal antibody and human protein relaxin (Nguyen et al. 1993; Lam et al. 
1997). This effect is enhanced when protein formulations are stored at elevated 
temperatures.  
For polysorbates autoxidation may additionally cause stronger hemolysis (Azaz et al. 
1981). Additionally, some of the approved surfactants products are also attributed to 
show severe side effects like anaphylaxis, though in very low odd ratios (Attwood 
1983). 
Consequently the term “dual effects” of surfactants on protein stability is stressed by 
a number of authors. The positive effect at the interfaces is accompanied by the 
slightly negative effects during storage. Suppliers of surfactants for protein 
formulation consequently offer special low oxidizing products purified by 
chromatography. But as the occurrence of H2O2 equivalents is autologous one 
cannot completely suppress this phenomenon.  
1.2.2.6. Approaches to Understand Interaction of Proteins and 
Surfactants  
 
In order to understand the interaction between surfactants and proteins different 
analytical techniques can be applied. The three methods that were mainly utilized in 
this thesis are isotheral titration calorimetry (ITC), Two-Dimensional Nuclear Magnetic 
Resonance Spectroscopy (2D-NMR) and Flourescence Correlation Spectroscopy 
(FCS). These methods will be introduced in their respective chapters.  
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1.2.2.6.1. Isothermal Titration Calorimetry 
 
ITC is one of the major tools for the determination of thermodynamics in protein 
science (Liang 2008). Especially protein binding energetics can be estimated using 
this technique (Leavitt and Freire 2001). An ITC machine in general is a 
microcalorimeter with an attached syringe that is capable of titrating small amounts of 
e.g. ligands into a sample cell. A general set-up is depicted in Figure 3. The sample 
cell contains the solution of interest and is attached to a syringe. The reference cell 
usually contains water or buffer. 
 
 
Figure 3: Sketch of a microcalorimeter set-up for ITC 
 
The main outcome of ITC-measurements is a binding isotherm depending on the 
amount of injected substance. Furthermore, ITC provides information on free energy 
of binding, enthalpy of binding and the heat capacity change in one single 
experiment. By testing at different temperatures the entropy of binding can be 
determined, too (Simon et al. 2002). Unfortunately evaluating binding isotherms in a 
single experiment is only feasible when strong interactions occur or when 
concentrations are extremely high (Chou et al. 2005). A good example for strong 
protein-surfactant interactions is the lysozyme-sodium dodecylsulfonate (SDS)-
system where the anionic surfactants binds to the lysyl, histidyl, and arginyl amino 
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acid side chains and hence starts to unfold the protein to open more binding spots. In 
contrast for non-ionic surfactants the binding sites will be hydrophobic patches on the 
protein surface and no further binding occurs after these are saturated (Jones 1992). 
The interaction of SDS with proteins is probably the best studied and understood 
system and massively described in literature (Laemmli 1970; Hicks et al. 1992; 
Horowitz and Hua 1995; Keire and Fletcher 1996; D'Auria et al. 1997; Giancola et al. 
1997; Gao and Wong 1998; Bhattacharyya and Das 1999; Nielsen et al. 2000; 
Hillgren et al. 2002; Levin et al. 2005; Nielsen et al. 2005a; Nielsen et al. 2005b; 
Bagger et al. 2007a; Nielsen et al. 2007a; Nielsen et al. 2007b; Andersen Kell et al. 
2008; Otzen et al. 2008; Andersen Kell et al. 2009). Unfortunately, these interactions 
are not transferable into pharmaceutical formulation work, as SDS is too membrane 
solubilizing and hence hemolytic (Schott 1973; Lopez et al. 1998). Also the critical 
micelle concentration of pharmaceutically applied surfactants differ greatly from that 
of SDS. Hence, completely different amounts of monomeric surfactant interact with 
the protein in a completely different fashion and as the CMCs of the applied 
surfactants are much lower, a weaker interaction due to the pure lack of monomers 
will be detected.  
To determine weak interactions between surfactants and proteins other approaches 
have be used (according to the publication by Otzen et al. (Andersen Kell et al. 
2008)). By choosing two specific areas in the thermogram and by determining their 
shift towards higher concentrations binding stoichiometry can be calculated. If the x-
axis of these thermograms is displayed in a protein to surfactant ratio all peaks 
should be similar in its maximum if there is some kind of specific binding area on the 
protein. Another way of displaying the data is putting only the surfactant 
concentration on the x-axis to prove purely surfactant-related events in a protein 
environment (Nielsen et al. 2005a). This way all graphs should show a similar shape 
with binding enthalpies and onset of micellization proportionally increasing to protein 
concentration (Andersen Kell et al. 2008). The interaction between pharmaceutical 
nonionic surfactants and nonspecific binding proteins is rather weak. In comparison, 
the binding of an antibody to its antigen reveals two magnitudes higher enthalpies 
(Pierce et al. 1999). Theories whether surfactants act as artificial chaperones also 
exist for the system rhodanese and insulin with Brij 35 (Bhattacharyya and Das 1999) 
or hGH and polysorbate (Bam et al. 1996). But for an active folding process, the 
 17 
 
measured enthalpies by ITC seem very low. Contrary to this theory is the often found 
result of strong entropic driven reactions. But chaperones and their backfolding 
should reduce and not increase the entropy of a system as a higher ordered state will 
be achieved through this repair mechanism. 
 
1.2.2.6.2. Two-dimensional NMR spectroscopy 
 
Another way of probing the molecular interactions between proteins and surfactants 
is Nuclear Magnetic Resonance (NMR) spectroscopy. For example Ulvenlund et al. 
(Sjoegren et al. 2005) investigated the interactions between polypeptides and 
alkylglycosides. They applied 2D-NMR spectroscopy to prove the interaction of 
oligopeptides comprising only one or very few different amino acids. With the help of 
two dimensional Nuclear Overhauser Effect spectroscopy (NOESY) cross-peaks 
arising from spins that are spatially close can be seen, but the signals must not be 
coupled via molecular bonds like in correlated NMR spectroscopy. Furthermore, it is 
possible to suppress such signals to be sure that no spatially close scalar (from the 
same molecule) signals disturb the NOESY cross-peak (Gawrisch et al. 2002). For 
NOE the average maximum distance between two spins is about 5.5 Å as the cross-
relaxation signal intensity is dependent by the power of 6 to the distance between the 
coupled spin signals (Gawrisch et al. 2002). Matilainen et al. (Matilainen et al. 2008) 
used NOESY to determine the interaction between cyclodextrins and glucagon. 
Nakanishi et al. studied the same excipients in combination with the Alzheimer‟s 
disease related β-amiloid (Qin et al. 2002). Both groups found that the hydrophobic 
amino acids were packed into the cavity of the cyclic oligosaccharides. Wong et al. 
(Wymore and Wong 1999) applied To our knowledge the interaction between 
pharmaceutically applied proteins and surfactants has not yet been studied by 
NOESY. 
 
1.2.2.6.3. Fluorescence Correlation Spectroscopy 
 
Fluorescence Correlation Spectroscopy (FCS) is a technique firstly described by 
Magde et al. in 1972 (Magde et al. 1972). As a proof of principle they determined the 
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binding constant of ethidium bromide to DNA strands (Elson and Magde 1974; 
Magde et al. 1974). With the technical development of FCS single molecule tracking 
was possible due to the invention of confocal fluorescent microscopes and hence 
smaller detection volumes (Krichevsky and Bonnet 2002). 
Further inventions led to scanning FCS systems, where the focus of the microscope 
moves through the sample cell (Figure 4) to increase the chances of detecting larger 
protein aggregates with diffusion times that would not be detectable with the regular 
apparatus. This method is called scanning for intensively fluorescent targets or SIFT 
(Giese et al. 2005; Levin et al. 2005). In the SIFT set-up following excitation with two 
different laser lines, two different fluorophores („„green‟‟and „„red‟‟) can be analyzed 
simultaneously in the same focal volume in a confocal setup with single molecule 
sensitivity. The laser focus is moved through the sample by an optical scanning unit. 
Whenever an aggregate carrying multiple fluorescent labels passes the focus this 
results in a short burst of high fluorescence intensity. Individual aggregates pass the 
focus at different points in time and can be analysed in regard to labelling ratio. Today 
FCS is also heavily used in lead optimization as a convenient tool for high-throughput 
screening (Auer et al. 1998) and is also applicable in living cells (Bacia et al. 2006). 
 
 
Figure 4: Principle of aggregation analysis by dual-colour SIFT (from Giese, 
Bader et al. 2005) 
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The interaction of proteins with micelles should be investigated using FCS by 
determining diffusion rates and calculating theoretical particle sizes. For this purpose 
typically fluorescent labeling of the protein is required which raises the functional 
question of potential effects of the label itself in the protein properties. To determine 
the diffusion rates of monomers and bigger oligomers in parallel a labeling degree of 
1:1 was desired. This allows the fluorescence detector to find as bright particles (in 
this case large aggregates) as possible without being overloaded. Further sample 
properties like counts per particle (cpp) describing the brightness of the fluorescent 
conjugate and the total intensity of the sample could be determined. The cpp would 
represent the brightness of a fluorescent labeled protein. The inclusion complex of 
one or more protein molecules in a micellar “carrier” could result in an increased 
diffusion time detected in the focus of the apparatus. The big advantage of FCS over 
Photon Correlation Spectroscopy (PCS) is its lower detection limit and the smaller 
sample volume required for measurements. In theory a sample volume of a few fl=10-
15l would be sufficient for measurement (Krichevsky and Bonnet 2002). As the 
resulting signal fluctuation is derived from Rayleigh scattering the signal intensity of  
PCS is strongly dependent on the particle radius as described in equation 1: 
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where I is the signal intensity with the wavelength λ, I0 is the intensity of the laser 
source, θ is the angle of the scattered light, R is the distance from the particle, n is 
the refractive index of the particle, and d/2 is the particle radius. Hence the presence 
of big aggregates will suppress signals from smaller particles by sheer intensity (for 
further details see (Gun'ko et al. 2003)). This dependence is not as strong for FCS as 
the received signal is derived from the presence time in the focus. A bigger particle in 
the focus is not necessarily brighter as the amount of labeled protein is only a 0.1 %. 
So the possibility of aggregate formation with not labeled proteins is higher than with 
labeled ones. 
With the help of different lasers and different fluorescent dyes it is furthermore 
possible to distinguish between different species and types of interactions in solution 
(Bieschke et al. 2000). In case of lipid bilayers the interaction between proteins and 
surface active substances could already be demonstrated (Takakuwa et al. 1999). 
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Chattopadhyay et al. used a similar experimental set-up to investigate the addition of 
the amino acid arginine in formulations on protein stability (Ghosh et al. 2009). For 
micellar systems in a pharmaceutical environment the interaction has not yet be 
determined. 
 
1.2.2.6.4. Electron Paramagnetic Resonance Spectroscopy 
 
Electron paramagnetic resonance is a nondestructive experiment where the 
surfactant micelles are spiked with a spin label. The spectroscope reveals the ratio of 
hindered to freely rotating label and gives a statement on the monomeric amount of 
label in the sample. From the calculation of free micelles, free surfactant molecules 
and the protein concentrations, binding numbers can be extrapolated. Sukow et al. 
found out that Triton X in higher concentrations leads to higher binding numbers and 
correlated this with conformational changes of the protein (Sukow et al. 1980). 
Randolph et al. tried to calculate binding numbers of Brij and Tween to the proteins 
hGH and interferon gamma. (Bam et al. 1995). The drawback of this method is the 
spin labeling that might interfere with the formation of micelles and alter the 
experimental environment. 
 
1.2.2.6.5. Viscometry 
 
The surface behavior of surfactant films or protein films that are spiked with 
surfactants can be studied using viscosity measurements. Pearson et al. in 1968 
used a system of surface tension, surface viscometry and surface potential to 
determine the partitioning of different proteins in cationic surfactant films (Pearson 
1968). This experiment gives insight into the interfacial behavior of proteins and their 
competition for interfaces with surfactants. McAuley et al. used interfacial rheometry 
by means of an oscillating de Nouy ring (Pearson 1968; McAuley et al. 2009). 
Different ratios of protein to surfactant are equilibrated and shear elasticity module as 
well as shear viscosity are tested. After viscoelastic protein films were formed or if the 
surfactants showed higher surface pressure no film would be formed. This 
experiment can only be performed once, as due to the shear stress, the films will be 
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destroyed. This explains the drawback of this experimental set-up. It only gives 
insight into static systems, where the protein and the surfactant form films at an air-
water or oil-water interface. In reality the partition of proteins and surfactants during 
shaking and generation of new interfaces is of interest and molecular size may have 
more impact in dynamic systems.  
To overcome the problem of static systems, an overflowing cylinder (OFC) can be 
used. Unfortunately up to today this has not been applied in a pharmaceutical 
relevant system (Van Kalsbeek and Prins 1999; Eastoe and Dalton 2000; Bain 2008). 
A resistance plate and flow straightener generate plug flow beneath the free surface 
of the OFC so that it overflows uniformly on all sides. The outcome of the 
measurement is the difference between flow velocities at the surface and within the 
liquid stream. The rate of expansion of the surface and thus the interfacial flow rate is 
characterized by the help of dynamic surface tension measurements with a Wilhelmy 
plate or by ellipsometry (Manning-Benson et al. 1997). The dynamic surface tension 
is only dependent on surface activity and neither on the flow rate over the cylinder, 
nor on instrumental parameters.  
 
1.2.2.6.6. Small angle X-ray scattering 
 
Small angle X-ray scattering can give insight into the three dimensional structure of 
proteins and surfactant micelles. When a binding number is already calculated the 
shape of the protein-surfactant complex can be deriven from the data. This 
experimental set-up is yet only been used for model systems. But Otzen et al. could 
show the pathway of denaturation of bovine acyl-coenzyme-A-binding protein by 
SDS over several unfolded states and different kind of micelles, respectively. A 
similar mechanism could be proven for Humicola insolens Cutinase by Westh et al. 
(Nielsen et al. 2005b; Andersen Kell et al. 2009). 
 
1.2.2.6.7. Surface tension measurements 
 
Similar to surface viscometry, surface tension measurements in a classical Wilhemy 
set-up can give insight into the partitioning of surfactants into protein films and vice 
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versa. It is typically utilized in a static mode (Zourab et al. 1983; Wu et al. 2006; 
McAuley et al. 2009). Dynamic approaches are the use of a Langmuir trough or the 
use of thin-film balances (see Figure 5) (Bergeron et al. 1996; Sedev et al. 1999).  
 
 
Figure 5: Schematic picture of a thin film balance from (Bergeron et al. 1996) 
 
Another way of performing dynamic surface tension measurements is the 
(axisymmetric) drop shape analysis (Hansen and Rødsrud 1991; Chen et al. 1998). 
Maximum bubble pressure has also been tested to analyze the interaction between 
proteins and surfactants (Fainerman and Miller 1998). All these techniques require 
optical analysis of the formulations. With the help of these methods dilatational 
surface phenomena can be studied comparable to the overflowing cylinder. 
 
1.2.2.6.8. Atomic force microscopy 
 
Atomic force microscopy presents another tool to study protein surfactant 
interactions. The elasticity of films and foams can be determined with the help of 
highly sensitive cantilevers. Woodward et al. determined the displacement of milk 
proteins from surface by the addition of nonionic surfactants (Woodward et al. 2009). 
Furthermore, Wilde et al. found out that the displacement of proteins by surfactants in 
foams is strongly dependent on the charge of the polar headgroups of the surfactants 
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(Wilde et al. 2002). The additional information of atomic force microscopy is the 
image of the film with a high resolution. Surface pressure and surface tension can 
also be studied comparable to a de Nouy Ring for the air-water interface as well as 
for liquid-liquid interfaces (Goddard 2002). 
 
1.2.2.6.9. Equilibrium Dialysis 
 
The experimental set-up for equilibrium dialysis is rather simple. Protein and 
surfactant are placed in a donator separated from the acceptor by a semipermeable 
membrane with a molecular weight cut-off smaller than the proteins molecular weight. 
After incubating for longer time periods the surfactant concentration is quantified for 
the dialysate as well as for the protein side. Binding numbers can be calculated from 
the amount of protein in the cell and the surplus of surfactant in the protein solution. 
Sukow performed studies on the binding of the nonionic surfactant Triton X to rabbit 
and bovine serum albumin (Sukow et al. 1980; Sukow and Bailey 1981). Two 
important drawbacks of this method are that it is very time consuming and that the 
dialysis membrane might hamper big surfactant associates from migrating to the 
buffer side. Furthermore, during the long time period instability of the protein may 
substantiate. 
 
1.2.2.6.10. Flourescence Spectroscopy 
 
Fluorescence spectroscopy has been used in different ways to determine protein-
surfactant interactions. One approach is to measure the quenching of the intrinsic 
fluorescence of the proteins‟ aromatic amino acids. Unfortunately the sensitivity of 
this method is not very high and only limited statements on mechanisms can be 
made (Hillgren et al. 2002; Nielsen et al. 2005a). An advantage of this method that it 
enables to study kinetics using high throughput machines (Andersen Kell et al. 2009). 
Total internal reflection fluorescence is utilized when adsorption phenomena take 
place. As for example human Growth hormone is adsorbed on different surfaces 
(Buijs et al. 1998). The removal of fluorescent dyes like nile red or Bis-ANS from 
hydrophobic patches of the protein‟s surface can also be studied (Bam et al. 1996). 
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The dyes could also be used as markers for unfolding due to the addition of 
surfactants (Hawe et al.). The addition of pyrene to protein solutions was used to 
determine shifts in CMC and hence binding numbers by Westh et al. (Andersen Kell 
et al. 2008). 
The drawback of all extrinsic set-ups is the addition of a very hydrophobic substance 
to the sample environment and hence an alteration of the system (Hawe et al.).  
 
1.2.2.6.11. Other 
 
There are further methods in biophysics and biochemistry that could possibly be 
applied on pharmaceutical protein surfactant systems like Pulsed-field-gradient spin-
echo (PGSE)-NMR (Hillgren et al. 2002), 1H-NMR together with 13C-NMR (Gawrisch 
et al. 2002), Brewster angle microscopy (Mackie et al. 2001) surface plasmon 
resonance spectroscopy, mass spectrometry, dynamic scanning calorimetry although 
often discussed as tricky (Katakam et al. 1995; D'Auria et al. 1997), optical 
reflectrometry (Sun and Tilton 2001), and 14C in situ radio tracing (Baszkin et al. 
2001) that are not explained in deeper detail. 
1.3. Objective of this thesis 
 
Surfactants are the excipients of choice to reduce interface induced stress to 
pharmaceutical proteins. The PEG based surfactants that are approved today pose a 
problem due to their oxidizing behavior. One objective is to test new excipients that 
are comparable to the gold standard polysorbate. The surfactants should be 
comparable with respect to lowering of the surface tension, CMC in absolute and/or 
molar ratios, hemolytic activity, solubility, and other general physico-chemical 
properties. On the other hand they should show some advantages over the 
polysorbates:  
No PEG residue or other oxidation related moieties 
Higher purity to assure better batch to batch reproducibility 
Easy and cheap to synthesize 
If possible, derived purely from renewable resourc 
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Most important, the alternative surfactants have to provide protein stabilization 
properties similar or better than the polysorbates. Different stress methods are 
applied to different pharmaceutical proteins and the extent of aggregation and 
oxidation is studied. 
 
As stated in the introductory part it is still unclear by which mechanism surfactants 
are able to stabilize protein pharmaceuticals. Henc the interaction on a molecular 
level is studied in cooperation with partners via with Isothermal Titration Calorimetry 
(ITC), Nuclear Overhausen Enhancement Magnetic Resonance Spectroscopy 
(NOESY) and two dimensional Fluorescence Correlation Spectroscopy (2D-FCS).  
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2. Physicochemical characterization of 
technical mixtures of sugar based 
surfactants 
 
2.1. Introduction 
 
Surfactants can be classified into four groups based upon the charge of the polar 
headgroup of the surfactants ( 
Table 2). First scientific classifications were offered by Bancroft et al. almost 100 
years ago (Bancroft 1912). One may also group surfactants by their hydrophilic-
lipophilic balance value (HLB-value). This classification is still in use for now more 
than 50 years (Griffin 1949), although not completely accurate (Pasquali et al. 2008). 
Furthermore surfactants can be classified by their tendency to form either W/O or 
O/W emulsions (hence W/O or O/W-emulsifier).  
 
Class of surfactant Examples 
Cationic surfactants Quats 
Anionic surfactants SDS, SLS 
Zwitterionic surfactants Phosphatidylcholine 
Nonionic surfactants Polysorbates, PEG fatty acid esters 
 
Table 2: Surfactant classification by charge of the polar headgroup 
 
Cationic surfactants are widely used as cleansing vehicles in the petrochemical 
industry or as preservatives (Attwood 1983; von Rybinski and Hill 1998). Anionic 
surfactants are commonly used in biochemistry and their most prominent example is 
sodium dodecyl sulphate (SDS), ubiquitarily used in gel electrophoresis (Shapiro et 
al. 1967). In some cases anionic surfactants are used in semisolid or liquid oral 
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formulations. Zwitterionic surfactants could theoretically be used in protein 
formulation although their surface activities are rather low compared to nonionic 
surfactants. But usually they are applied in pharmaceutical industry in early 
formulation for solubilization of poorly soluble drugs. Zwitterionic surfactants can be 
used as transport vesicles e.g. liposomes as they tend to form bigger associates 
(Schurtenberger et al. 1985). In pharmaceutical industry probably the main 
application of charged surfactants can be found in topical formulations such as 
creams or ointments as classical emulsifiers.  
In this work all tested substances belong to the class of nonionic surfactants. 
Although not charged, the HLB values of these substances are also rather high as 
complete water solubility is mandatory for later use in aqueous parenteral solutions. 
Nonionic surfactants usually show a low critical micelle concentration (CMC) in water, 
as their tendency for self-association is high. This is commonly explained by the lack 
of shielding charges around the nonpolar parts of the molecule and the resulting low 
solubility in water (Rulison 1995; Patist et al. 2000).  
 
 
Figure 6: Effect of absolute surfactant amount on physical state and viscosity 
of SLS and a mixture of alkylpolyglycosides in water (from (von Rybinski and 
Hill 1998)) L1 represents the simple micellar solution. At L1 Gel, the number of 
micelles is already high enough to increase viscosity.  
 
At lower concentration nonionic surfactants usually dissolve as monomers and 
dimers. At the CMC associates to larger spherical structures, in which the part of the 
molecules is placed on the outside that shows a similar polarity as the solvent. In our 
case it is the carbohydrate part that is directed to the aqueous environment. By 
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increasing the concentration surfactants molecules form rod-like micelles, hexagonal 
or cubic phases and finally lamellar liquid-crystalline phases depending on the 
substance (see Figure 6). Theoretically some nonionic surfactants would also be able 
to form inverse micelles in an oily environment, but this is not of relevance for this 
work. For protein formulations only the concentration range in which spherical 
micelles are formed, is of interest as higher concentrations of surfactant would lead 
to cell rupture and hence adverse side effects during application (Soderlind et al. 
2003).  
In contrast to the alterations of viscosity, the pronounced surface tension changes 
occur in the concentration range up to the CMC. Above the CMC the air liquid 
interface becomes fully occupied by surfactant molecules and the surface tension is 
not further decreased by the addition of more surfactant molecules (see Figure 7). By 
increasing the surfactant concentration the surface tension typically decreases in an 
inverse exponential fashion until the point of self association. 
 
 
Figure 7: Surface tension of different alkylpolyglycosides and mixtures with 
other surfactants (from (Rosen and Sulthana 2001)) 
 
In reality this holds only true for highly pure systems. If technical mixtures of 
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surfactants are used surface tension decreases similarly, but the CMC is not a sharp 
break, instead one finds a minimum in between the two (Patist et al. 2000). This 
alteration can be explained by the different chain lengths of the various molecules in 
a technical product. In the mixture, there is a greater variability in the attractive forces 
between the molecules and the first molecules that form micelles are the ones with 
the highest self attraction. Successive inclusion of the better soluble molecules leads 
to mixed micelles and a higher surface tension. This ratio than describes the constant 
surface tension segment (Figure 8). 
 
 
Figure 8: Surface tension of different purities of SDS (from (Krüss-GmbH 2003)) 
 
In this chapter different sugar based surfactants were studied and compared to 
polysorbates. These sugar based surfactants can contain a sugar moiety attached to 
a fatty alcohol (alkyl glycoside) or to a fatty acid (sugar ester). Different providers 
have these products in their portfolio. E.g., the Ryoto products for example can be 
obtained with different HLB values; adjusted values from 7 to 15 are on the market. 
These sucrose fatty acid esters are mainly added to food products. Cognis offers 
HPLC purified SDS 
(300m²/g octadecyl silica) 
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alkyl glycosides as different brands. The Plantacare products are mainly used as 
surfactant in cosmetic cleansing preparations as they form clear solutions and the 
Emulgade products as emulsifiers. NV-10 is a product from Expedeon. It is directly 
dedicated to stabilize proteins during the downstream process. In  
Table 3 properties, applications, and the ingredients as declared by the supplier are 
listed. 
 
Supplier Brand 
name 
Properties Typical 
application 
Declared 
components 
Ryoto 
(Syntapharm) 
S 1570 Water 
soluble 
HLB = 15 
Food industry  
(beverages) 
Sucrose fatty acid 
esters (mainly 
sucrose stearate) 
 P 1570 Water 
soluble 
HLB = 15 
Food industry  
(beverages) 
Sucrose fatty acid 
esters (mainly 
sucrose palmitate) 
 S 1170 Water 
soluble 
HLB = 11 
Food industry 
(ice cream) 
Sucrose fatty acid 
esters (mainly 
sucrose stearate) 
 S 770 Water 
soluble 
HLB = 7 
Food industry Sucrose fatty acid 
esters (mainly 
sucrose stearate) 
 Monoester 
P 
Water 
soluble  
HLB 15-16 
Pharmaceutical 
Industry 
Sucrose fatty acid 
esters (> 70% 
sucrose palmitate) 
Dai-Ichy Kogyo 
Seiyaku 
(Sisterna) 
Sisterna 
Sucrose 
Esters 
Water 
soluble  
HLB ~ 16 
O/W emulsifier Sucrose fatty acid 
esters (mainly 
mono-esters) 
Cognis Plantacare 
2000 UP 
Water 
soluble 
Aqueous 
solutions in 
cosmetic industry 
Oligosaccharides 
attached to fatty 
alcohols 
 Plantacare 
818 UP 
Water 
soluble 
Aqueous 
solutions in 
cosmetic industry 
Oligosaccharides 
attached to fatty 
alcohols 
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 Plantacare 
1200 
Waxy 
flakes 
Emulsifier in 
pharmaceutical 
industry 
Oligosaccharides 
attached to fatty 
alcohols (lauryl 
glucoside) 
 Emulgade Waxy 
flakes 
Emulsifier in 
pharmaceutical 
industry 
Oligosaccharides 
attached to fatty 
alcohols 
Expedeon NV 10 Water 
soluble 
Protein stabilizer 
during 
downstream 
Oligosaccharides 
attached to 
hydrophobic 
residues 
 
Table 3: List of properties, applications, and ingredients as declared in the 
supplier’s documents for different sugar based surfactants 
 
All these substances were checked for their application in aqueous pharmaceutical 
protein formulation. Hence, the applied amounts are low, but should be solubility upt 
to 1% (m/V) has to be given. For the characterization of the different classes of 
substances the CMC was determined as well as their tendency to cause hemolysis in 
porcine erythrocytes. Some experiments were performed with more than one method 
as a proof of concept or to use an orthogonal method for CMC determination. In 
some instances additional information could be gained from these experiments (e.g. 
micelle size from PCS measurements). As some systems are not clearly chemically 
specified, we tried to elucidate the structure and composition of the materials and 
potential byproducts. Residual metal ions might catalyze chemical degradation 
(Stadtman 1993), other impurities might be hemolytic (Azaz et al. 1981), cause 
immunogenic reaction (Attwood 1983) and should be known before added to protein 
formulations for invasive application. Summarizing, the aim of this study was to 
determine, whether the new surfactants can be compared to polysorbates in terms of 
physical, chemical and biological properties, and whether the new surfactants will 
show advantages over the approved products in this regard. 
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2.2. Materials and Methods 
 
2.2.1 Materials 
 
Plantacare 818 UP (PC 818), Plantacare 2000 UP (PC 2000), Plantacare 1200 
(PC 1200) and Emulgade PL and Emulgade S were kindly donated from Cognis 
(Düsseldorf, Germany). Nvoy 10 (NV 10) was donated by Expedeon Protein 
Solutions (Cambridge, United Kingdom). Sisterna Sucrose Ester (Sisterna) was 
donated by Dai-Ichy Kogyo Seiyaku Co. (Kyoto, Japan). Furthermore Ryoto sugar 
esters were donated by Syntapharm (Mühlheim, Germany). The Ryoto products 
tested were: Monoester P (MP), Sugar Ester P1570 (P1570), Sugar Ester S1570 
(S1570), Sugar Ester S1170 (S1170) and Sugar Ester S770 (S770). Polysorbate 20 
(PS 20) and Polysorbate 80 (PS 80) were obtained from Merck chemicals 
(Darmstadt, Germany) and stored at 2-8 °C under nitrogen atmosphere until use. 
The water used in all experiments was deionized water from the university supply 
purified in a PURELAB Plus system (ELGA labwater, Celle, Germany) with a 
conductivity of <0.055 µS/cm.  
Acetonitrile was of HPLC grade (Merck chemicals, Darmstadt, Germany). The 
water/acetonitrile mixtures were degassed in an ultrasonic bath for 3 h at room 
temperature. The eluent was kept under stirring on a heating plate at 45 °C to 
prevent gas bubbles from entering into the system 
Pyrene was of synthesis grade (Merck chemicals, Darmstadt, Germany) and ethanol 
for dilution of technical grade (Sigma-Aldrich, Munich, Germany). Buffer salts and 
other reagents were of analytical grade or higher. 
 
2.2.2 Methods 
 
2.2.2.1 Solubility testing 
 
Surfactant solutions of 0.1% to 20% (m/V) were prepared. If instant dissolution 
occurred, the products were equilibrated for 24 h. If turbid systems resulted, the 
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product was equlibrated either in a water bath at 50 °C or in an ultrasonic bath at 
ambient temperature for 24 h. When visual solubility could not be achieved the 
system was claimed insoluble. Optically clear solutions were centrifuged at 10000 g 
for 10 min and checked for undissolveld material  
 
2.2.2.2 Tensiometry 
 
Surface tension was measured with a K100 MK2 tensiometer (Krüss, Hamburg, 
Germany) equipped with a F12 thermostat (Julabo, Ostfildern, Germany) and a 765 
Dosimat (Metrohm, Leinfelden-Echterdingen, Germany) using LabDesk 3.1 software 
(Krüss, Hamburg, Germany). As a reference purified water was analyzed 
(requirement: 72.0±0.1 mN/m ; n=3) before analysis of the surfactants. The Critical 
Micelle Concentration (CMC) was determined from sharp breaks in surface tension 
vs. logarithm of surfactant concentration plots. A custom-made glass vessel 
(dimensions are displayed in Figure 9) and a platinum iridium plate were used for all 
experiments. A total of 11 concentrations were tested for each surfactant. One 
measurement lasted at least 300 sec. Experiments (n = 3) were performed at 25 °C. 
All samples were left for 30 min for temperature equilibration before measurements. 
 
 
Figure 9: Dimensions of the custom-made glass vessel for CMC determination 
via surface tension measurement 
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2.2.2.3 Pyrene Interaction Fluorescence 
 
The interaction of the hydrophobic fluorescent dye pyrene (Figure 10) was used to 
determine the CMC of the surfactants alternatively to the surface tension 
measurements.  
 
 
Figure 10: Chemical structure of pyrene 
 
The fluorescence intensity of pyrene shows strong solvent dependency. In a polar 
environment such as the inner core of surfactant micelles the intensity of the 0-0 
vibronic band is significantly enhanced at the expense of other bands. The strong 
perturbation of the vibronic band intensities has been used as a probe to accurately 
determine CMCs (Kalyanasundaram and Thomas 1977).  
 
Figure 11: Pyrene monomer fluorescence in aqueous sodium lauryl sulphate 
solutions, at concentrations below (left) and above the CMC (right). 
 
Fluorescence spectra were recorded and the ratio I1/I3 was calculated, where I1 was 
the emission at 373 nm and I3 was the emission at 393 nm. Pyrene was excited at a 
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wavelength of 335 nm. Due to a change in polarity as the hydrophobic molecule 
pyrene is inserted into the hydrophobic alkyl residues in the inner core at the 
occurrence of micelles, the ratio becomes <1.  
Surfactant concentrations comprised the same range as used in surface tension 
measurements. Experiments were performed with a Cary Eclipse spectrofluorimeter 
(Varian, Palo Alto, USA). Pyrene was added at 200 mM as an ethanolic solution. 
10 µl of this solution was added to 1990 µl surfactant solution. 2 ml of the surfactant 
pyrene mixture were studied in quartz cuvettes with 1 cm pathway. Figure 11 shows 
the surfactant concentration dependent changes in the pyrene fluorescence. 
 
2.2.2.4 Hemolytic Activity 
 
Hemolytic activity was measured with porcine erythrocytes. Coagulation was 
prevented by adding 200 ml 3.8 % (m/V) trisodium citrate buffer pH 7.4 to 800 ml 
fresh blood. Erythrocytes were washed six times with citrate buffer and centrifuged at 
3.500 g and 5 °C for 45 min. Different surfactant concentrations (in the same citrate 
buffer as used for purification) were added to the porcine erythrocytes suspension at 
a 1:5 ratio. After incubation for 1 hour at 37 °C under gentle shaking samples were 
centrifuged (3.500 g for 15 min). The supernatant was tested for free hemoglobin at 
A = 415 nm using an UV 8453 UV-spectrometer and UV-Visible ChemStation 
software (Agilent, Santa Clara, USA). Each experiment was performed with n=5. 
100 % hemolysis was determined by diluting 10 µl erythrocytes in 990 µl Millipore 
water. By adding pure buffer to the erythrocyte suspension the basal hemolysis over 
the experimental time (0%) was tested. The degree of hemolysis produced by 
surfactants (%H) was calculated according to equation 2. 
100% 0 


totHb
HbHb
H              (2) 
Hb is the amount of hemoglobin found in the sample, Hb0 is the amount of basal 
hemoglobin found in the blank and Hbtot is the amount of hemoglobin after 100 % 
hemolysis, resp. their absorbance at 415 nm at 37 °C. Hemolytic activity (HC5%) was 
defined as the concentration at which at least 5 % hemoglobin was found in the 
supernatant (adapted from (Reinhart and Bauer 1995) and (Seyfert et al. 2002)). 
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2.2.2.5 Photon Correlation Spectroscopy (PCS) 
 
Size determination of micelles in 1 % surfactant solutions was performed on a 
Zetasizer nano ZS (Malvern Instruments, Herrenberg, Germany) considering the 
sample viscosity (2.2.2.6) with a 633 nm laser. The hydrodynamic diameter was 
calculated with DTS NANO v5.10 software (Malvern Instruments, Herrenberg, 
Germany). The sample, in single-use UV-plastic cuvettes (Brand GmbH and Co KG, 
Wertheim, Germany), was at first equilibrated for 1 min at 25 °C and subsequently 
the time scale of the scattered light intensity fluctuations of the sample was 
measured. Each sample was recorded in triplicate, each with 20 runs. The size was 
obtained using the cumulants analysis by fitting a single exponential to the correlation 
function in order to obtain the volume-weighted mean size. For CMC determination 
PCS was also applied. For these experiments, the autocorrelation function was 
observed. In the presence of micelles a fit could be applied. Lacking micelles the 
calculated size drops by at least one order of magnitude or increases substantially 
due to few dust particles as the system tries to fit the few obtained signals into a size 
distribution. Thus, with increasing concentration at the CMC a clear correlation could 
be fit the first time and the micelle size as well as the CMC can be detected. 
 
2.2.2.6 Viscometry 
 
As viscosity is a crucial parameter for PCS measurements the viscosity of the 
surfactant solutions was determined on an AMVn falling sphere viscometer (Anton 
Paar, Graz, Austria). 800 µl of a 1 % surfactant solution was filled in a 1.6 mm 
diameter tube and viscosity was recorded at 25 °C ± 0.1 °C. A 60° angle was applied 
and every solution viscosity was determined 10 times. 
 
2.2.2.7 Elemental Analysis 
 
For elemental analysis for carbon, nitrogen, hydrogen and sulfur by the central 
analytics group at the Department of Chemistry at the Ludwig-Maximilians-
Universität, Munich samples were cracked into an oxidized form (CO2, H2O, NO, 
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NO2, SO2, SO3 and N2) of the respective atom. The resulting gases were analyzed 
using a gas chromatograph and a Thermal Conductivity Detector. The applied system 
was a Vario EL elemental analyzer (Elementar Analysensysteme GmbH, Hanau, 
Germany).   
Additionally Inductive Coupled Plasma analytics were performed for the Plantacare 
products as the material data sheet provided the information that traces of 
magnesium might be present in the products. Analysis for sodium (Na), magnesium 
(Mg) and calcium (Ca) was conducted. 
 
2.2.2.8 Reversed-Phase High Performance Liquid Chromatography 
(RP-HPLC) 
 
For separation of the technical products and quantification of the ingredients, RP-
HPLC was performed with a Refractive-Index (RI) detector ERC-7515A (Erma CR. 
Inc. Kawaguchi City Japan) and an Evaporative Light Scattering detector (ELSD). 
Both were coupled to an 1100 Agilent HPLC system using a HP 3590E digital/analog 
converter (Agilent Technologies, Waldbronn, Germany). RP 8 and RP 18 columns 
were applied (Klaffke et al. 1998; Kuehn and Neubert 2004). The eluent was 
composed of 60 % (w/w) acetonitrile and 40 % (w/w) water. The flow was set to 
0.5 ml/min. 
 
2.2.2.9 Content of Peroxides 
 
H2O2 equivalents were tested with Merckoquant® peroxide test strips (Merck, 
Darmstadt, Germany) with levels of detection between 1 mg/ml and 100 mg/ml 
according to the user‟s manual. If the test strip limit of 100 mg/l hydrogen peroxide 
equivalents was exceeded the samples were diluted by factor 10 until the result was 
in the specification range. 
In additional experiments selected samples were placed in the Suntest CPS light 
stress testing machine (Heraeus, Hanau) at 54 W/m², xenon lamp, for 72 hours to 
compare artificially aged surfactant solutions. 
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Figure 12: Example photograph of peroxide test  
 
 
2.2.2.10 Mass spectrometry 
 
For mass spectrometry (MS) the central analytics group at the Department of 
Pharmacy at LMU ionization was achieved by electron spray ionization. Analysis was 
made in positive mode. The Q-TOF detector was coupled to an Agilent Liquid 
Chromatography (LC) system. Samples were prepared as 100 ppm solutions in 
methanol and not separated but injected via the LC system. As no internal standards 
were added to the samples all results are only of qualitative relevance. But as all 
nonionic surfactants are very similar in their ionization behavior (Kuehn and Neubert 
2004) this method can also provide useful semiquantitative information on these 
products. For the NV10 product additionally different ionization mechanisms were 
applied in the central analytics group of the Department of Chemistry at LMU. 
 
2.3. Results and Discussion 
  
The tested surfactants can be classified into four subgroups: 
 
Surfactants with solubility < 0.1% 
Surfactants with solubility < 1% 
Surfactants with solubility > 1% 
NVoy polymers (also with good water solubility) 
Below limit of detection 
> 10 mg/mL 
> 100 mg/mL 
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The workflow is visualized in Figure 13. The first one is listing the poorly water 
soluble surfactants that were not further tested as they tend to form aqueous slurries 
or gels that could not be diluted or dissolved by heat or incubation in an ultrasonic 
bath.  
To reduce unnecessary work for the analysis of these products, a workflow was used 
as described in Figure 13. Depending on the water solubility more and more 
experiments were performed to gain deeper knowledge of the physico-chemical 
behavior of these excipients. As stress testing of protein formulation is cost and work 
intensive only those excipients that show overall usefulness for potential application 
in parenteral formulation were included in the stress studies and the biophysical 
experiments. 
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Figure 13: Work flow for surfactant analytics 
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2.3.1 Poorly Soluble Surfactants 
 
2.3.1.1. Poorly Soluble Sugar Esters 
 
Although the supplier claimed good water solubility for his products with a HLB of 15 
(Ryoto 2007), most of the Ryoto sugar esters could not be dissolved adequately (see  
Table 4). This might be due to the higher amounts of long chain fatty acids (esters 
with the declared stearic acid), especially diesters in these products. 
 
Substance Solubility in water Suppliers technical data sheet 
S770 No No solubility in water/HLB 7 
S1170 No No solubility in water/HLB 11 
S1570 0.1% - 1% Soluble at 25 °C/HLB 15 
P1570 0.1% - 1% Partially soluble at 25 °C in water/fully 
soluble at 75 °C/HLB 15 
 
Table 4: Summary of aqueous solubility of different Ryoto sucrose fatty acid 
esters. 
 
P1570 and S1570 showed partial solubility in water. The remaining solid fraction is 
most probably composed of long fatty acid esters, di- or triesters with poor solubility 
(described e.g. by (Aveyard et al. 1998)). Upon heating or sonification, the 
substances could be turned into highly viscous gel like systems that were still 
separated from the water phase. Similar results were obtained with the Sisterna 
product. The Sugar Ester® (HLB 16 according to manufacturer information) was only 
partially soluble in water. Since its solubility is below 0.1 mg/ml it was not further 
tested. Although the product data sheet refers to sucrose palmitate as the main 
substance, mass spectrometry gives a hint that sucrose stearate might be the main 
substance (see Figure 14). The main peak has m/z of 626.1 (m+H2O
+ or m+NH4
+) 
and the second largest peak is at m/z 631.2 (m+Na+). The other large peaks 
represent sucrose palmitate with m/z 598.2 (m+H2O
+/ m+NH4
+) and m/z 603.1 
(m+Na+). In literature the peaks m+Na+, m+H2O
+ and m+NH4
+ are described to form 
during ionization of glycosides (Schneider et al. 1997; Cuyckens et al. 2001). 
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Furthermore, peaks of glucose stearate and palmitate (m/z 429.2 and 401.1 = m+H+), 
as well as diesters can be detected (m/z 864.3 mixed ester with palmitic and stearic 
acid and m/z 892.3 sucrose distearate).  
 
 
 
 
Figure 15: Mass spectrum of S770 
 
Figure 14: Mass spectrum of Sisterna Sugar Esters 
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Figure 16: Mass spectrum of S1170 
 
Figure 15 and 16 show the mass spectra of S770 and S1170. Both exhibit higher 
molecular weight species and in general a wide signal distribution indicating a very 
heterogeneous mixture. But the higher peak at a large molecular mass 1136 m/z 
occurs in the S770 sample, representing a possible sucrose triester. Whereas for 
S770 the larger peak is the sucrose stearate, for S1170 sucrose stearate is almost 
even to sucrose palmitate. Both spectra show similar relative intensities for the 
diester peaks (m/z 869 to 898). The higher amounts of triesters explain the lower 
HLB value as well as higher melting peaks (data not shown). 
Furthermore, mass spectra of S1570 (Figure 17) and P1570 (Figure 18) were 
recorded. Again similar peaks were found in the samples for P1570. The product 
mainly contains mono- and diesters of palmitic and stearic acid with glucose. 
Although S1570 and P1570 should just differ in their main distribution of fatty acids, 
one could detect that the S1570 is a product of different monoesters of higher fatty 
acids and has a completely different mass spectrum compared to P1570. From this 
one spectrum, structure and composition of the product can not be evaluated as 
some artefacts occur in the spectrum that can not be explained by simple rules of 
multiple esterfication, oligosaccharides or differences in fatty acid chain length. 
Probably due to free fatty acids in the mixture a m + H2O + 55 and a m + H2O + 72 
(additional hydroxilation) peak are detected, representing a cyclic fragment of a fatty 
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acid attached to the sugar fatty acid ester . 
  
Figure 17: Mass spectrum of S1570 
 
The spectrum of P1570 shows a main peak at m/z 603.5 and an additional large 
peak at 631.6. These are the m + Na+ of sucrose palmitate and stearate, respectively. 
Furthermore the signal at 898.1 is sucrose palmitate + Na+, whereas the signal at 
869.7 is a mixed diester of sucrose with palmitic and stearic acid. 
 
 
Figure 18: Mass spectrum of P1570  
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Some additional testing was performed with the supernatant of an 100 mg/ml 
dispersion after centrifugation. For S770 no adequate PCS correlation could be 
obtained. For the other products micelle sizes of 40-100 nm were detected ( 
Table 5).  
Compared to PS 20 and other nonionic surfactants (Al-Saden et al. 1982; Ericsson et 
al. 2004) the associates were substantially larger (see 3.2.2). This might be due to 
remainders of poorly water soluble components. As could be expected the viscosity 
of these supernatants was similar to the viscosity of water. The experimentally 
obtained viscosity values were applied for the PCS fitting. 
 
Product name Associate size / Zave [nm] Viscosity [mPas∙s] 
S1570 92 1.01 
P1570 50 1.04 
S1170 95 1.01 
Sisterna Sugar Esters 43 1 
 
Table 5: Associate size (from PCS measurements) and viscosity at 20 °C of the 
soluble part of the insoluble sugar esters from centrifuged dispersions with 
100 mg/l 
 
2.3.1.2. Hardly Soluble Alkyl Glucosides 
 
Similar to the poorly water soluble sugar esters some of the alkyl glycosides could 
not be completely dissolved in water. PC 1200 was supplied as a semisolid highly 
viscous bulk. Emulgade PL and Emulgade S were supplied as waxy flakes with 
melting points around 50 °C. These three substances could not be dissolved or 
processed into a gel even at higher temperatures or under sonification. Although 
PC 1200 was described as lauryl glucoside by the supplier and thus should show 
solubility at higher temperature. Again, this might be due to a higher content of longer 
fatty alcohol glycosides or poly alkyl glycosides. Mass spectrometry of this product 
was performed (see Figure 19). 
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Figure 19: Mass spectrum of PC 1200 
 
The main peak at 533.4 m/z represents the m+Na+ peak of lauryl diglucoside. The 
second peak can be attributed to a dilauroyl diglucoside which might represent the 
insoluble part of the mixture. 371.3 m/z is lauroyl monoglucoside and 695.6 m/z is the 
lauroyl triglucoside. Aside of lauroyl glucosides myristyl glucosides are also present 
in the mixture with m/z 399.5, 561.4 and 723.5 as the mono- di- and trisaccharide. 
The signals at m/z 779.8 and 807.8 represent stearyl and eicosanyl triglucoside or 
dialkyl triglucosides. As the latter two show quite high intensities, these are probably 
responsible for the low aqueous solubility as well as the dodecyl and tetradecyl 
monoglucosides (m/z 371.3, 399.5) as these are the more hydrophobic molecules.  
Both Emulgade products are technical mixtures of not only alkyl glucosides but also 
PEG-alkyl ethers. As can be derived from the product name, they are typically utilized 
in emulsions in O/W or W/O systems and not as solubilizers in pure aqueous 
systems. No hydrogen peroxide equivalents could be detected in the diluted samples 
that were applied for viscosity and PCS measurements. 
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2.3.2. Soluble Surfactants 
 
2.3.2.1 Water Soluble Sugar Esters 
 
The product MP (Ryoto Monoester P) is declared to be a mixture of sucrose fatty acid 
esters with the main component sucrose monopalmitate with a minimum content of 
70% in the powder. MP was soluble up to 0.1% (m/v) in water as well as in 
phosphate buffer at ambient temperature. Higher concentrations could be achieved 
by heating the samples. This thermodynamic solubility was sufficient to prepare 1% 
stock solutions for example for protein agitation tests. Solutions with 1% did not show 
visual precipitation or gelation within one week storage. As the product description by 
the supplier was similar to that of the Sisterna Sugar Ester this different behavior was 
unexpected. Subsequently, surface tension measurements were performed and a 
CMC of this excipient in water of ~50 mg/l and hence in the range of other nonionic 
surfactants (Wan and Lee 1974; Reinhart and Bauer 1995) was obtained. The same 
CMC was obtained in phosphate buffer. This is in accordance with work published by 
Zhang et al who could detect electrolyte effects on association behavior of surfactant 
molecules of n-dodecyl beta -D-maltoside solutions only at very high electrolyte 
concentrations. The effect can be described by structure forming or structure 
breaking effects, respectively (Zhang et al. 1996). The surface tension of an aqueous 
system above CMC is about 35.5 mN/m. Pyrene interaction revealed as well a CMC 
of ~ 50 mg/l.  
PCS measurements at 10 mg/ml delivered a micelle size of 7 nm which is in the 
range of other nonionic surfactants (Al-Saden et al. 1982). In addition PCS 
measurements confirmed a CMC between 30 and 50 mg/l. 
In an additional experiment the hemolytic activity of the surfactant was studied using 
porcine erythrocytes. HC5% was 100 mg/l and thus twice as high as the CMC. Thus, 
the application of the surfactant at the CMC is not expected to be a problem 
physiologically. For the ability to stabilize protein formulations, see chapter . 
The purity of the product was described as a content of at least 70% sucrose 
monopalmitate ester. No further details were given on the composition of the 
products besides the HLB of 16. Inductive coupled plasma analytics were performed 
to gather knowledge on the purity of MP. There were significant amounts of Ca and 
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Mg present. Traces of ubiquitous Na could be detected. However, the concentration 
of Na is in the range of a few ppb. Figure 20 shows the mass spectrum of MP. The 
higher purity is also confirmed by a lower number of significant additional peaks. The 
m/z signal at 598.2 is showing the H2O adduct of sucrose monopalmitate, the peak at 
m/z 1178.2 is the a cluster of 2M + H2O
+ of sucrose monopalmitate and the signal at 
m/z 401 is either a fragment with one monosaccharide cracked or a side product and 
then most probably glucose or fructose palmitate, where the disaccharide was 
cleaved at the carbon and not at the oxygen atom. As you can see, MP is rather pure 
and is mostly free of stearic acid esters. Due to this, solubility in water is higher 
compared to the other Ryoto products. 
 
 
Figure 20: Mass spectrum of MP 
 
The samples were free of hydrogen peroxide equivalents and thus might show an 
advantage in storage tests compared to PS 20 and PS 80. 
 
2.3.2.2. Water Soluble Alkyl Glucosides (plus analysis on PS 20 and 
PS 80) 
 
PC 818 and PC 2000 are ethers between sugars (mostly mono-, di-, and 
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trisaccharides) and fatty alcohols. PC 818 is composed of fatty alcohols with chain 
length between C8 and C18. For PC 2000 no such limitations on the fatty alcohol 
chain length are described by the manufacturer. Both products are completely water 
soluble at all ratios. As their structure and their composition is very close to 
polysorbates the analysis of polysorbates is described in this part (see also chapter 
3). 
Surface tension measurements show that micellization occurs at concentrations 
above 450 mg/l for PC 2000 and 210 mg/l for PC 818 respectively. Both substances 
decrease the surface tension to a similar level of 29 mN/m ± 0.5 mN/m. In phosphate 
buffer the CMC remains almost unaltered for both substances. Only pyrene 
interaction showed a difference for PC 2000 with a two times higher CMC. With the 
help of pyrene interaction fluorescence measurements CMC values of 400 (and 
800 mg/l in phosphate buffer) and 200 mg/l for PC 2000 and PC 818 respectively 
were observed. All results regarding micellization and a comparison to PS 20 and 
PS 80 are shown in  
Table 6 
 
Product 
 
CMCSTM [mg/l] 
 
CMCPF[mg/l] 
 
Surface Tens. 
CMC [mN/m] 
Micelle 
diameter [nm] 
PC 818 210 200 29.4 29 
PC 2000 450 400 29 15 
PS 20 100 100 28 9 
PS 80 20 20 42 11 
 
Table 6: Physico-chemical attributes of PC 818, PC 2000, PS 20, and PS 80. 
CMCSTM is the CMC observed by tensiometry. CMCPF is the CMC observed via 
pyrene fluorescence interaction and hydrodynamic micelle diameter from PCS 
measurements. 
 
As expected, the hydrodynamic diameters of PC 818 and PC 2000 micelles are in a 
comparable range of a few nanometers, slightly bigger than PS 20 and PS 80 
micelles. Results for polysorbates are in agreement with literature values (Wan and 
Lee 1974; Patist et al. 2000). The viscosity of 100 mg/l aqueous dilutions of PC 818 
and PC 2000 is 1 mPas∙s. 
Also the hemolytic activity was tested for PC 818 and PC 2000. The HC5% is 200 mg/l 
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and 1000 mg/l, respectively. Thus, the ratio of HC5% to CMC is approximately two. 
For PS 20 the ratio is higher as the HC5% value is 1000 mg/l and the CMC of PS 20 is 
lower than that of the Plantacare products making the substance a bit safer with 
respect to hemolysis. Overall this safety margin is comparable with other sugar 
based surfactants in literature (Soderlind et al. 2003; Neimert-Andersson et al. 2006; 
Soederlind and Karlsson 2006). The difference to PS 20 might be a drawback when it 
comes to filing of such an excipient mixture for invasive application and hence further 
experiments with e.g. whole blood might become compulsory.  
The purity of PC 818 and PC 2000 was tested with an RP-HPLC method according 
to the group of Neubert (Klaffke et al. 1998; Kuehn and Neubert 2004). As there was 
no UV-activity expected for these substances a RI-detector was applied for detection. 
With evaporative light scattering detection it was neither possible to gain linear 
results nor to achieve reproducibility. Our results were in accordance with literature 
values (Klaffke et al. 1998; Kuehn and Neubert 2004). The most prominent molecule 
in the mixtures is octyl diglucoside with area percentages of 30% and 40% for PC 
818 and PC 2000, respectively. The dodecyl diglycoside made up 20% and 22% 
resp. (data not shown). The other substances showed peak areas of 5%. As no 
internal standards were available, only semiquantitative statements can be made 
based on the HPLC results. These data are also in general accordance with the 
results obtained from mass spectrometry (see Figure 21 and Figure 22) with main 
peaks at m/z 477.6 (m + Na+), although direct comparisons can not be drawn as 
completely different physical properties have influence on the signal intensities. In the 
mass spectra the peak for dodecyl diglycoside appears bigger than in the HPLC (m/z 
533.4 = m + Na+). It is hard to find differences in the composition of both mixtures, 
but PC 2000 shows a slightly higher degree of shorter fatty alcohols and hence more 
hydrophilic species than PC 818 plus stronger signals at m/z 639, representing octyl 
triglucoside, which is a more polar molecule. Also more monoglucosides (especially 
dodecyl monoglucoside 371.3 (M + Na+)) are found for PC 818. This would explain 
the higher tendency for self aggregation of PC 818 as more hydrophobic surfactants 
have in general a lower CMC (Rulison 1995; Sierra and Svensson 1999; Chen et al. 
2006; Neimert-Andersson et al. 2006). Diglucosides and are present with different 
chain lengths in a comparable frame with m/z signals of 477.6, 505.3, 533.4, 561.4 
representing all even numbers chain lengths from C8 to C14. These analogy is also 
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present in smaller extends for the triglucosides (639.6, 667.5, 695.6, 723.6), and 
monoglucosides (m/z 315.5, 343.3, 371.3, 399.3) and even tetraglucosides can be 
detected for both substances (m/z 801.5 and 857.1). And interestingly 779.8 and 
807.8 (C18 and C20), which also can be dialkyl triglucosides. In the better water 
soluble mixtures these both peaks appear together with more substance of higher 
hydrophilicity. This might be the reason, why PC 818 and PC 2000 are water soluble. 
 
 
Figure 21: Mass spectrum of PC 818 
 
Both commercial products are mixtures of 50% water and 50% alkyl glucoside 
resulting in highly viscous fluids. When these are lyophilized fairly hygroscopic white 
powders can be obtained. The technical data sheet refers to traces of Mg that might 
be present in the products. These traces could not be observed via inductive coupled 
plasma analytics. Furthermore no Ca and only minimal amounts of Na could be 
detected. The pH of a pure 1% aqueous mixture is 3.0 providing autopreservation. 
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Figure 22: Mass spectrum of PC 2000 
 
Furthermore the amount of oxidizing species (hydrogen peroxide equivalents) was 
determined in 10% solutions. Even after 72 h light stress in a SunTest system no 
peroxide degradation products could be detected using Merckoquant® test strips. On 
the other hand PS 20 and PS 80 showed remarkably high contents of oxidizing 
impurities when exposed to light. For both substances peroxide levels > 100 mg/l 
were measured. The pure substances freshly diluted from cooled and nitrogen stored 
PS 20 and PS 80 respectively showed peroxide levels of 5 mg/l. 
 
2.3.2.3. NV 10 
 
The Expedeon product NV 10 is declared by the supplier as an oligosaccharide with 
hydrophobic side chains, but with no statement of the linker between the hydrophilic 
and the hydrophobic part. From figures in the product manual one can assume that 
the hydrophobic parts are attached to various parts at a linear oligosaccharide. The 
oligosaccharide itself is a starch hydrolysate. NV 10 was tested under the 
assumption that this small polymer would behave similar to a classical surfactant. 
Indeed it was possible to lower surface tension to approx. 47-48 mN∙m (see Figure 
23). The molecule is claimed to have a molecular weight of 5 kDa. This is about four 
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times the size of hydroxypropyl β cyclodextrin (MW~1500), another starch 
hydrolysate derivative that decreases the surface tension to a similar level (Serno et 
al. 2010). The decrease of surface tension follows a similar shape as for regular 
surfactants. At 1% the decrease of surface tension seems to level of. A clear 
transition reflecting a CMC could not be identified. 
 
 
Figure 23: Surface tension of NV 10 in relation to its concentration 
 
Pyrene interaction spectroscopy reveals a change in polarity of the whole system 
already at 0.001%. This leads to the assumption that the hydrophobic polymer 
molecules themselves or associates with a low number of participating molecules 
provide an unpolar environment. 
PCS measurements were performed to determine the size of potential associates. 
But with the set-up applied it was not possible to define any structure or “micellar 
state” to the substance even at higher concentrations. This is another indicator that 
NV 10 is not behaving like a regular nonionic surfactant.  
From patent literature (Daniel Brian Jones 2007) it was expected that the structure 
might be congruent with PC 818 or PC 2000 meaning that an oligosaccharide is 
attached to a fatty alcohol. It is stated from the manufacturer that the product is a 
small polymer in the size range of 5 kDa. One explanation for the attachment of the 
hydrophobic part is the bonding via glycosidic linkage. The elemental analysis 
indicated a nitrogen content of 0.8%. Thus, the likage between lipophilic and 
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hydrophilic structural element by also by formed via the nitrogen atoms e.g. as amid 
bonds. Carbon and oxygen represent the main portions in the molecular structure 
with approximately 46% each. Hydrogen could be found with about 6.9%. 
Mass spectrometry was performed with electrospray ionization, but could not provide 
further insight into the molecular structure (Figure 24). The main peak has a m/z of 
397.2, which might be the Na adduct of the substance with a mass peak of 373.7 and 
a third peak is represent the m + H+ / 2z signal (m/z 186). These signals could of 
course also originate from a multiply charged molecule. The signal at 114 m/z is most 
probably a fragment (octane, hexadecane) from the hydrophobic part of the polymer). 
When different detection and different ionization were performed the spectra were 
completely different (see Figure 25-22). On the one hand the mass peak at m/z 397 
disappeared and on the other hand peaks at m/z 544 (MALDI, positive ionization) 
and m/z 860 (MALDI, negative ionization) appeared. Using chemical ionization a 
broad mix of fragments and /or multiply charged molecules resulted. Thus, no 
conclusive results can be obtained from mass spectrometry on the structure of the 
NV 10 polymer. 
 
 
Figure 24: Mass spectrum of NV10 (ES Ionization) 
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Figure 25: Mass spectrum of NV10 (Matrix assisted laser desorption ionization, 
positive mode) 
 
 
Figure 26: Mass spectrum of NV10 (Matrix assisted laser desorption ionization, 
negative mode) 
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Figure 27: Mass spectrum of NV10 (chemical ionization) 
 
Furthermore for purity determination inductive coupled plasma experiments were 
performed to check for Mg, Ca and Na. No traces of these ions were present in the 
product. From overall analysis no decent statement can be given on the structure 
and composition of the product. However, NV10 is able to decrease the surface 
tension, but no CMC could be assigned. Nevertheless unpolar regions in the 
individual molecules or low number molecular associates form hydrophobic regions 
that are able to interact with pyrene. In addition, the product contains nitrogen which 
cannot be explained based on the provider‟s information. Hence, contrary to our prior 
hypothesis this product is not similar to the alkyl glucosides but is certainly derived 
from other classes and does not form higher molecular structures. When the 
hemolytic activity was tested for this substance the HC5% was in a high range of 
1 mg/ml, which may be related to a rather polymeric nature. 
 
2.4. Conclusions 
 
Applicability of the sugar based surfactants is strictly dependent on their solubility in 
water and the formation of clear solutions in a broad temperature range and in 
concentrations up to at least 1%. Therefore insoluble and poorly water soluble 
surfactants needed to be identified and only characterized with limited efforts. To 
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better understand this class of surfactants it was useful to determine the composition 
of the products. Mass spectrometry gave insight into the distribution of hydrophobic 
residues and carbohydrate parts in technical mixtures. On the one hand most of them 
showed mostly alkyl residues ranging from C16 to C18 and from mono- to triesters. On 
the other hand the hydrophilic part in most of the substances was found to be a 
disaccharide, most probably either sucrose or maltose. So only the CMC and hence 
solubilization properties seems to be of higher importance for the manufacturers of 
the sugar esters. The solubility is mainly altered by the sugar moiety in sugar based 
surfactants (Boyd et al. 2000; Soederlind and Karlsson 2006), which in turn remained 
unaltered for all ester products. Sucrose itself is not sufficiently hydrophilic enough to 
overcome the low solubilities of palmitic or stearic acid. Hence most of the sucrose 
esters were not sufficiently water soluble (see also characterization of trehalose 
palmitate). 
For the alkyl glucosides in turn from mono- to tetraglucosides different degrees of 
water solubility could be found and these might be attributed to the average amount 
of carbohydrate per molecule. 
Only a minority of the products (MP, PC 818 and PC 2000) were sufficiently water 
soluble. The other products, being sucrose fatty acid esters (the other Ryoto products 
and the Sisterna sugar ester) or alkyl glucoside (PC 1200) were not, although the 
HLB value of these mixtures would lead to the conclusion that these products should 
show adequate solubility. 
From the tested products the most promising candidates were PC 2000 and PC 818. 
These products mainly consist of octyl diglucoside and dodecyl diglycoside. 
Moreover some mono- tri and tetraglucosides are also present in these mixtures. The 
shorter chain lengths of the fatty alcohols and in turn the presence of longer 
carbohydrates leads to a better solubility. CMC, hemolytic activity, surface tension, as 
well as micelle size are similar to the properties of polysorbates. Of advantage for 
protein formulation might be, that the products show hardly any oxidizing potential, 
neither impurity nor structurally derived.  
As a runner-up to the most promising candidates appears NV 10. The chemical 
analysis could not shed a clear light on the structure of the excipient and the 
underlying chemistry. A more detailed analysis of the excipient is necessary for 
evaluating its potential in pharmaceutical protein formulation, including 
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biodegradability, biocompatibility and chemical composition. As stated by the 
manufacturer some pharmaceutical companies already use the material in up- and 
downstream processing of pharmaceutical proteins. The low hemolytic activity is a 
major advantage. 
Ryoto Monoester P, which mostly consists of sucrose monopalmitate, is another 
potentially useful candidate for protein formulation. It shows fairly high, but not 
complete aqueous solubility, exhibits reasonably low hemolytic activity and behaves 
physico-chemically similar to polysorbates. 
Summarizing, from the screening of physical-chemical properties, there are possible 
alternatives to the polysorbate products. But is has to be kept in mind that all these 
products are not designed for parenteral use and other parameters such as 
endotoxin levels have not been considered for feasibility. 
In further studies, these products, mainly the Plantacare mixtures, should be tested in 
protein formulations under stress conditions. In agitation stress studies it would be 
desired to show comparable protein stabilization. As no oxidizing species could be 
detected in these mixtures, it is expected that storage under elevated temperatures 
will lead to significantly lower amounts of chemically degraded protein with sugar 
based surfactants in contrast to the  
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3. Synthesis, Characterization and 
Assessment of Suitability of 
Trehalose Fatty Acid Esters as 
Alternatives for Polysorbates in 
Protein Formulation  
3.1. Introduction 
 
A large number of protein pharmaceuticals, both in liquid as well as lyophilized, is 
formulated with the addition of nonionic surfactants such as block copolymers and 
polysorbates, for example the insulin Lantus®, pegylated erythropoetin Mircera®, a 
human growth hormone formulation Nutropin® or the humanized monoclonal antibody 
Herceptin®. Different groups have shown that these surfactants pose dual effects on 
the protein. On the one hand they stabilize proteins physically against various kinds 
of surface correlated stress, e.g. adsorption at container surfaces (Charman et al. 
1993; Wu et al. 2008) , denaturation at the air-water interface (Bam et al. 1995; Bam 
et al. 1998) or the ice-water interface (Chang et al. 1996; Kreilgaard et al. 1998; 
Webb et al. 2002). On the other hand these polyethylene glycol based surfactants 
can put long-term chemical stability at risk (Knepp et al. 1996; Ha et al. 2002; Kiese 
et al. 2008; Wang et al. 2008). Mostly oxidizing reactions are described in the 
literature. These are explained by peroxide remnants in the technical products. An 
increase in hemolysis is referred to peroxide residues, too (Azaz et al. 1981). 
Adverse reactions in patients are known for some of these surfactants (Attwood 
1983), which is another reason to search for other options for surface stabilization.  
An alternative for these substances should show a good safety profile, the same 
surface related stabilizing effects, but no impact on long-term chemical stability of 
pharmaceutical proteins. Sugar based surfactants feature surface behavior similar to 
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polysorbates. They are already in pharmaceutical and cosmetical use for topical and 
oral formulations (Savic et al. 2005; El-Laithy Hanan 2009; Kirchherr et al. 2009). In 
addition, they are known as reagents for the stabilization of membrane proteins 
(Prive 2007; Lopez et al. 2009). Alkyl glycosides and sugar fatty acid esters are 
environmentally friendly (Garcia et al. 1997; Baker et al. 2000) as only renewable 
components, sugars (mono- to oligosaccharides) for the hydrophilic and fatty 
alcohols or fatty acids for the hydrophobic part are required. Synthesis can be 
performed both chemically (von Rybinski and Hill 1998; Chen et al. 2006; Hill 2007) 
and biochemically (von Rybinski and Hill 1998; Chen et al. 2005; Hill 2007). Technical 
mixtures are already on the market and well characterized (Rades and Mueller-
Goymann 1997; von Rybinski and Hill 1998; Kuehn and Neubert 2004). Of course, 
the lack of PEG-residues and hence peroxides should pose the advantage regarding 
oxidizing behaviour of this class of surfactants against the already approved 
substances. 
In this chapter we describe the synthesis and scrutiny of trehalose fatty acid 
monoesters. Trehalose is a well known stabilizer in protein formulations (Uritani et al. 
1995; Sun and Davidson 1998; Cleland et al. 2001). Having this in mind the authors 
were looking for a good water soluble surfactant. We designed a synthesic strategy in 
four steps resulting in highly pure products. These surfactants are unlike 
polysorbates, which are technical mixtures of all kinds of molecules with a broad 
heterogeneity. The authors were furthermore interested in a correlation of chain 
length and protein stability. Thus we sought for substances that are comparable to 
Polysorbate 20 (PS 20) and Polysorbate 80 (PS 80) in regard of formulation 
feasibility. We characterized the physico-chemical properties of trehalose esters, 
such as CMC, micelle size, viscosity and calorimetric behavior. Furthermore they 
were tested for hemolytic activity as surfactants tend to rupture cell membranes 
(Reinhart and Bauer 1995; Soderlind et al. 2003; Soederlind and Karlsson 2006). 
Finally, the protein stabilizing capacity of the trehalose esters was tested in agitation 
stress studies of human growth hormone . 
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3.2. Materials and Methods 
3.2.1 Materials 
 
Palmitic acid, lauric acid, capric acid, anhydrous pyridine, trimethylsilyl chloride, 
hexamethyldisilazane, 4-(dimethylamino)pyridine (4-DMAP) and N,N‟-
dicyclohexylcarbodiimide (1,3-DCC) were purchased from Sigma-Aldrich (St. Louis, 
MO, USA) and used as received. Solvents for NMR were purchased from Euriso-Top 
SA (Saint-Aubin Cedex, France). Α,α-Trehalose was purchased from Georg Breuer 
GmbH (Königstein, Germany). Flash column chromatography was performed using 
silica gel 60 (40 – 63 µm) (VWR International GmbH, Bruchsal, Germany). All other 
chemicals were reagent grade, commercially available products. If indicated, solvents 
were dried using standard procedures. For the physicochemical analysis of the sugar 
based surfactants the water used in all experiments was purified in a PURELAB Plus 
system (ELGA labwater, Celle, Germany) and had a conductivity <0.055 µS/cm. 
Pyrene for synthesis and all buffer salts were obtained from Merck KGA (Darmstadt, 
Germany). Buffer salts were of analytical grade or higher. 
Human growth hormone (hGH) was gratefully donated by Bernina Plus & HDS.  
Porcine blood was collected at the municipal slaughterhouse. Further purification and 
processing to an erythrocyte suspension is explained in the methods part. 
 
3.2.1.1 Preparation of 2,3,4,6,2‘,3‘,4‘,6‘-octa-O-(trimethylsilyl) 
trehalose (1) 
 
α,α-Trehalose dihydrate (7.00 g, 18.5 mmol) was placed in a flask containing 100 ml 
of anhydrous pyridine. Trimethylsilyl chloride (20.0 ml, 158.0 mmol) was added over a 
period of 30 minutes, hexamethyldisilazane (40.0 ml, 188.0 mmol) was added the 
same way and the mixture was mechanically stirred under nitrogen atmosphere for 
18 hours at room temperature. The solvent was removed by flash evaporation, the 
resulting residue was treated with 100 
50 ml). The combined organic extracts were dried over anhydrous MgSO4 and then 
the solvent was removed by flash evaporation. The residue was crystallized in 
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methanol to give 2,3,4,6,2„,3„,4„,6„-octa-O-(trimethylsilyl)-α,α-trehalose (1) (15.7 g, 
17.0 mmol, 92 %) as a white solid. MP: 82 °C (lit.: 80 – 82 °C). IR (KBr): ν (cm-1) = 
2959, 1251, 1155, 1117, 1071, 1023, 901, 878, 840, 748, 682, 536, 457. 1H-NMR 
(CDCl3): δ (ppm) = 4.91 (d, 2 H, J = 3.1 Hz, 1-H, 1‟-H), 3.88 (t, 2 H, J = 9.0 Hz, 2-H, 
2‟-H), 3.78 (m, 2 H, 5-H, 5‟-H), 3.66 (m, 4 H, 6-H, 6‟-H), 3.42 (t, 2 H, J = 9,1 Hz, 4-H, 
4‟-H), 3.37 (dd, 2 H, J1 = 3.2 Hz, J2 = 9.3 Hz, 3-H, 3‟-H), 0.14 – 0.09 (m, 72 H, 8 
SiMe3). 
13C-NMR (CDCl3): δ (ppm) = 96.8 (C-1, C-1‟), 76.1 (C-2, C-2‟), 75.7 (C-5, C-
5‟), 75.3 (C-3, C-3‟), 74.3 (C-4, C-4‟), 64.7 (C-6, C-6‟), 3.6 (2 SiMe3), 3.5 (2 SiMe3), 
2.7 (2 SiMe3), 2.2 (2 SiMe3). MS (ESI): m/z (rel. int. in %) = 941 [M+Na]
+ (87), 936 
(100), 977 (47), 361 (40). 
 
3.2.1.2. Preparation of 2,3,4,2‘,3‘,4‘-hexa-O-(trimethylsilyl)-α,α-
trehalose (2) 
 
2,3,4,6,2‟,3‟,4‟,6‟-Octa-O-(trimethylsilyl)-α,α-trehalose (1) (0.920 g, 1.00 mmol) was 
placed in a 250 ml flask containing 25 ml of methanol and cooled to 0 °C. A solution 
of potassium carbonate (0.140 mg, 1.0 mmol) in methanol (30 ml) was added 
dropwise over a period of 20 minutes. The reaction mixture was stirred for 5 hours at 
0 °C, complete conversion was checked by TLC. The reaction was stopped by 
adding glacial acetic acid (115 µL, 2.0 mmol). The solvent was removed by flash 
evaporation, the crude product was treated with brine and extracted with diethyl ether 
(3 x 30 ml). The combined organic extracts were dried over magnesium sulfate, 
removing the solvent by flash evaporation yielded 2,3,4,2„,3„,4„-hexa-O-
(trimethylsilyl)-α,α-trehalose (2) as a white solid (0.640 g, 0.82 mmol, 82 %). MP: 
114 °C (lit. 115 – 118 °C). IR (KBr):  ν (cm-1) = 3503, 2959, 1405, 1251, 1171, 1126, 
1110, 1076, 1011, 948, 897, 873, 843, 748, 683, 623, 589, 519, 456.  
1H-NMR (CDCl3): δ (ppm) = 4.90 (d, 2 H, J = 3.1 Hz, 1-H, 1‟-H), 3.86 (t, 2 H, J = 9.0 
Hz,  
2-H, 2‟-H), 3.84 (m, 2 H, 5-H, 5‟-H), 3.71 (m, 4 H, 6-H, 6‟-H), 3.48 (t, 2 H, J = 9.2 Hz, 
4-H, 4‟-H), 3.41 (dd, 2 H, J1 = 3.2 Hz, J2 = 9.3 Hz, 3-H, 3‟-H), 0.16 – 0.12 (m, 54 H, 6 
SiMe3). 
13C-NMR (CDCl3): δ (ppm) = 94.8 (C-1, C-1‟), 73.5 (C-2, C-2‟), 73.0 (C-5, C-
5‟), 72.9 (C-3, C-3‟), 71.5 (C-4, C-4‟), 61.8 (C-6, C-6‟), 1.1 (2 SiMe3), 1.0 (2 SiMe3), 
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0.2 (2 SiMe3). MS (ESI): m/z (rel. int. in %) = 797 [M + Na]
+ (21), 792 (100), 379 (28), 
361 (10), 289 (18). 
 
3.2.1.3 Preparation of 6-O-monopalmitoyl-, 6-O-monolauroyl- and 6-
O-monocaprinoyl-2,3,4,2‘,3‘,4‘-hexa-O-(trimethylsilyl)-α,α-
trehalose (3a, 3b, 3c) 
 
2,3,4,2„,3„,4„-Hexa-O-(trimethylsilyl)-trehalose (2) (0.770 g, 1.00 mmol), together with 
4-DMAP (0.160 g, 1.30 mmol) and the corresponding carboxylic acid (for 3a: palmitic 
acid C16H32O2; for 3b: lauric acid C12H24O2; for 3c: capric acid C10H20O2) (1.30 mmol) 
were placed in a flame dried 25 mL Schlenck flask, containing anhydrous 
dichloromethane (5 mL). A solution of 1,3-DCC (0.250 g, 1.20 mmol) in anhydrous 
dichloromethane (3 ml) was added dropwise. The mixture was mechanically stirred 
for 18 hours at room temperature under a nitrogen atmosphere. The resulting 
precipitate was removed by filtration under reduced pressure and washed with 
dichloromethane (5 ml). The crude product was obtained by removing the solvent 
from the combined, dried dichloromethane solutions by flash evaporation and purified 
by flash column chromatography (hexane, diethyl ether 7:3).  
3a: 6-O-Monopalmitoyl-2,3,4,2„,3„,4„-hexa-O-(trimethylsilyl)-α,α-trehalose (0.330 g, 
0.33 mmol, 33 %, colorless oil). IR (NaCl): ν (cm-1) = 3447, 2925, 2855, 2360, 2342, 
1743, 1457, 1251, 1166, 1111, 1077, 1009, 965, 898, 874, 844, 748, 668, 518. 1H-
NMR (CDCl3): δ (ppm) = 4.93 (t, 2 H, J = 3.1 Hz, 1-H, 1‟-H), 4.30 (dd, 1 H, J1 = 11.8 
Hz, J2 = 2.3 Hz, 6-H), 4.07 (dd, 1 H, J1 = 11.8 Hz, J2 = 4.5 Hz, 6-H), 4.02 (m, 1 H, 5-
H), 3.92 (m, 2 H, 2-H, 3-H), 3.85 (m, 1 H, 5‟-H), 3.71 (m, 2 H, 6‟-H), 3.47 (m, 4 H, 4-
H, 2‟-H, 3‟-H, 4‟-H), 2.35 (m, 2 H, 2‟‟-H), 1.63 (m, 2 H, 3‟‟H), 1.27 (m, 24 H, 4‟‟-H – 
15‟‟-H), 0.88 (m, 3 H, 16‟‟-H), 0.15-0.12 (m, 54 H, 6 SiMe3). 
13C-NMR (CDCl3): δ 
(ppm) = 173.7 (C-1‟‟), 94.3 (C-1‟), 94.2 (C-1), 73.3 (C-5), 73.1 (C-2), 72.8 (C-5‟), 72.6 
(C-4‟), 72.5 (C-3‟), 71.7 (C-2‟), 71.2 (C-4), 70.6 (C-3), 63.1 (C-6), 61.5 (C-6‟), 34.0 (C-
2‟‟), 31.8 (C-14‟‟), 29.5 (C-4‟‟ – C-10‟‟), 29.3 (C-11‟‟), 29.2 (C-12‟‟, C-13‟‟), 24.7 (C-3‟‟), 
22.6 (C-15‟‟), 14.0 (C-16‟‟), 1.3 – 0.6 (6 SiMe3). 
3b: 6-O-Monolauroyl-2,3,4,2„,3„,4„-hexa-O-(trimethylsilyl)-α,α-trehalose (0.402 g,  
0.42 mmol, 42 %, colorless oil). IR (NaCl): ν (cm-1) = 3522, 2957, 2926, 2856, 2361, 
1744, 1455, 1385, 1327, 1251, 1165, 1110, 1076, 1009, 965, 898, 873, 842, 749, 
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681.  
1H-NMR (CDCl3): δ (ppm) = 4.92 (t, 2 H, J = 3.2 Hz, 1-H, 1‟-H), 4.29 (dd, 1 H, J1 = 
11.9 Hz, J2 = 2.5 Hz, 6-H), 4.06 (dd, 1 H, J1 = 11.9 Hz, J2 = 4.7 Hz, 6-H), 4.01 (m, 1 
H, 5-H), 3.91 (m, 2 H, 2-H, 3-H), 3.85 (m, 1 H, 5‟-H), 3.70 (m, 2 H, 6‟-H), 3.45 (m, 4 
H, 4-H, 2‟-H, 3‟-H, 4‟-H), 2.35 (m, 2 H, 2‟‟-H), 1.63 (m, 2 H, 3‟‟H), 1.26 (m, 16 H, 4‟‟-H 
– 11‟‟-H), 0.88 (m, 3 H, 12‟‟-H), 0.14 – 0.10 (m, 54 H, 6 SiMe3). 
13C-NMR (CDCl3): δ 
(ppm) = 173.7 (C-1‟‟), 94.4 (C-1‟), 94.3 (C-1), 73.4 (C-5), 73.2 (C-2), 72.8 (C-5‟), 72.6 
(C-4‟), 72.5 (C-3‟), 71.8 (C-2‟), 71.3 (C-4), 70.7 (C-3), 63.2 (C-6), 61.6 (C-6‟), 34.1 (C-
2‟‟), 31.8 (C-10‟‟), 29.5 – 29.1 (C-4‟‟ – C9‟‟), 24.7 (C-2‟‟), 22.6 (C-11‟‟), 14.0 (C-12‟‟), 
1.3 – 0.3 (6 SiMe3).  
MS (ESI): m/z (rel. int. in %) = 979 [M + Na]+ (34), 975 (100), 471 (43), 271 (90). 
3c: 6-O-Monocaprinoyl-2,3,4,2„,3„,4„-hexa-O-(trimethylsilyl)-α,α-trehalose (0.420 g, 
0.45 mmol, 45 %, colorless oil). IR (NaCl): ν (cm-1) = 3521, 2957, 2926, 2856, 1743, 
1457, 1404, 1385, 1326, 1251, 1165, 1110, 1077, 1008, 964, 898, 874, 843, 749, 
683.  
1H-NMR (CDCl3): δ (ppm) = 4.92 (t, 2 H, J = 2.55 Hz, 1-H, 1‟-H), 4.29 (dd, 1 H,  
J1 = 11.9 Hz, J2 = 2.2 Hz, 6-H), 4.06 (dd, 1 H, J1 = 11.7 Hz, J2 = 4.6 Hz, 6-H), 4.01 (m, 
1 H, 5-H), 3.89 (m, 2 H, 2-H, 3-H), 3.83 (m, 1 H, 5‟-H), 3.70 (m, 2 H, 6‟-H), 3.45 (m, 4 
H, 4-H, 2‟-H, 3‟-H, 4‟-H), 2.34 (m, 2 H, 2‟‟-H), 1.63 (m, 2 H, 3‟‟H), 1.26 (m, 12 H, 4‟‟-H 
– 9‟‟-H), 0.88 (t, 3 H, J = 7.1 Hz, 10‟‟-H), 0.13 – 0.10 (m, 54 H, 6 SiMe3). 
13C-NMR 
(CDCl3):  
δ (ppm) = 173.9 (C-1‟‟), 94.6 (C-1‟), 94.5 (C-1), 73.6 (C-5), 73.4 (C-2), 73.0 (C-5‟), 
72.8  
(C-4‟), 72.7 (C-3‟), 72.0 (C-2‟), 71.5 (C-4), 70.9 (C-3), 63.4 (C-6), 61.7 (C-6‟), 34.3 (C-
2‟‟), 32.0 (C-8‟‟), 29.5 – 29.2 (C-3‟‟ – C-6‟‟), 24.9 (C-3‟‟), 22.8 (C-9‟‟), 14.2 (C-10‟‟), 1.3 
– 0.3 (6 SiMe3). MS (ESI): m/z (rel. int. in %) = 953 [M + Na]
+ (23), 946 (91), 361 
(100), 279 (63). 
 
3.2.1.4  Preparation of 6-O-monopalmitoyl-, 6-O-monolauroyl- and 
6-O-monocaprinoyl-α,α-trehalose (4a, 4b, 4c) 
 
The corresponding esters 3a, 3b, 3c of 2,3,4,2„,3„,4„-hexa-O-(trimethylsilyl)-α,α-
trehalose (0.74 mmol) were placed in a 25 ml flask, containing 8 ml of a mixture of 
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trifluoroacetic acid, tetrahydrofuran and water in a ratio of 8:17:3. The resulting 
solution was mechanically stirred for 1 hour at room temperature. 4a was obtained as 
a white precipitate which was collected by filtration under reduced pressure and 
crystallized in acetone. 4b and 4c did not precipitate and thus were purified by 
removing the solvent using flash evaporation, followed by flash column 
chromatography (ethyl acetate, methanol 4:1). 
4a: 6-O-Monopalmitoyl-α,α-trehalose (Mono-PT) (0.310 g, 0.53 mmol, 72 %, white 
solid). MP: softening at 130 – 135 °C, melting at 203 – 207 °C; (lit. 198 – 200 °C). IR 
(KBr): ν (cm-1) = 3421, 2926, 2854, 2361, 1740, 1636, 1467, 1378, 1150, 1109, 1078, 
1046, 989, 939, 805, 721, 576, 527.1H-NMR (CDCl3): δ (ppm) = 5.08 (dd, 2 H, J1 = 
11.2 Hz, J2 = 3.6 Hz, 1-H, 1‟-H), 4.36 (dd, 1 H, J1 = 12.0 Hz, J2 = 1.6 Hz, 6-H), 4.19 
(dd, 1 H, J1 = 12.0 Hz, J2 = 5.1 Hz, 6-H), 4.02 (m, 1 H, 5-H), 3.79 (m, 4 H, 2-H, 2‟-H, 
5‟-H, 6‟-H), 3.66 (m, 1 H, 6‟-H), 3.47 (m, 2 H, 3-H, 3‟-H), 3.34 (m, 2 H, 4-H, 4‟-H), 2.34 
(t, 2 H, J = 7.4 Hz, 2‟‟-H), 1.61 (m, 2 H, 3‟‟-H), 1.29 (m, 24 H, 4‟‟-H - 15‟‟-H), 0.90 (t, 3 
H, J = 7.2 Hz, 16‟‟-H). 13C-NMR (CDCl3): δ (ppm) = 175.5 (C-1‟‟), 95.2 (C-1‟), 95.1 
(C-1), 74.6 (C-2‟), 74.4 (C-2), 73.9 (C-5‟), 73.2 (C-3, C-3‟), 71.9 (C-4, C-4‟), 71.4 
(C-5), 64.4 (C-6), 62.6 (C-6‟), 35.0 (C-2‟‟), 33.1 (C-14‟‟), 30.9 – 30.3 (C-4‟‟ – C-13‟‟), 
26.1 (C-3‟‟), 23.8 (C-15‟‟), 14.5 (C-16‟‟). MS (ESI): m/z (rel. int. in %) = 1183 
[2∙M + Na]+ (20), 603 [M + Na]+ (100). 
4b: 6-O-Monolauroyl-α,α-trehalose (Mono-LT) (0.294 g, 0.56 mmol, 76 %, white 
solid). MP: softening at 130 – 134 °C, melting at 159 – 163 °C; (lit.: 156 – 158 °C). IR 
(KBr): ν (cm-1) = 3421, 2926, 2854, 2361, 1740, 1636, 1467, 1378, 1150, 1109, 1078, 
1046, 989, 939, 805, 721, 576, 527. 1H-NMR (CDCl3): δ (ppm) = 5.08 (dd, 2 H, J1 = 
11.1 Hz, J2 = 3.6 Hz, 1-H, 1‟-H), 4.36 (d, 1 H, J = 11.7 Hz, 6-H), 4.19 (dd, 1 H, J1 = 
11.9 Hz, J2 = 4.9 Hz, 6-H), 4.02 (m, 1 H, 5-H), 3.79 (m, 4 H, 2-H, 2‟-H, 5‟-H, 6‟-H), 
3.66 (m, 1 H, 6‟-H), 3.47 (m, 2 H, 3-H, 3‟-H), 3.33 (m, 2 H, 4-H, 4‟-H), 2.34 (t, 2 H, J = 
7.2 Hz, 2‟‟-H), 1.61 (m, 2 H, 3‟‟-H), 1.29 (m, 16 H, 4‟‟-H - 11‟‟-H), 0.90 (t, 3 H, J = 6.6 
Hz, 12‟‟-H). 13C-NMR (CDCl3): δ (ppm) = 175.5 (C-1‟‟), 95.2 (C-1‟), 95.1 (C-1), 74.6 
(C-2‟), 74.4 (C-2), 73.9 (C-5‟), 73.2 (C-3, C-3‟), 71.9 (C-4, C-4‟), 71.4 (C-5), 64.4 
(C-6), 62.7 (C-6‟), 35.0 (C-2‟‟), 33.1 (C-10‟‟), 30.8-30.2 (C-4‟‟ – C-9‟‟), 26.1 (C-3‟‟), 
23.8 (C-11‟‟), 14.5 (C-12‟‟). MS (ESI): m/z (rel. int. in %) = 547 [M + Na]+ (41), 563 
[M + K] + (100), 1071 [2∙M + Na]+ (43), 1087 [2∙M + K]+ (45). 
4c: 6-O-Monocaprinoyl-α,α-trehalose (Mono-CT) (0.286 g (0.57 mmol, 78 %, white 
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solid). MP: 163 - 164 °C. IR (KBr): ν (cm-1) = 3500, 3355, 2933, 2908, 2361, 2343, 
1685, 1457, 1149, 1100, 1081, 1030, 998, 956, 803, 612. 1H-NMR (CDCl3): δ (ppm) = 
5.08 (dd, 2 H, J1 = 11.1 Hz, J2 = 3.7 Hz, 1-H, 1‟-H), 4.36 (dd, 1 H, J1 = 11.9 Hz, J2 = 
2.1 Hz, 6-H), 4.19 (dd, 1 H, J1 = 12.1 Hz, J2 = 5.2 Hz, 6-H), 4.01 (m, 1 H, 5-H), 3.79 
(m, 4 H, 2-H, 2‟-H, 5‟-H, 6‟-H), 3.66 (m, 1 H, 6‟-H), 3.47 (m, 2 H, 3-H, 3‟-H), 3.32 (m, 2 
H, 4-H, 4‟-H), 2.34 (t, 2 H, J = 7.6 Hz, 2‟‟-H), 1.61 (m, 2 H, 3‟‟H), 1.30 (m, 12 H, 4‟‟-H - 
9‟‟-H), 0.90 (t, 3 H, J = 6.9 Hz, 10‟‟-H). 13C-NMR (CDCl3): δ (ppm) = 175.5 (C-1‟‟), 
95.2 (C-1‟), 95.1 (C-1), 74.6 (C-2‟), 74.4 (C-2), 73.9 (C-5‟), 73.2 (C-3, C-3‟), 71.9 (C-
4, C-4‟), 71.4 (C-5), 64.4 (C-6), 62.6 (C-6‟), 35.0 (C-2‟‟), 33.1 (C-8‟‟), 30.6 – 30.3 
(C-4‟‟ – C-7‟‟), 26.1 (C-3‟‟), 23.8 (C-9‟‟), 14.5 (C-10‟‟). MS (ESI): m/z (rel. int. in %) = 
519 [M + Na]+ (100), 516 (56), 509 (7). 
 
All three steps are summarized in Figure 28. 
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Figure 28: Reaction scheme of the preparation of Mono-PT (4a), Mono-LT (4b) 
and Mono-CT (4c): i) K2CO3, MeOH, 0 °C, 5 h; ii) 1,3-DCC, 4-DMAP, carboxylic 
acid, dry dichloromethane, 18 h, rt; iii) TFA, THF, H2O, 1 h, rt. 
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3.2.1.5 Instruments used for identification of the synthesized 
products 
 
IR spectra were recorded on a Perkin Elmer FT-Infrared Spectrometer Paragon 1000 
(Perkin Elmer, Waltham, MA, USA). 1H NMR and 13C NMR spectra were taken on a 
Jeol JNMR-GX400 (400 MHz/100 MHz), and a Jeol JNMR-GX500 
(500 MHz/125 MHz) (Jeol, Tokyo, Japan), and chemical shifts are reported in ppm, 
downfield from tetramethylsilane. ESI-mass spectroscopy was performed on an API 
2000 (Applied Biosystems, Foster City, CA, USA). Melting points were taken on a 
Büchi Melting Point B-540 (BÜCHI Labortechnik GmbH, Essen, Germany). TLC was 
performed on POLYGRAM SIL G/UV254 plates (Macherey-Nagel, Düren, Germany). 
 
3.2.2. Methods 
 
 
3.2.2.1 Tensiometry 
 
Surface tension was measured with a K100 MK2 tensiometer (Krüss, Hamburg, 
Germany) equipped with a F12 thermostat (Julabo, Ostfildern, Germany) and a 765 
Dosimat (Metrohm, Leinfelden-Echterdingen, Germany) using LabDesk 3.1 software 
(Krüss, Hamburg, Germany). Before the surface tension of surfactants was 
determined, the system was tested with purified water. When surface tensions of 
72.0 ± 0.1 mN/m were found for water in three consecutive measurements, surfactant 
solutions were tested. The Critical Micelle Concentration (CMC) was determined from 
sharp breaks in surface tension vs. logarithm of surfactant concentration plots. A 
custom-made glass vessel and a platinum iridium plate were used for all 
experiments. A total of 11 concentrations were tested for each surfactant. One 
measurement lasted at least 300 sec. Experiments (n = 3) were performed at 25 °C 
for Mono-LT and Mono-CT. Because of its low solubility at room temperature Mono-
PT was tested at 45 °C. 
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3.2.2.2 Pyrene Interaction Fluorescence 
 
Pyrene fluorescence was applied to alternatively determine the CMC according to 
(Kalyanasundaram and Thomas 1977). Fluorescence spectra were recorded and the 
ratio I1/I3 was calculated, where I1 was the emission at 373 nm and I3 was the 
emission at 393 nm. Excitation wavelength was 335 nm. Due to a change in polarity 
when micelles occur, the ratio becomes <1 at the CMC. Surfactant concentrations 
comprised the same range as applied to surface tension measurements. 
Experiments were performed in quartz cuvettes with 10 mm pathlength using a Cary 
Eclipse spectrofluorimeter (Varian, Palo Alto, USA). 10 µl of a 200 mM pyrene 
solution in ethanol was added to 1990 µl surfactant solution (N=3). 
 
3.2.2.3 Hemolytic Activity 
 
Hemolytic activity was measured with porcine erythrocytes. Coagulation was 
prevented by adding 200 ml 3.8 % (m/V) trisodium citrate buffer pH 7.4 to 800 ml 
fresh blood. Samples were washed six times with citrate buffer and centrifuged at 
3.500 g and 5 °C for 45 min. Different surfactant concentrations (in the same citrate 
buffer used for purification) were added to the porcine erythrocytes suspension at a 
1:5 ratio. After incubating for 1 hour at 37 °C under gentle shaking samples were 
centrifuged (3.500 g for 15 min). The supernatant was tested for free hemoglobin at A 
= 415 nm using an UV 8453 UV-spectrometer and UV-Visible ChemStation software 
(Agilent, Santa Clara, USA). Each experiment was performed with N=5. 100 % 
hemolysis was determined by diluting 10 µl erythrocytes in 990 µl Millipore water. 0 % 
hemolysis was tested by adding pure buffer to the erythrocyte suspension. The 
degree of hemolysis produced by surfactants (%H) was calculated according to 
equation (adapted from (Reinhart and Bauer 1995) and (Seyfert et al. 2002)). 
 
3.2.2.4 Photon Correlation Spectroscopy (PCS) 
 
Size determination of micelles in 1 % (m/V) surfactant solutions was performed on a 
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Zetasizer nano ZS (Malvern Instruments, Herrenberg, Germany) with a 633 nm laser. 
The hydrodynamic diameter was calculated with DTS NANO v5.10 software (Malvern 
Instruments, Herrenberg, Germany). The sample, in single-use UV-plastic cuvettes 
(Brand GmbH and Co KG, Wertheim, Germany), was at first equilibrated for 1 min at 
25 °C (and 5 min for 45 °C, respectively) and subsequently the time scale of the 
scattered light intensity fluctuations of the sample was measured. Each sample was 
recorded in triplicate, each with 20 runs. The size was obtained using the cumulants 
analysis by fitting a single exponential to the correlation function in order to obtain the 
volume-weighted mean size. The viscosity at 25 °C was used as input value for the 
fitting. 
 
3.2.2.5 Viscometry 
 
As viscosity is a crucial parameter for PCS measurements the viscosity of the 
surfactant solutions was determined on an AMVn falling sphere viscometer (Anton 
Paar, Graz, Austria). 800 µl of a 1 % (m/V) surfactant solution was filled in a 1.6 mm 
diameter tube and viscosity was recorded from 20 °C to 45 °C ± 0.1 °C for every 
5 °C. A 60° angle was applied and every solution viscosity was determined 10 times. 
 
3.2.2.6 Differential Scanning Calorimetry (DSC) 
 
1 % (m/V) aqueous surfactant solutions (N=1) were analyzed using a DSC821 
calorimeter (Mettler Toledo, Columbus, USA) and heated from 10 °C to 75 °C at 
10 °C/min. Transitions were analyzed by STAR software supplied with the instrument. 
3.2.2.7 Agitation stressing of human growth hormone formulations 
 
0.95 ml of a 0.2 mg/ml human growth hormone formulation was sterile filtrated into 
2R vials. The protein was formulated in 10 mM phosphate buffer pH 7.2 containing 
different surfactant concentrations. Every concentration was tested in triplicate. A 
MM200 swinging mill (Retsch, Haan, Germany) was applied for a quick agitation 
stress for 10 min at 8 Hz. Consequently protein recovery was studied using size 
 84 
 
exclusion chromatography (SEC), and protein aggregation was studied via turbidity 
(A350nm), light obscuration and visual inspection for particulate matter. 
 
3.2.2.8 Size Exclusion Chromatography (SEC) 
 
The monomer content of the protein formulation as well as the dimer formation was 
investigated via SEC. A HP 1100 HPLC system (Agilent Technologies, Waldbronn, 
Germany) equipped with a diode array detector and a 3000 SWXL gel filtration 
column (Tosoh Bioscience, Tokyo, Japan) was used for this experiment. 50 µl of a 
centrifuged protein sample was injected into the HPLC. Within the HPLC a 0.2 µm 
online filter was used. The running buffer was composed of 50 mM NaH2PO4 and 
150 mM NaCl at a pH of 7.2. The analytics were performed at a flow-rate of 
0.5 ml/min with UV-detection at 216 nm. 
 
3.2.2.9 Turbidity Measurement 
 
Turbidity of the shaken samples was quantified by means of UV-absorption at 
350 nm. 200 µl samples were placed in a 96 well plate and tested in a Fluostar 
Omega reader with analysis software (BMG Labtech, Offenburg, Germany). Pure 
buffer was used as a blank sample. 
 
3.2.2.10 Light Obscuration 
 
Sub-visible particle counting was carried out via a light obscuration method. The 
particles are deduced by the size from the amount of light blocked as the particles 
pass in a single file fashion. According to Ph. Eur. method 2.9.19 and USP method 
<788> the experiment was adapted using a reduced sample volume. The analysis 
was performed using a SVSS-c particle counting system (Pamas, Stuttgart, 
Germany). At fixed fill and ejection rates of 10 ml/min, each sample was measured at 
a volume of 0.3 ml per injection. A first injection of 0.5 ml was discarded to assure 
that the sample will end up directly in the Hamilton syringe and the mean value was 
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obtained from three injections. Between each sample analysis, the system was 
rinsed with water to the point at which the 1 µm particle count of the apparatus was 
less then 20. Sub-visible particles bigger than or equal to 10 and 25 µm are 
presented as cumulative counts per ml. 
 
3.2.2.11 Visual Inspection 
 
A visual inspection for particulate matter was performed in front of a black and a 
white screen manually adapted to Ph. Eur. method 2.9.20.  
3.3. Results and Discussion 
 
3.3.1 Synthesis of Sugar Based Surfactants Mono-PT, Mono-LT und Mono-CT 
 
Few papers have previously been published on the preparation of fatty acid 
monoesters of α,α-trehalose, in any cases the primary hydroxyl group at C-6 was 
esterified (Suzuki et al. 1999; Raku et al. 2003; Chen et al. 2005). Due to the 
symmetrical character of the disaccharide α,α-trehalose, both primary hydroxyl 
groups at C-6 and at C-6‟ show equal reactivity. Consequently, the two monoesters at 
C-6-OH or C-6‟-OH can be considered equivalent, but double acylation to give a 6,6‟-
diester has to be avoided. Chen et al. (Chen et al. 2005) obtained monolinoleoyl α,α-
trehalose by a lipase-catalyzed condensation of trehalose with linoleic acid under 
sophisticated reaction conditions, Raku et al. (Raku et al. 2003)[ performed 
transesterifications of α,α-trehalose with a couple of fatty acid vinyl esters catalyzed 
by Bacillus subtilis protease to obtain various α,α-trehalose monoesters. In contrast, 
a lipase-catalyzed esterification of α,α-trehalose with a fatty acid, accelerated by 
microwave irradiation, gave mainly the 6,6‟-diester.  
For the preparation of the target surfactants an improved protocol based on Datta‟s 
work was developed (Figure 28). Fully silylated 2,3,4,6,2„,3„,4„,6„-octa-O-
(trimethylsilyl)-α,α-trehalose (1) was prepared from α,α-trehalose dihydrate using the 
silylating agents trimethylsilyl chloride and hexamethyldisilazane in anhydrous 
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pyridine following with improved stoichiometry. Product 1 was easily purified by 
crystallization from methanol. Selective deprotection of both primary hydroxyl groups 
to give 2,3,4,2„,3„,4„-hexa-O-(trimethylsilyl)-α,α-trehalose (2) was performed using a 
methanolic potassium carbonate solution. After complete conversion, the reaction 
was stopped by addition of a defined amount of glacial acetic acid to neutralize the 
reaction mixture. Using an excess of glacial acetic acid results in complete 
deprotection of the silylated α, α-trehalose. The crude product 2 could be used for the 
subsequent acylation step without further purification. Predominant monoacylation of 
the symmetrical diol 2 to give the monoesters 3a, 3b, 3c of 2,3,4,2„,3„,4„-hexa-O-
(trimethylsilyl)-α,α-trehalose was achieved using Steglich conditions. In this reaction, 
the carboxylic acids add 1,3-DCC formatting O-acylisoureas. Esterification of the 
hydroxyl group is facilitated by an acyl group carrier like 4-DMAP. As a side reaction, 
the O-acylisourea can undergo a 1,3-rearrangement to give a non-reactive N-
acylurea. Typically, this side reaction is very slow, but if sterically ambitious molecules 
like the sixfold silylated α,α-trehalose and long chained fatty acids are used, this side 
reaction can cause a significant loss in yield. We found, that using stoichiometric 
instead of catalytic amounts of 4-DMAP leads to a significant increase in yields of the 
monoacyl products. But still, this step gives only moderate yields (33 – 45 %). The 
products were separated from unreacted starting material 2 and from 6,6‟-diesters by 
flash column chromatography and were obtained as colorless oils. The aspired 
monoesters of α,α-trehalose 4a, 4b, 4c were prepared by complete removal of the 
remaining six silyl protecting groups with trifluoroacetic acid in aqueous 
tetrahydrofuran. Mono-PT precipitated from the reaction mixture and could be 
separated by filtration. This compound could not be purified by silica gel flash column 
chromatography, since it is able to dissolve significant amounts of silica gel. Finally, 
crystallization from acetone gave pure Mono-PT (4a) as a white solid. Mono-LT (4b) 
and Mono-CT (4c) did not precipitate from the solution after deprotection. Removing 
the solvent using flash evaporation resulted in oily crude products which could be 
purified by flash column chromatography, giving Mono-LT and Mono-CT as white 
solids. The structures of all compounds were confirmed by the data from IR, 1H NMR, 
13C NMR and mass spectroscopy. 
Potential impurities within the trehalose-based excipient could be the agents used 
during synthesis of the excipient. Furthermore the excipient could contain 6,6'-diester 
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which is obtained due to double acylation of the 2,3,4,2',3',4'-hexa-O-(trimethylsilyl)-
α,α-trehalose. After purification of the product, none of these substances could be 
detected by NMR spectroscopy or mass spectrometry. 
 
3.3.2 Physical Characterization 
 
3.3.2.1 Surface Tension and Critical Micelle Concentration 
 
Both surface tension measurements as well pyrene interaction spectroscopy yielded 
comparable CMC results in water (Table 7).  
 
 CMC STM 
(mg/ml) 
CMC PF 
(mg/ml) 
CMC STM 
(mM) 
CMC PF 
(mM) 
Mono-CT 2.14 1.92 4.32 3.87 
Mono-LT 0.21 0.33 0.40 0.62 
Mono-PT 0.006 n.d.* 0.01 n.d. 
 
Table 7: CMC of Mono-CT (4c), Mono-LT (4b) and Mono-PT (4a) in water as 
derived from surface tension measurements (STM) and pyrene fluorescence 
(PF). *not determined. 
 
An increase in hydrophobic chain length resulted in a decrease of the CMC. This is in 
accordance with other publications on sugar based surfactants (Aveyard et al. 1998; 
Chen et al. 2006). The general rule that a two carbon atoms longer fatty acid results 
in an approximately 10-fold lower CMC could be applied to the trehalose monoesters 
(Aveyard et al. 1998). The CMC at 25 °C was not significantly affected by the buffer 
salts used for hemolytic activity and protein stability tests (data not shown). This was 
expected as the surfactants are nonionic and should show only minor interaction with 
ions in the solution (Thorsteinsson et al. 2005), when salts are used in concentrations 
to control pH and regulate osmolarity of the final drug product. Mono-CT showed a 
CMC of 1.92 mg/ml and a decrease of surface tension to 29 mN/m. Mono-LT reached 
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a decrease of surface tension of ~39 mN/m at a CMC of 0.33 mg/ml. For 
Polysorbates a similar values were observed as PS 20 has its CMC at 0.15 mg/ml 
with a decrease in surface tension ~38 mN/m and PS 80 has a CMC of 0.014 mg/ml 
with surface tension values of ~45 mN/m (Wan and Lee 1974). 
 
3.3.2.2 Micelle Size Characterization and Rheometry 
 
PCS experiments were performed at 25 °C and 45 °C. Due to the relatively poor 
solubility at 25 °C Mono-PT could not be analyzed at the lower temperature. As 
reported by Soderman for other sugar based surfactants, all hydrodynamic diameters 
were in the range of 5-15 nm (Ericsson Caroline et al. 2005). 
 
 Volume Mean  Diameter 
(nm) at 25 °C 
Volume Mean Diameter 
(nm) at 45 °C 
Mono-CT 5.0 5.5 
Mono-LT 6.3 7.3 
Mono-PT n.d.* 10.12 
PS 20 6.9 7.9 
PS 80 7.4 9.1 
 
Table 8: Volume mean diameter of different sugar surfactants and PS 20 and PS 
80 at 25 and 45 °C *not determined 
 
Mono-CT had a size of 5.0 nm at 25 °C and 5.5 nm at 45 °C, Mono-LT had a size of 
6.3 nm at 25 °C and 7.3 nm at 45 °C, Mono-PT had a size of 10.1 nm at 45 °C ( 
Table 8). The size increased with fatty acid chain length. The size range was 
comparable to other surfactants such as PS 20 (6.9 nm at 25 °C and 7.9 at 45 °C) or 
PS 80 (7.4 nm / 9.1 nm) and is in good agreement with the data reported for other 
non-ionic Macrogol-based surfactants (Becher and Arai 1968). Results were strongly 
dependent from viscosity and consequently from temperature. Temperature-
dependent viscosities are displayed in Figures 29a and 29b. 
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Figure 29a: Temperature dependence of the kinematic viscosity of 1 % 
solutions of Mono-CT (♦) and Mono-LT () (Mono-PT (■) at 45 °C). 
 
For both Mono-CT and Mono-LT, viscosities of 1 % (m/V) solutions were almost 
identical, with marginally lower values for Mono-CT. Mono-PT was only measured at 
45 °C and in this area, the increase in viscosity was comparable for all three 
trehalose monoesters, and in the range of the viscosity of water. The ratio of viscosity 
of a 1 % (m/V) surfactant solution to pure water at any temperature between 20 and 
45 °C was between 1.025 and 1.038.  
 
Figure 29b: Relative viscosity ηSurfactant/ηwater (b) of 1 % solutions of Mono-CT (♦) 
and Mono-LT () (Mono-PT (■) at 45 °C). 
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The maximum increase could be detected at 30 °C. In contrast, Sodermann et al., 
who worked with the same concentrations of tetradecylmaltoside found a far more 
pronounced maximum of >1.2 at 60 °C (with 1.1 at 30 °C) indicating a shape 
transition of the micelles. Thus, the surfactants described here are expected to form 
spherical micelles and to preserve the structure in the temperature range evaluated. 
 
3.3.2.3 DSC Characterization 
 
Calorimetric measurements of 1 % (w/w) solutions showed no transitions for Mono-
CT and Mono-LT in the range between 10 °C and 75 °C. In contrast, Mono-PT 
exhibited an endothermic transition at 43 °C. In the temperature range the solubility 
also increases substantially. At this point the flexibility of the fatty acid increases and 
melting occurs. Therefore, the applicability of Mono-CT and Mono-LT in a 
temperature range which is relevant for biopharmaceuticals is given. In an additional 
test no cloud point could be detected for 1 % (m/m) aqueous solutions between 20 
and 90 °C for Mono-CT and Mono-LT (data not shown).  
 
3.3.2.4 Hemolytic Activity 
 
An important safety concern of surface active substances is possible rupture of cell 
membranes and formation of mixed micelles with membrane lipids. All trehalose-
based surfactants tended to destabilize blood cell membranes below their CMC. The 
HC5% values were approximately 10 and 5 times below the CMC for Mono-CT and 
Mono-LT, respectively. Mono-PT shows a HC5% at a concentration 4 times above 
CMC. For comparison, PS 20 shows the same hemolytic activity at a concentration of 
1 mg/ml, which is factor 10 higher than the CMC ( 
Table 9). Concentrations usually applied in protein stabilization are approximately at 
or slightly below CMC. Hence, Mono-CT and Mono-LT appear to be suitable 
candidates for further testing concerning protein stabilization, but hemolytic side 
effects should be carefully evaluated. For Mono-PT the calculated HLB was 12.7, for 
Mono-LT 14.0 and for Mono-CT 14.8. In comparison PS 20 has a HLB-value of 16.7 
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and PS 80 has a value of 15.0. Hence, both polysorbates are slightly more 
hydrophilic than the trehalose monoesters.  
 
 HC 5 % (mg/ml) HC 5 % (mM) 
Mono-CT 0.1984 0.400 
Mono-LT 0.0524 0.140 
Mono-PT 0.025 0.05 
 
Table 9: Hemolytic activity of Mono-CT, Mono-LT and Mono-PT. 
 
In literature HLB-values are described as a less significant factor for hemolytic 
activity, however the membrane interaction appears to be more dependent on the 
structural alignment of the surfactants (Zaslavsky et al. 1978; Ohnishi and Sagitani 
1993). Somfai et al. studied other sugar based surfactants and found similar results 
for both highly pure substances as well as technical products, but the cell 
compatibility could be improved by redesigning the hydrophobic chain, e.g. branching 
at the hydroxyl group of 12-hydroxystearic acid (Soderlind et al. 2003; Neimert-
Andersson et al. 2006; Soederlind and Karlsson 2006). In general, determining 
hemolytic activity of substances using washed red cells might result in lower HC5% 
values than in whole blood as other substances present in blood could compete with 
cell membranes for binding to surfactants. 
 
3.3.3 Agitation stress of human growth hormone 
 
Due to its poor solubility at 2 – 8 °C and 25 °C Mono-PT was not included in the 
stability testing of hGH. The expected required concentration of surfactant for protein 
stabilization is in the range of 0.1 to 1 mg/ml (0.01 - 0.1 % (m/V)) as PS 20 and 80 
tend to show their best stabilizing behavior at these concentrations, just below and 
approximately at CMC. Consequently a range of 0.001 to 5 mg/ml was included in 
the studies. 
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3.3.3.1 Particle formation 
 
Visible particles were found in all formulations with surfactant concentrations 
≤0.1 mg/ml. Analysis of subvisible particles via light obscuration also indicated strong 
formation of particles >10 µm and >25 µm upon shaking (Fig. 30). During agitation for 
a short period, concentrations of 0.1 mg/ml PS 80 and Mono-CT suppress the 
formation of visible and subvisible aggregates. Samples with lower Mono-CT 
concentrations showed higher particle numbers than all other formulations but also a 
high standard deviation. For Mono-LT 1 mg/ml was necessary for the stabilization. 
The turbidity measurements, detecting particles in the sub-µm range with high 
sensitivity indicated the same trend.  
 
Figure 30a: Subvisible particles >10µm) of hGH solutions after agitation in 
presence of Mono-LT (white), Mono-CT (black) und PS 80 (grey). 
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Figure 30b: Subvisible particles >25µm of hGH solutions after agitation in 
presence of Mono-LT (white), Mono-CT (black) und PS 80 (grey). 
 
As for visible and subvisible particles extensive protein aggregation occurs at 
concentrations below 1 mg/ml for Mono-CT and Mono-LT and below 0.1 mg/ml for 
PS 80 (Fig. 4). Thus, particle analysis demonstrates the stabilizing effect of Mono-CT 
and Mono-LT. Similar or slightly higher concentrations as compared to PS 80 appear 
to be necessary for sufficient stabilization of hGH. HGH is known for its high 
aggregation tendency during agitation stress and the stabilizing effects of surfactants 
have been described for example by Katakam et al. (Katakam et al. 1995). 
 
Figure 31: Turbidity of hGH solutions after agitation in presence of Mono-LT 
(white), Mono-CT (black) und PS 80 (grey).. 
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3.3.3.2 Size Exclusion Chromatography 
 
Results on SEC show a clear dependency of monomer recovery from surfactant 
concentration for all surfactants (Fig. 5). Very low recovery of less than 40 % resulted 
in the formulations containing 0.01 or 0.001 mg/ml surfactant as well as in the 
0.1 mg/ml mono-LT and PS80 containing formations. 
 
 
Figure 32: SEC monomer recovery of hGH solutions after agitation in presence 
of Mono-LT (white), Mono-CT (black) und PS 80 (grey). 
 
This compared to a recovery of only 24.6 ± 8.6 % in surfactant free formulations. The 
amount of dimers and trimers recovered in SEC after agitation was negligible. This 
loss in recovery corresponded to substantial formation of large aggregrates which 
were excluded from SEC but detected by particle analysis and turbidity 
measurements. This could also be prevented by the new trehalose-based 
surfactants.  For hGH adsorption plays a major role and has been shown to occur at 
filter materials, silica or methylated silica surfaces (Maa and Hsu 1996; Buijs and 
Hlady 1997; Buijs et al. 1998; Maa and Hsu 1998). In order to study this effect, hGH 
was also stored statically without shaking in surfactant free formulation. The recovery 
of hGH decreased over time and leveled off after 6 hours. After 24 h 80 % hGH were 
lost due to adsorption. Addition of 0.1 % (m/V) PS 80, Mono-CT and Mono-LT could 
suppress this effect providing up to 95 % recovery. Thus, the loss in monomer 
recovery in the shaken samples was due to both aggregation and adsorption. 
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Recovery higher than 95 % could only be assured at concentrations of 1 mg/ml and 
5 mg/ml for all three surfactants. These concentrations were slightly above the 
minimum concentration necessary to suppress particle formation. Overall, Mono-CT 
trends to provide the highest recovery values.  
Mono-CT as well as Mono-LT are comparable to PS 80 with regard to their protein 
stabilizing ability in this case study with hGH. A concentration of 1 mg/ml seems to be 
sufficient to stabilize this hydrophobic protein against stress from harsh agitating with 
a high headspace volume. Polysorbate is usually applied in concentrations between 
0.017 mg/ml and 1.6 mg/ml (Hawe et al. ; Wang 1999; Treuheit et al. 2002; Hawe 
and Friess 2008)for this purpose. This corresponds to the results of this study with a 
stabilizing concentration for both trehalose esters and PS 80 of 1 mg/ml. SEC 
revealed that hGH did not form dimers nor trimers upon agitation. Instead, marked 
formation of larger particles as demonstrated by turbidity measurement, subvisible 
and visible particles occurs. This corresponds to results seen by other groups 
(Katakam and Banga 1997). Depending on the type of stress different types of 
aggregates can be produced (Ha et al. 2002; Mahler et al. 2009). In this case 
shaking induced the formation of very large vesicles.  
 
3.4. Conclusions 
 
Three trehalose-based surfactants were synthesized in high purity. Mono-PT with the 
lowest HLB value in this group shows insufficient water solubility at 2 – 8 °C and 
25 °C and therefore appears to be less suitable for protein formulation. The two 
substances with shorter fatty acid chains, Mono-CT and Mono-LT seem to have the 
potential to be applied in biopharmaceutical formulations. The formation of micelles 
and the reduction in surface tension are comparable to PS 80 and PS 20. Both these 
sugar based surfactants show slightly higher hemolytic activity as compared to 
polysorbates. A change from a linear to a branched hydrophobic part of the surfactant 
might lead to an improvement in regards of the ratio of CMC to haemolytic activity as 
described by Somfai et al. for other sugar based surfactants (Soederlind and 
Karlsson 2006). Mono-CT and Mono-LT form transparent and colorless aqueous 
solutions and do not show phase transitions or separation at pharmaceutically 
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applied temperatures. Due to their high purity and their molecular structure, induction 
of chemical instability of biopharmaceuticals is less likely compared to polysorbates. 
Similar as polysorbates, Mono-CT and Mono-LT were able to stabilize hGH against 
aggregation upon shaking as well as adsorption. As trehalose is known to be a good 
bulking agent and lyoprotector (Wang 2000) these substances might show an even 
better performance in freeze-dried formulations. Consequently, trehalose-based 
surfactants offer great potential for application in biopharmaceutical formulations. 
Potential use requires large toxicological studies and enourmous regulatory hurdles 
would have to be met, but some manufacturers of sugar based surfactants got 
approval for clinical use after only a few animal studies (Maggio 2008) and increased 
IP space by application of new excipients could trigger this.  
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4. Stress test of protein formulations 
with different nonionic surfactants 
4.1. Introduction 
 
For the development of pharmaceutical formulations stress tests are an important 
tool to evaluate the shelf life of different recipes. As already described in the 
introduction chapter proteins can be exposed to different kinds of stresses. The 
addition of nonionic surfactants in general reduces interface induced stress. These 
interfaces typically exist between the aqueous protein solution and the neighboring 
phases. The most important interface is formed towards the gas phase, typically air 
or nitrogen (Maa and Hsu 1997; Baszkin et al. 2001). This interface can be expanded 
and becomes more dynamic via shaking or stirring, which increases the applied 
stress and speed up the development process (Kiese et al. 2008; Eppler et al. 2010; 
Serno et al. 2010). The other important interface is between the protein formulation 
and its container. Proteins are also stressed at the water-ice interface during freezing 
and thawing (Tang and Pikal 2005). In all these cases nonionic surfactants were able 
to stabilize the protein against the interfacial stress. In this chapter the comparison of 
different sugar-based surfactants against polysorbates as the gold standard in 
pharmaceutical formulations (Wang 2005) is made. Some drawbacks can come 
along with the use of polyethyleneglycol-based surfactants, such as oxidation of the 
protein (Wang et al. 2008). Also direct side effects (Donbrow et al. 1978; Azaz et al. 
1981) have already been described already in the literature, see also chapter 2. The 
most promising sugar based surfactants candidates selected based on their physical 
chemical properties plus self-synthesized trehalose esters were tested for their 
protein stabilizing capacity during agitation and storage at elevated temperatures. For 
the agitation stress tests it would be desirable for the new surfactants to show a 
behavior comparable to polysorbates as the stabilizing abilities of the latter are 
already satisfying. With respect to storage at elevated temperatures it would be 
hoped that the sugar based surfactants would score better as peroxide equivalents 
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were not detectable in these mixtures even after longer storage under UV radiation 
(see chapter 2). 
 
4.2. Materials and Methods 
 
4.2.1. Material 
 
For synthesis of the trehalose esters, please refer to chapter 3. All sugar based 
surfactant mixtures were kindly donated by their suppliers. Plantacare products were 
donated by Cognis (Düsseldorf, Germany), Ryoto Products were donated by , NV10 
was donated by Novexin. Polysorbate 20 (PS 20) and Polysorbate 80 (PS 80) were 
obtained from Sigma Aldrich (Munich, Germany). Analytical grade buffer salts and 
HPLC grade Acetonitrile and Trifluoracetic acid were obtained from Merck Chemicals 
(Darmstadt, Germany). The deionized water used for the experiments was taken 
from a PURELAB Plus system (ELGA labwater, Celle, Germany). The water had a 
conductivity <0.055 µS/cm.  
 
4.2.2. Methods 
 
4.2.2.1. Stress Tests 
 
4.2.2.1.1. Agitation stress test of hGH containing formulations 
 
hGH is a very sensitive protein when it comes to surface related stress. But the 
problem is to find the amount of stress that is sufficient to lead to aggregation and 
stop at a time point where you can differentiate between a stabilizing and a non 
stabilizing formulation (Eppler et al. 2010). Shaking (St. John et al. 2001), vortexing 
in centrifugation tubes (Katakam et al. 1995), or stirring with magnet bars (Maa and 
Hsu 1997) are typically used to stress hGH. None of these approaches worked as it 
was either too harsh or not sufficiently stressful. Ultimately,  a Retsch MM 200 
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swinging mill (Retsch GmbH, Haan, Germany) was employed. For hgH containing 
formulations, agitation of 1.9 ml of 0.1 mg/ml hGH in 10 mM phosphate buffer pH 7.4 
together with different concentrations of nonionic surfactants was performed in 2R-
Vial at 8 Hz for 10 min. 
 
4.2.2.1.2. Stress Tests with Il-11 Containing Formulations 
 
For IL-11, agitation of 2 ml of 0.5 mg/ml IL-11 10 mM phosphate buffer and the 
respective amount of nonionic surfactant was performed on a horizontal shaker at 
20 Hz for 172 h at ambient temperature.  
Storage stability of 0.5 mg/ml protein formulations containing nonionic surfactants 
was performed at 2-8, 25, 40 and 50°C on the basis of the ICH guidelines ICH Q1. 
Storage was performed in 2R-vials with a fill volume of 1 ml. Samples contained 
10 mM glycine and 10 mM phosphate buffer pH 7.0 plus one type of surfactant. At 
0.01% were stored PS 20, PC 2000, PC 818 and NV-10 and trehalose caprinate (n=2 
/ plus a surfactant free control sample). Furthermore PS 80 and trehalose laurate 
were applied at 0.1% and 0.001% as well. Additional samples of pure PC 2000 and 
PS 80 have been exposed to UV-radiation (366 nm) for a period of one week. 
Samples of stressed surfactants were prepared by spreading of a 10 ml sample of 
10% surfactant solutions. Samples were filled and crimp sealed into cleaned and 
heat sterilized vials. Storage stress experiments in incubators were performed in 
paper container boxes to exclude light radiation induced oxidation effects. 
Furthermore, additional experiments were performed with freeze-dried formulations. 
All freeze-dried formulations contained additionally 1% glycine to the buffer salts and 
the surfactant. The amino acid is used as bulking agent. This excipient is also used in 
the market formulation of Neumega® in a concentration of 2.3%. Freeze-drying was 
performed with an Epsilon 2-6D freeze dryer (Martin Christ GmbH, Osterode, 
Germany). 2 ml of the above mentioned formulations were lyophilized as follows: 
Freezing: 3 h from ambient temperature to -50 °C, no vacuum 
Primary Drying: 21 h at -20 °C, 0.05 mbar 
Secondary Drying: 48 h at -10 °C, 0.01 mbar 
Samples were closed at 800 mbar vacuum. All vials revealed cosmetically elegant 
cakes. Formulations were stored under 40 °C and 50 °C and samples were taken 
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both after one and two weeks. 
 
4.2.2.2. Size Exclusion Chromatography 
 
hGH: A HP 1100 HPLC system (Agilent Technologies, Waldbronn, Germany) 
equipped with a diode array detector and a 3000 SWXL gel filtration column (Tosoh 
Bioscience, Tokyo, Japan) was used for this experiment (50 µl injection volume). The 
running buffer was composed of 50 mM NaH2PO4 and 150 mM NaCl at a pH of 7.2. 
The analysis were performed at a flow-rate of 0.5 ml/min with UV-detection at 
216 nm. 
Il-11: Size exclusion chromatography was performed using a TSK G2000 SWXL 
column (Tosoh Bioscience, Tokyo, Japan) at 4±2 °C (50 µl injection volume at 
0.1 mg/ml) on the same HPLC system. A running buffer containing 0.1mM glycine, 
500mM sodium chloride and 50mM morpholinoethanesulfonic acid (MES) at pH6.0 
was used at a flow rate of 0.75 ml/min. Detection wavelength was set at 225 nm. 
Concentrations of the samples of both proteins were calculated based on AUC in 
comparison with freshly prepared protein standards. 
 
4.2.2.3. Turbidity measurments 
 
Turbidity of the shaken samples was quantified via UV-absorption at 350 nm. 200 µl 
samples were placed in a 96 well plate and tested in a Fluostar Omega reader with 
analysis software (BMG Labtech, Offenburg, Germany). Pure buffer was used as a 
blank sample. Samples were corrected against an unshaken control, hence negative 
values occur for the more stable formulations. 
 
4.2.2.4. Light Obscuration measurements 
 
Sub-visible particle counting was carried out via a light obscuration method. The 
particle size is deduced from the amount of light blocked as the particles pass in a 
single file fashion. According to Ph. Eur. method 2.9.19 and USP method <788> the 
experiment was adapted using a reduced sample volume. The analysis was 
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performed using a SVSS-c particle counting system (Pamas, Stuttgart, Germany). At 
fixed fill and ejection rates of 10 ml/min, each sample was measured at a volume of 
0.3 ml per injection. A first injection of 0.5 ml was discarded to assure that the sample 
will end up directly in the Hamilton syringe and the mean value was obtained from 
three injections. Between each sample analysis, the system was rinsed with water to 
the point at which the 1 µm particle count of the apparatus was less than 20. Sub-
visible particles bigger than or equal to 10 and 25 µm are presented as cumulative 
counts per ml. To prevent artifact particles from the pure water, the system was 
rinsed 15 min prior to sampling. 
 
4.2.2.5. Visual Inspection 
 
A visual inspection for particulate matter was performed in front of a black and a 
white screen manually adapted to Ph. Eur. method 2.9.20.  
 
4.2.2.6. SDS-Page 
 
Covalent aggregation of Interleukin 11 was analyzed via non-reducing denaturing 
SDS polyacrylamid gel electrophoresis. NuPage 10% and NuPage running buffer 
(Invitrogen, Karlsruhe, Germany) were used for these experiments. The 
elecotrophoresis was performed at a constant current of 0.03 A per gel. NuPage LDS 
sample buffer was added to the samples, which were denaturated for 10 minutes at 
95 °C. 20µl of the solution was transferred into the gel. The amount of protein was 
set to 5 µg protein. The gels were stained with Colloidal Blue staining kit (Invitrogen, 
Karlsruhe, Germany). 
 
4.2.2.7. Reversed Phase HPLC 
 
Related species of IL-11 were detected at a wavelength of 214nm at the variable 
wavelength detector and the diode array detector (adapted from (Yokota et al. 2000)). 
Two eluents, water plus 0.1% triflouric acetic acid [A] and water/acetonitril 
(20/80(m/m)) plus 0.1% triflouric acetic acid [B] were used in the gradient. The 
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gradient ranged from 30% B to 100% B and flow rate from 0.5-2 ml/min. One 
experiment lasted 35min. A Poros R1/10 4.6x100 (Applied Biosystems, Darmstadt, 
Germany) RP column was used at ambient temperature for separation. A blank buffer 
chromatogram was subtracted from every sample to flatten and smooth the base 
line. The percentage of the related species was calculated from this subtracted 
system by determining the AUC of the observed peaks as a percentage of the total 
peak area. In Figure 33 a typical chromatogram is shown. Nature of the single peaks 
is explained in Kenley and Warne (Kenley and Warne 1994).  
 
 
Figure 33: Chromatogram of related species detection of IL-11 after RP-HPLC 
 
For RP-HPLC of oxidized IL-11 the eluent for the detection was the same as for the 
detection of related species. For detection of oxidized methionine the column 
temperature was set to 40 °C and the samples were diluted to a final concentration of 
0.08 mg/ml. The amount of oxidized methionine was detected as area under the 
curve from the shoulder peak eluting shortly before the main protein peak (Yokota et 
al. 2000). The amount of oxidized methionine was detected as a peak shoulder of the 
protein peak as visualized in Figure 34. 
Peak recovery, % oxidized species, and % oxidized methionine were calculated from 
the AUC of the chromatograms. For further details on the single degradation products 
separated with these methods, please refer to Fitzner (Fitzner 2003). 
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Figure 34: Typical chromatogram of an RP-HPLC analysis for oxidized 
methionine species. The shoulder eluting before the main protein peak at 24 
min represents the Il-11 with oxidized methionine. All other peaks are summed 
up to other oxidized species. 
 
4.3. Results and Discussion 
 
4.3.1. Stress Testing of Il-11 
 
4.3.1.1. Thermal Stress 
 
All liquid IL-11 formulations revealed a significant loss in monomer content and high 
amounts of insoluble aggregates already after short periods of time at 50 °´C. HPLC 
analysis revealed lower drug content in the soluble phase and most samples were 
visibly turbid as detected by the naked eye. UV measurements at 350 nm confirmed 
the increased turbidity.  
SDS page was performed with the highest temperature samples. Analysis revealed 
the absence of covalent aggregate formation with Coomassie blue staining (Figure 
35). 
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Figure 35: SDS page of Il-11 formulations with different nonionic surfactants 
after storage 50 °C for 6 weeks (Coomassie Blue staining). Control 
corresponds to unstressed IL-11, C-12 and C-10 to trehalose laurate and 
caprinate, respectively, PS80 0.1% to 0.1% polysorbate 80 (higher surfactant 
concentration), PS80 ox and PC 2000 ox to the preoxidized surfactant 
formulations. 
 
The only sample that showed differences to the control was the samples with the 
highest amount of PS 80 (PS80 0.1%) and to a slightly lesser extend the sample 
containing 0.01% PS 20. But contrary to the expected covalent dimers it could be 
found that the protein seems to form fragments. Extra bands for dimers are present 
in all samples, but to a very low extend. One can only speculate that the formulations 
with PC2000 perform better on this measure.  
RP-HPLC data for related species detection are shown in Figure 36-7. For all 
surfactants the amount of total protein was decreased and the oxidized content of all 
samples increased. Differentiation between the effect of the different surfactant types 
is not feasible. 
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Figure 36: IL-11recovery in [mAU*s] from samples stored at 40 °C for 2 weeks 
with different nonionic surfactants. Dark grey corresponds to native IL-11, light 
grey to related species. Start values 12100 mAUs and 600 mAUs. 
 
 
After a storage time of two weeks at 40 °C in the samples with high surfactant 
content (0.1% PS80 or C10, respectively) the protein was almost vanished. Highest 
protein recovery is gained from PC 2000 containing samples. Compared to the 
samples before storage, protein loss is about 15% for all samples at 0.01% or 
0.001% surfactant concentration. 
 
 
Figure 37: Il-11recovery in [mAU*s] from samples stored at 40 °C for 6 weeks 
with different nonionic surfactants. Dark grey corresponds to native Il-11, light 
grey to related species. Start values 12100 mAUs and 600 mAUs. 
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were completely precipitated. At this sampling point the 0.01% and 0.001% 
polysorbates containing samples together with the PC 2000 containing sample 
showed the highest recoveries. 
 
 
Figure 38: Il-11recovery in [mAU*s] from samples stored at 50 °C for 2 weeks 
with different nonionic surfactants. Dark grey corresponds to native Il-11, light 
grey to related species. Start values 12100 mAUs and 600 mAUs. 
 
Samples stored at 50 °C showed stronger aggregation than the 40 °C samples. Only 
approximately 60-75% of the starting protein content could be recovered. Also at 
40 °C the high surfactant concentrations caused complete precipitation of the protein.  
 
 
Figure 39: Il-11recovery in [mAU*s] from samples stored at 50 °C for 6 weeks 
with different nonionic surfactants. Dark grey corresponds to native Il-11, light 
grey to related species. 
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same holds true for the samples stored for six weeks. After six weeks, recoveries for 
the sugar based surfactants stay at the two weeks level, but the polysorbate samples 
exhibit further decrease. Another observation is that the absolute amount of related 
species remains similar at 50 °C. 
Thus one can say that a differentiation between surfactants is difficult. It seems at 
higher temperatures that the sugar based surfactants, especially PC 2000, are 
superior to the standard polysorbates. But recoveries were quite low and the 
analytics have only been performed with the soluble part of the protein. PS 80 at 
0.1% showed the highest amounts of fragments in SDS-page. The experiments at 
40 °C showed no clear trend. An explanation for this might be that polysorbates tend 
to destabilize the native state more and favor unfolding and hence precipitation of the 
protein at elevated temperatures. This would also explain, the almost complete 
precipitation of the high surfactant concentration formulations. Phenomena like this 
are already discussed in literature from the groups of Randolph for the intermediate 
molten globule state of hGH or Westh for the binding and unfolding behavior of SDS 
with cutinase from Humicula insolens (Bam et al. 1996; Nielsen et al. 2005). 
 
Figure 40: RP-HPLC results in [mAU*s] of lyophilized Il-11 with different 
nonionic surfactants at 0.01 % (w/V) after 1 week storage at 50 °C (Control 
values: 500 for oxidized species, 1200 for oxidized Methionine, and 60000 for 
the native protein peak). Dark grey represents unaltered IL-11, light grey 
oxidized methionine, and grey other oxidized species. 
 
After lyophilization, the protein formulations behaved all very similar. Figure 40 shows 
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exemplarily the RP-HPLC analytics for oxidized methionine. The same picture was 
found for 40 °C storage and for the analysis of related species. All surfactant 
formulations showed higher protein recovery than surfactant free Il-11 formulation 
after two weeks, but further differentiation is not possible.  
 
4.3.1.2. Agitation Stress 
 
After shaking for 24 h no visible changes in protein content, particle counts or 
turbidity could be found in comparison to the surfactant free formulations. SEC 
recovery for all formulations was between 97±3% and 99±2%. After 172 h the highest 
surfactant concentrations showed the highest recovery of protein (Figure 41). PS 80 
showed a trend to slightly lower recovery than the sugar based surfactants and NV 
10 a trend to the best protein protection. Generally, these differences lie within the 
standard deviations and are hence insignificant. Interestingly, the lowest surfactant 
concentration of 0.0001% showed almost as good results as 0.1 and 0.05% 
surfactant. The fact that intermediate surfactant concentrations reveal detrimental 
results is already described in literature for IgG monoclonal antibodies (Mahler et al. 
2005; Matheus 2006). The reason for this behavior remains unclear. Another 
observation is, similar to hGH, that the amount of dimers and trimers remains 
constant (data not shown). This is confirmed by the light obscuration and turbidity 
results. Unfolded protein seems to aggregate to larger particles in the subvisible and 
visible size range. For all surfactants the highest particle counts after 172 h are found 
at 0.005-0.0005%. The lowest concentration showed lower amounts of visible and 
subvisible particles. Yet, all concentrations were lower in particle counts and turbidity 
than the surfactant free formulation. As this experiment was performed in a very early 
stage of the thesis, trehalose fatty acid esters were not yet available, and were 
therefore not tested. Turbidity and light obscuration measurements were also 
performed with a corresponding outcome (Figure 43 and 44). The higher the 
surfactant concentration is the lower the turbidity of the formulations. The turning 
point of protein stability lies between 0.01% and 0.1% surfactant. Although the 
protein content is still decreased at 0.01%, no visible particles are formed. This 
concentration is comparable to the concentration needed for Il-11 stability. 
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Figure 41: Il-11 recovery from SEC after shaking at various concentrations of 
nonionic surfactants (control 100%, surfactant free formulations 25±5%). 
 
4.3.2. Stress Testing of hGH 
 
4.3.2.1. Agitation Stress 
The results from shaking hGH in the presence of trehalose esters are also displayed 
in chapter 3. 
 
Figure 42: Protein recovery from SEC results of hGH after shaking  
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Similar results were obtained from shaking hGH together with technical mixtures of 
sugar based surfactants. Also the Plantacare products show comparable behavior to 
PS 80 in terms of protein protection. A concentration of 0.1% provided good protein 
protective effect. As a negative control, surfactant free hGH had a residual protein 
content of only 16±4%. 
As the surfaces generated with the stress methods are more dynamic, higher 
surfactant content may be needed to cover all surfaces generated by shaking in the 
swinging mill. As proved by Friess et al. and also protected as patent, the head space 
is crucial for shaking stability of the protein (Friess et al. 2008; Kiese et al. 2008) We 
used a large headspace to let the fluid spread widely and build new and large 
surfaces to substantially stress the protein formulations. 
 
 
Figure 43: Turbidity of hGH after shaking. 
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Figure 44: Particles >10 µm of hGH containing formulations after shaking. 
 
4.3.2.2. Adsorption at Container Surfaces During Storage 
 
Proteins are eager to adsorb to different kinds of surfaces (Mathes 2010). Especially 
hydrophobic proteins tend to have reduced contents after simple storage due to 
adsorption to different container materials (Johnston 1996). During the shaking stress 
studies some problems occured with the content of unstressed hGH as control 
standard. The protein content within the HPLC vial decreased up to 10% over 24 h 
when no surfactant was added (Figure 45). hGH is known for its tendency to adsorb 
on different kinds of liquid-solid interfaces, such as filter material (Maa and Hsu 
1998), polystyrene surfaces (Katakam and Banga 1997), and different silicas (Buijs 
and Hlady 1997). Hence, we tested also for the ability of the surfactants to prevent 
adsorption to container walls. 
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Figure 45: hGH adsorbs to HPLC vial wall at 4 °C rack temperature. 
  
Figure 46 shows hGH adsorption of 0.5 mg/ml solution without surfactant to the 
container wall of a 2R-vial depending on the history of the container. The autoclaved 
containers demonstrated the highest rates of adsorption. These containers were 
further used to evaluate the ability of the surfactants to prevent adsorption. 
Autoclaving the glass vials made them more prone to adsorption. This is most 
probably to due to the removal of ions from the glass surface or the higher energy 
intake depolarizing the glass surface (Burke et al. 1992). 
 
 
Figure 46: Adsorption of 0.5 mg/ml hGH to three differently prepared types of 
2R-vials. 
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In Figure 47 the adsorption of protein with 0.01 % surfactant in the formulation is 
shown. The surfactants were not able to reduce adsorption.  
 
 
Figure 47: Protein adsorption of 0.2 mg/ml hGH in the presence of 0.01% 
nonionic surfactant. 
 
Figure 48 shows the same experiment with a higher surfactant concentration of 
0.1%. In this case PS 80 shows the best result. However, no surfactant could 
effectively reduce adsorption although polysorbates are already described to prevent 
adsorption better at the applied concentrations (Duncan et al. 1995). 
 
Figure 48: Protein adsorption of 0.2 mg/ml hGH in the presence of 0.1% 
nonionic surfactant. 
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In all cases approximately 20% loss of protein content was measured after 6 h 
incubation at ambient temperature. It appears that the best choice in these 
experiments would be 0.1% PS 80 as this was the only formulation where adsorption 
could be reduced significantly. However, none of the surfactants showed inferior 
behavior. Higher amounts of surfactant (1% or higher) might have increased protein 
contents. Mathes came to a similar conclusion (Mathes 2010). Surfactants can only 
to a certain extend prevent the adsorption to containers. This is depending on the 
surface activity and hydrophobicity of the protein, surface tension of the surfactant 
and several other factors such as unfolding at the interface (Goddard 2002). In this 
case hGH seems to have a high affinity to the interface which can be adequately 
addressed with the surfactants. 
 
4.4. Conclusions 
 
In this chapter Il-11 and hGH were exposed to different kinds of stress, thermal, 
kinetic and interfacial. In order to eliminate the aggregate formation of Il-11during 
shaking experiments 0.1% surfactant was necessary. This was already too much 
surfactant for the storage experiments at elevated temperaturesas 0.01% performed 
sufficiently well and showed no differences to 0.001%.  
For hGH 0.1% surfactant was not enough to prevent adsorption at container walls. 
For shaking stress full protection of the protein could be achieved by addition of 0.1% 
of all applied surfactants. The stresses applied on both proteins in this study could be 
reduced by the addition of sugar based surfactants. But for different experimental set-
ups it was necessary to apply different concentrations of surfactants to prevent 
proteins from aggregation and adsorption. Other groups also applied agitation stress 
as predictor for formulation stability and came up with different amounts of surfactant 
needed for protein stabilization. Recombinant human Interferon-gamma can be 
stabilized with 0.03% PS 20 (Webb et al. 2002), 0.004% PS 20 stabilizes PEG-GCSF 
but has inverse effects when stored at higher temperatures (Treuheit et al. 2002), 
Albutropin can be stabilized protein concentration dependent by PS 20 and PS 80 at 
a molar ratio greater than 10:1 and 9:1, respectively (Chou et al. 2005) For hGH 
ratios of 4-5:1 surfactant molecules per protein molecule are described to prevent 
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aggregation (Bam et al. 1998). For an IgG1 antibody the concentration of 0.01% was 
not sufficient to fully prevent denaturation against shaking (Mahler et al. 2005). In 
another shaking experiment 0.1% PS 80 was sufficient to stabilize Il-2 against 
shaking but also destabilized when stored over longer periods (Wang et al. 2008), 
which is opposite to our findings that more surfactant is needed against shaking 
stress, than against storage stress. 
It could be shown that sugar based surfactants can be applied in the same 
concentration range as polysorbates to achieve similar results in protein stabilization 
for all stress methods applied. In the different models the differences between the 
Plantacare products, the trehalose fatty acid esters and, when tested, NV 10 to 
polysorbates are minor. For storage stress of Il-11 NV 10 showed the best 
performance, in the adsorption experiments PS 80 of hGH showed the best recovery, 
and when hGH is shaken the trehalose fatty acid esters were the most promising 
candidates. Also the concentration range needed for protein stabilization is similar to 
what can be found in literature. The required concentration of surfactant is strongly 
protein and model dependent and in this case was between 0.001% and >0.1%. 
Influencing factors for the amounts needed to prevent protein from aggregation at an 
interface might be the surface charge (isoelectric point) and amount of hydrophobic 
amino acids on the protein surface (Ramsden and Prenosil 1994; Larsericsdotter et 
al. 2001), the unfolding energy and melting temperature (Andersen Kell et al. 2009). 
Type of buffer and pH value also have an impact on the amount of surfactant needed 
for stabilization (Ruiz et al. 2005), or the tendency to form aggregates as “planned by 
nature”, e.g. insulin dimers and hexamers (Brange et al. 1997). 
This makes the sugar based surfactants an attractive alternative to polysorbates. 
Unfortunately, the storage stress model could not prove an advantage over 
polysorbate, even when higher peroxide contents were produced prior by radiation of 
the surfactant samples. This should be tested again with another molecule that is 
more prone to oxidation.  
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5. Studies on the Binding Interactions 
between Nonionic Surfactants and 
Proteins in Liquid Formulations  
5.1. Introduction 
 
Surfactants are frequently added stabilizers in protein drug formulations. They are 
used because they can on the one hand reduce protein adsorption to container 
surfaces (Hawe and Friess 2008). On the other hand they can help to avoid protein 
aggregation in solution, specifically when aggregation is interface stress induced 
(Charman et al. 1993; Bam et al. 1998). It is speculated on the mechanism how the 
surfactants achieve this effect. There might be the surface competition that leads to 
physical stable formulations. But also specific interaction was discussed. E.g. 
coverage of hydrophobic sites on the protein resulting in reduced interaction with 
interfaces. It has to be kept in mind that hydrophobic interaction is just one minor 
fraction of the attractive forces. 
At the same time strong interaction of surfactant with protein may shift the unfolding 
equilibrium towards the unfolded state, if unfolding is the rate limiting step (Nielsen et 
al. 2000). The exposed hydrophobic sites and larger surface of the protein provide 
the energetically basis that the unfolded state is more stabilized than the native. 
Theories whether surfactants can act as artificial chaperones also exist, but for an 
active folding process, the measured enthalpies seem to be too low (Bhattacharyya 
and Das 1999; Garidel et al. 2009). To shed further light into this complex situation 
we studied the interaction of proteins with surfactants focusing on isothermal titration 
calorimetry, supported by NMR studies of selected samples. 
Isothermal Titration Calorimetry (ITC) is one of the major tools for the determination 
of thermodynamics in protein science (Liang 2008), especially in protein binding 
energetics (Leavitt and Freire 2001). The main outcome of ITC-measurements is a 
binding isotherm reflecting interaction as a function of the amount of injected 
 124 
 
substance. If the data can be modeled, ITC provides information on free energy- , 
enthalpy- entropy- and stoichiometry of binding in one single experiment. By testing 
at different temperatures the heat capacity change can be tested as well (Simon et al. 
2002). Unfortunately determining binding isotherms in a single experiment is only 
feasible when strong interactions occur or when protein and/or ligand concentrations 
are extremely high (Chou et al. 2005). 
Protein surfactant interactions studied via ITC are described by McAuley et al. who 
found weak, possibly hydrophobic interactions between lactate dehydrogenase and 
polysorbates (McAuley et al. 2009) or by Garidel et al. who analyzed the interaction 
between polysorbates and immunoglobulines and bovine serum albumin (BSA) 
(Garidel et al. 2009). We disregarded the frequently applied BSA from our studies as 
this protein might show good binding enthalpies but an not serve as a good model as 
this interaction is specific to the fatty acid binding pocket of BSA (4) and not 
transferable to other protein drugs. 
A good example for strong protein-surfactant interactions is the lysozyme-sodium 
dodecylsulfate-system (Jones 1992) as the attracting forces are driven by 
electrostatic interactions and not only by hydrophobic ones. However, these 
interactions are not transferable into pharmaceutical formulation work, as for 
hemocompatibility reasons nonionic surfactants are applied and these cannot interact 
via attractive charge-charge attractions. 
We used ITC to determine the nonspecific interaction between nonionic surfactants 
and model proteins. As the expected interaction in this study are very weak 
compared to the enthalpies studied typically in biophysical studies, binding was 
determined indirectly by analyzing the shift of the critical micelle concentration (CMC) 
with the addition of proteins in the sample cell (Otzen et al (Andersen Kell et al. 
2008)). The shift of the thermogram with increasing protein concentration renders 
information on the binding stoichiometry. 
Further information on direct interaction between proteins and surfactants can in 
general be gained from Nuclear Magnetic Resonance (NMR) spectroscopy. With the 
help of two dimensional Nuclear Overhauser Enhancement spectroscopy (NOESY) 
cross-peaks arising from spins from moieties on different molecules that are spatially 
close can be identified. This allows determination of interactions and provides 
information on the site of interaction. The average maximum distance between two 
  
 
spins that can be detected via NOESY is about 5.5 Å. Ulvenlund et al. (Sjoegren et 
al. 2005) studied the interaction between polypeptides and alkyl polyglycosides and 
proved that folding to beta-sheets was improved with the addition of surfactants. 
Matilainen et al. (Matilainen et al. 2008) used NOESY to determine the interaction 
between cyclodextrins and glucagon and found inclusion complexes in acidic 
solution. Wong et al. (Wymore and Wong 1999) applied NOESY to determine the 
molecular dynamics and the temperature dependence of the partitioning coefficient of 
substance P peptides in sodium dodecylsulfate (SDS) systems. But to our knowledge 
the interaction between parenterally applied proteins and surfactants has not yet 
been studied by NOESY. 
The outcome of interaction of three surfactants with three different selected proteins 
was investigated. Polysorbate 80 (PS 80) was selected as one of the most frequently 
used surfactants in protein formulation acting as a benchmark. One drawback of PS 
80 is its potential to reduce long term stability of formulations due to enhanced 
oxidation rates of the protein. This adverse effect was related to the presence of side 
products (Wang et al. 2008). Therefore, additionally two sugar- and fatty alcohol-
based nonionic surfactants, Plantacare 818 UP (PC 818) and Plantacare 2000 UP 
(PC 2000) were implemented in the study (Kuehn and Neubert 2004). They are not 
yet approved for invasive application but might become an alternative to the 
established surfactants in the future. They show similar surface behavior to 
polysorbates (De Grip and Bovee-Geurts 1979; Aveyard et al. 1998) and are 
environmentally friendly (Garcia et al. 1997; von Rybinski and Hill 1998). 
Three proteins were used in this study. α-Lactalbumin (α-LA) is known to interact with 
SDS when studied in the calcium free Apoform (Otzen et al. 2008) . The calcium 
bound Holoform interactions were expected to be smaller as a certain area on the 
protein‟s surface is then covered with Ca2+-ions. Human and bovine α-LA are known 
to act as a cytotoxic agent in the therapy of papilloma, cancer cells or actinic 
keratosis (Ruffet et al. 2008; Axelsen et al. 2009). Interleukin-11 (IL-11), which is 
applied to improve platelet recovery after chemotherapy induced thrombocytopenia 
(Bhatia et al. 2007) was used as a pharmaceutical relevant example as aggregation 
in formulation can be reduced with the help of surfactants (Page et al. 2000). 
Furthermore it is oxidation sensitive and consequently the combination with PC 818 / 
PC 2000 could potentially be of special interest (Yokota et al. 2000). For NOESY 
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experiments LA and human Growth Hormone (hGH) were applied. 
 
5.1. Material and Methods 
 
5.1.1. Material 
 
PS 80 and bovine α-LA >95 % calcium depleted was obtained from Sigma-Aldrich 
(Darmstadt, Germany). The sugar based nonionic surfactants PC 818 and PC 2000 
were kindly donated by Cognis KG (Düsseldorf, Germany). Recombinant Interleukin-
11 (IL-11) was kindly donated by Wyeth Pharmaceuticals (Andover, USA). Human 
Growth Hormone (hGH) was kindly donated by Bernina Plus & HDS (Martinsried, 
Germany).  
All buffer salts and pyrene were of analytical grade. Highly purified water was taken 
from a Millipore system. All materials were used as purchased and not further 
purified. 
In the ITC experiments buffers were used as follows: As a standard buffer 50 mM 
Sodium EDTA for the apoform of α-LA was used. For the holoform and for IL-11 a 
buffer containing 20 mM CaCl2 and 20 mM 3-(N-morpholino)propanesulfonic acid 
was used as standard buffer. 
 
5.1.2. Tensiometry 
 
Determination of CMC via surface tension measurement was performed with a K-100 
MK2 tensiometer (Krüss, Hamburg, Germany) in a custom built conical vessel with a 
platinum-iridium plate and a 765 Dosimat (Metrohm, Filderstadt, Germany). The CMC 
was calculated using LabDesk 3.1 software (Krüss, Hamburg, Germany). 
 
 
5.1.3. Pyrene Interaction Fluorescence Spectroscopy 
 
Pyrene fluorescence was applied to alternatively determine the CMC according to 
(Kalyanasundaram and Thomas 1977). Fluorescence spectra were recorded and the 
  
 
I1/I3 ratio was calculated, where I1 is the emission at 373 nm and I3 is the emission 
at 393 nm. Excitation wavelength was 335 nm. The CMC was defined as the 
surfactant concentration at which the I1/I3 ratio becomes smaller than <1 as the 
fluorescent dye migrates into the micelle core protected from water molecules. 
Experiments were performed in Quartz cuvettes with 10 mm pathway using a Cary 
Eclipse spectrofluorimeter (Varian, Palo Alto, USA). 10 µl of a 200 mM pyrene 
solution in ethanol was added to 1990 µl surfactant solution (N=3). 
 
5.1.4. Isothermal Titration Calorimetry 
 
ITC measurements were performed with a VP-ITC calorimeter (Microcal Inc., 
Northampton, USA). The obtained heat signals were integrated using the Origin 
software supplied by Microcal Inc. After filling of the sample solution into the sample 
cell and positioning the stirring syringe, the machine was equilibrated at 5 °C, 25 °C 
and 37 °C for at least two hours. After equilibration additional 120 sec of initial delay 
were set before the first injection started. Usually 35 injections of 8 µl with an 
injection speed of 0.5 µl/sec were added into the sample cell. Between every 
injection the heat flow was allowed to equilibrate back to baseline. The reference 
power was set to 25 µCal/sec for the experiments. 
In a typical experiment the reference cell was filled with water, the sample cell 
contained either buffer or protein solution. The sample cell was titrated with aliquots 
of nonionic surfactants. Usually, at first the surfactant concentration was set for 
micelles to occur around the 10th titration step in pure buffer. The same titration was 
repeated with protein solution in the sample cell. Pure buffer titration into the protein 
solution was performed as a blank control.  
 
5.1.5. Nuclear Magnetic Resonance (NMR) Spectroscopy 
 
NMR-experiments were performed with a JEOL 500+spectrometer (JEOL, Eching, 
Germany). For these experiments hGH was dialyzed against distilled water, 
lyophilized and reconstituted in D2O at 35 mg/ml under nitrogen atmosphere. α-LA 
powder was reconstituted in D2O under nitrogen atmosphere and PC 818 as bulk 
substance was lyophilized and reconstituted under nitrogen atmosphere to 15 mg/ml 
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to assure that micelles are present in a mixture of surfactant and protein. Before 2D 
experiments one dimensional 1H-NMR-spectra were recorded to determine the 
chemical shifts of the aromatic amino acids of the proteins and of the hydrophobic 
surfactant chain (-CH2- and -CH3). Consequently two-dimensional NOE-spectra were 
recorded to determine cross peaks of the above mentioned entities. 
 
5.2. Results and Discussion 
 
5.2.1. CMC Determination 
 
In order to analyze protein induced changes in the CMC of the surfactants by ITC 
experiments it was at first necessary to determine the CMC by other techniques for 
correlation with the events detected in ITC. The experiments were performed in water 
and the applied buffers and could not reveal major changes. PS 80 has a CMC of 
0.02 mg/ml or 0.015mM. For both alkyl polyglycosides micellization initiates at 
marginally higher concentration. PC 2000 exhibits a CMC of 0.04 mg/ml or 0.08 mM 
and PC 818 has a CMC of 0.02 mg/ml or 0.04 mM. The values are in good 
accordance with literature (Wan and Lee 1974; Boyd et al. 2000). Hill et al. describe 
this CMC as typical for nonionic surfactant mixtures, especially sugar based 
surfactant mixtures (von Rybinski and Hill 1998).   
 
5.2.2. ITC Measurements 
With the help of CMC-experiments ITC-experiments were planned so that after  
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Figure 49: Raw data of an ITC experiment 
  
 
approximately 10 injections the end of complete demizellization should be detectable. 
Raw data (Figure 49) of the experiments are transformed into thermograms (Figure 
50). The experiment can be separated in three phases: 1 and 2 in Figure 50 (as 
represented as enthalpy per mol injected surfactant) and 3 (schematic picture of the 
systems at each stage of the experiment). The three phases are also drawn as a 
figurative sketch in Figure 51. After complete interaction of the protein and the 
surfactant the CMC is exceeded and phase 3 will be a straight line that only 
represents heats of dilution. With a cell volume of ~1.4 ml and an injection volume of 
5 µl per injection 50 µl should contain enough surfactant that the first micelles stay 
intact. 
 
Figure 50: Typical thermogram of an ITC experiment. Phase 1 represents the 
titration steps where all micelles are disintigrated in the sample cell. Phase 2 is 
the represents the CMC as at this concentration some micelles stay intact. In 
Phase 3 only dilution of intact micelles occur due to concentration differences 
between syringe and sample cell. When the surfactant interacts with the 
surfactant, micellization occurs later, as some molecules are bound to the 
protein’s surface and not available for micelle formation. 
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Consequently CMC was exceeded and the endpoint could be detected as the interval 
where no or only minor changes in the thermogram occur (see 3 in Figure 50). Figure 
52 explains the data processing of the thermograms into the data that are discussed 
below. The raw data of a titration of surfactant into buffer (blank) and surfactant into 
protein (sample) were tested. Then a blank subtraction and a baseline parallelizing 
were performed to diminish background noise as recommended by the International 
Union of Pure and Applied Chemistry (Schwarz et al. 2008). If the x-axis of the ITC 
thermograms represents the protein to surfactant ratio all peaks should be similar in 
their maximum location, if there is specific binding. Another way of displaying the 
data is to plot against surfactant concentration. In this case, graphs which show a 
similar shape in binding enthalpies and onset of micellization proportionally 
increasing with protein concentration (Andersen Kell et al. 2008) demonstrate 
surfactant-related events in a protein environment (Nielsen et al. 2005). It turned out 
for our experiments that plotting against surfactant concentration led to better 
correlation than using the surfactant/protein ratio.  
 
 
 
 
Figure 51: Graphical demonstration of the three phases occurring during an ITC 
experiment. 
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Figure 52: Data processing. The two experiments surfactant into pure buffer 
(white circles) and surfactant into protein solution (black squares) are 
subtracted from each other (inverted light grey triangles) and parallelized. 
Additionally a correction to the baseline is done for better comparability of the 
experiments (dark grey triangles). 
 
The first experiment was carried out with PS 80 Na-EDTA buffer at a concentration of 
50 mg/l at 25 °C. The run showed remarkably low enthalpies and reflected only a 
dilution thermogram (data not shown). Also in a broader concentration range was a 
region in which a clear transition from demicellization to dilution of micelles upon 
contact with the sample material (in this case buffer) occurs. However, this transition 
could not be identified. Obviously, the energy of demicellization and micelle formation 
respectively is so small at room temperature that the event cannot be detected. 
Additionally, neither at 5 °C, nor at 37 °C the transition phase (phase 2) could be 
determined. Thus, in the pharmaceutically relevant temperature demicellization of 
PS 80 renders only minimal enthalpy, which is smaller than the dilution enthalpy and 
below the sensitivity of the calorimeter.  
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Figure 53: PC 818 into buffer at 5 °C. The parallel lines are for visualization of 
the differences in enthalpy before and after the CMC. 
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Figure 54: PC 818 into buffer at 37 °C. The parallel lines are for visualization of 
the differences in enthalpy before and after the CMC. 
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Figure 55: PC 818 into 0.01µM Apo-α-LA at 5°C. 
 
For PC 818, the experiments carried out at 5 mg/mL at 25 °C as well did not allow to 
follow the process of the demicellization. However, a transition from phase 1 to 
phases 2 and 3, respectively, could be observed at 5 °C and even more pronounced 
enthalpy change occurred at 37 °C (see Figure 53 and Figure 54). The 
demizellization process is driven by entropy and is strongly dependent on the 
temperature as it is characteristic for hydrophobic interactions (Nielsen et al. 2000). 
After reproducing the transition and optimization of the injection procedure with 
respect to injection time and spacing between two injections (300 s) 0.1 µm calcium 
free α-LA was added into the EDTA containing buffer providing the Apoform of α-LA. 
Injection of PC 818 into Apo-α-LA solution resulted a marked exothermic interaction 
at 5 °C (Figure 55), although the pure demicellization process was hardly exothermic 
at 5 °C (Figure 53). Otzen et al. found a similar effect for Apo-α-LA with other 
nonionic surfactants (Otzen et al. 2008). They claimed that already low amounts of 
surfactant are sufficient to destabilize the protein in its calcium-free form. The low 
melting temperature of Apo-α-LA of 20-32 °C indicates that unfolding might occur 
already at 5 °C (Hiraoka et al. 1980; Stuart et al. 1986; Vanderheeren and Hanssens 
1994). Thus the interaction between α-LA in its apoform and the alkyl polyglycosid-
surfactant can clearly be demonstrated and results in drastic destabilization of the 
protein. The results also demonstrates that the presence of surfactant may pull the 
equilibrium of unfolding for unfolding prone proteins towards the non-native state due 
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to direct interaction. Due to the low melting temperature the experiments with the 
apoform of α-LA at 25 °C and 37 °C were not performed. 
After changing the buffer to MOPS+CaCl2 (20 mM) α-LA is present in the Holo-form. 
Three concentrations of Holo-α-LA, 0.05 µM, and 0.2 µM were titrated with PC818 at 
an injecting concentration of 5 mg/mL at 5 °C. A change in the thermograms 
compared to the blank run could be detected with the presence of Holo-α-LA in the 
sample cell. This is indicating interactions between excipient and protein. This 
interaction was found to level off at 0.1 mM for both protein concentrations (Figure 
56). The interaction was exothermic at a very low level compared to the apoform 
experiments pointing out that the interaction do probably not result in unfolding of the 
protein.  
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Figure 56: PC 818 into Holo-α-LA at 5 °C at 0.05 mM (white circles) and 0.2 mM 
(black squares) protein concentration. 
 
For PC 2000 as titrant again the transition around CMC at 0.075 mM was in 
accordance to the CMC values determined via fluorescence spectroscopy and 
surface tension measurements. Finally, interaction of PC 2000 with Holo-α-LA was 
studied. At 5 °C PC 2000 also exhibited an interaction with Holo-α-LA up to a 
concentration of 0.06 mM surfactant (Figure 57).  
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Figure 57: PC 2000 into Holo-α-LA at 5 °C at 0.05 mM (grey triangles), 0.1mM 
(white circles) and 0.2 mM (black squares) protein concentration. 
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Figure 58: PC 2000 into Holo-α-LA at 37 °C at 0.05 mM (grey triangles), 0.1mM 
(white circles) and 0.2 mM (black squares) protein concentration. 
 
At 37 °C a similar change in the thermograms was detectable up to approx. 0.6 mM 
surfactant for concentrations of 0.05, 0.1 and 0.2 µM Holo-α-LA (  
Figure 58). The enthalpy of the interaction is low. The temperature change 
furthermore led to a conversion from endothermic to exothermic enthalpy. This leads 
to the conclusion that the observed effect is a form of hydrophobic hydration. Entropy 
driven effects are strongly temperature dependent as described in (Nielsen et al. 
2000). In contrast to the experiments with Apo-α-LA no unfolding is observed as the 
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enthalpies are several orders of magnitude smaller. The sustaining baseline shift 
results from slightly different pH values in the protein and surfactant solution. PC 818 
as well as PC 2000 are formulated without any preservative but are rather set to a 
low pH to inhibit microbial growth. The protein solution could not perfectly match this 
salt/pH system. Another impact resulting in disturbing of a clear baseline is the salt 
content in the surfactant raw material.  
The last set of experiments was conducted with IL-11 with concentrations of 0.2, 0.4 
and 0.8 µM protein. An interaction could be determined for both surfactants, PC 2000 
and PC 818, but the enthalpies were very weak, decreasing with rising the 
temperature from 5 to 37 °C by up to one order of magnitude. Interaction could be 
detected up to a surfactant concentration of 0.05 mM for PC 818 and 0.17 mM for 
PC 2000, respectively. 
In general, these small temperature dependent enthalpies point to nonspecific 
interactions as shown for example with salting out effects by smaller organic 
substances, possibly without unfolding of the protein (Hvidt and Westh 1998). The 
small enthalpies and the strong temperature dependence direct towards hydrophobic 
hydration as the driving process of the interaction between Holo-α-LA or IL-11 and 
the surfactants. IL 11 can be protected from shaking induced stress or stresses at 
surfaces during spray drying by nonionic surfactants (Friess and Fitzner 2001). We 
conclude that for these systems the stabilizing effect must originate from the interface 
coverage by the surfactants. Direct interactions are only marginal and should not play 
a major role. 
In literature some approaches towards determination of protein surfactant interaction 
via ITC have been made. Bam et al. found little interaction between the more 
hydrophobic interaction hGH and PS 80 (Bam et al. 1998) and proposed the 
stabilizing effect of the surfactant would derive from covering hydrophobic patches on 
the protein surface. Garidel et al. found no interaction between PS 80 and lysozyme 
as well as a monoclonal antibody (Garidel et al. 2009). For the fusion protein 
albutropin Manning et al. could only detect significant interaction between the 
albumin that has a specific fatty acid binding part on the protein surface and PS 20 
and PS 80 (Chou et al. 2005). 
This surface coverage effect of protein stabilizing surfactants has been proven for 
different other proteins and processes (Burke et al. 1992). Lysozyme adsorption onto 
  
 
hydrophobic silica can be prevented by the addition of PS 80 (Joshi and McGuire 
2009), n-Octyl-β-glucopyranoside and other nonionic surfactants reduce agitation 
induced aggregation of insulin(Sluzky et al. 1992) and recombinant human factor XIII 
could also be protected from agitation and freeze-thaw induced aggregation by PS 
20 addition (Kreilgaard et al. 1998). Replacement of protein from the surface by the 
surfactant were studied with the help of surface tension analytics (McAuley et al. 
2009; Serno et al. 2010), atomic force microscopy (Gunning et al. 2004), electron 
spectroscopy for chemical analysis (Adler and Lee 1999) and contact angle 
measurements (Zhang and Ferrari 1997). 
 
5.3. NMR - Spectroscopy 
 
In order to obtain further understanding of potential direct interactions of surfactants 
and proteins, NOESY-NMR experiments were performed. Besides LA in the Holo-
form, hGH was selected since it is characterized by a rather high content of 
hydrophobic, specifically aromatic amino acid side chains and PC 818 was used as a 
model surfactant. Figure 59 and Figure 60 show the NOE spectra of Holo-α-LA and 
PC 818 and hGH with PC 818, respectively. Cross peaks can be found between the 
chemical shifts at 0.9 ppm and 1.3 ppm in the surfactant spectrum and the chemical 
shifts at 7.2 ppm and 7.4 ppm in the protein spectrum. The latter two represent the 
aromatic amino acids of the proteins and cannot be found in the surfactant spectra. 
As expected these signals for hGH show a slightly higher intensity due the higher 
number of aromatic amino acids in the sequence. For both Holo-α-LA and hGH 
interactions could be found between the aromatic side chains and the hydrophobic 
fatty acid chain of PC 818. In this experiment interactions between aliphatic 
hydrophobic amino acid side chains of the protein sequence and the surfactant fatty 
acid chain could neither be proven nor ruled out as intermolecular signals overlay 
potential cross peaks between both molecules. The same holds true for interactions 
with the carbohydrate part of the surfactant.  
Overall, the cross peak signals are significant, but very low. This confirms the ITC 
results. Hillgren et al. could prove an interaction between PS 80 and lactate 
dehydrogenase by using Pulse-Field-Gradient Spin-Echo NMR (Hillgren et al. 2002). 
They found out that interactions between surfactants and proteins do take place, but 
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extent and related enthalpies are rather small. Taking into account that a very high 
concentration of both surfactant and protein is needed to obtain an adequate one 
dimensional spectrum, the overall interaction is most likely undetectable at 
pharmaceutically applied surfactant concentrations. 
 
 
Figure 59: 2D-NOE spectrum of the system PC 818 and Apo-α-LA. 
 
 
Figure 60: 2D-NOE spectrum of the system PC 818 and hGH. 
 
  
 
Interaction between a smaller artificial “protein” and alkyl polyglycosides could be 
proven by Sjoegren et al. (Sjoegren et al. 2005). In systems containing β-cyclodextrin 
and glucagon more hydrophobic protein moieties are packed into the hydrophobic 
cavity of the excipient (Qin et al. 2002; Matilainen et al. 2008). 
In our experiments it could be clearly demonstrated that the proteins interact with 
surfactants via the hydrophobic chain of the surfactant and the aromatic amino acids 
of the protein. An interaction of the hydrophobic aliphatic amino acids is very likely, 
but could not be proven with this experimental set-up. These interactions are very 
weak and could be detected only at high concentrations. This has two reasons. First, 
the signal of the aromatic amino acids is rather faint even at higher protein 
concentrations. Secondly, the interaction itself is delicate compared to the other 
signals that were detected via NOESY experiments. Consequently, these studies 
would have to be performed for all protein-surfactant combinations but this work was 
not practicable due to the enormous material consumption. To the best of the authors‟ 
knowledge, this is the first description of interaction proof by NOESY for the system 
pharmaceutical protein and nonionic surfactant. The method must be developed for 
enhanced sensitivity but nevertheless gives evidence for the direct vicinity of both 
substances in liquid formulations. 
It is open, whether this direct interaction leads to stabilization of proteins as proposed 
for hGH and PS 80 through shielding of the hydrophobic patches at the proteins 
surface (Bam et al. 1995). Alternatively, the interaction might lead to increased 
unfolding as described for alpha-helical bovine acyl-coenzyme-A-binding protein and 
SDS due to destabilization of the folded state of the protein (Andersen Kell et al. 
2009) shifting the equilibrium to unfolding. On the other hand surface competition of 
surfactants is a driving force for protein stabilization during the shelf life of a 
formulation and is widely described in literature (Maa and Hsu 1997; Zhang and 
Ferrari 1997; Gunning et al. 2004; Matheus 2006; Mahler et al. 2009; McAuley et al. 
2009; Serno et al. 2010). 
5.4. Conclusions 
 
In this study nonspecific interactions between sugar based nonionic surfactants and 
protein are clearly detectable, but no fixed binding numbers could be calculated via 
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ITC experiments. Holo-α-LA and IL11 do not show specific binding or unspecific 
binding with fixed binding ratios when titrated with PC 818 and PC 2000. The 
interaction seems to be more dependent on surfactant concentration than on a 
specific protein/surfactant ratio. As the enthalpy of interaction is strongly dependent 
on temperature hydrophobic hydration might be the driving force of interaction. 
Additionally, NOE spectroscopy points to hydrophobic interaction between aromatic 
amino acid side chains of Holo-α-LA and hGH and the hydrophobic chains of PC 818. 
These interactions are rather weak in nature. Future NMR-studies might take the 
effect of different surfactant concentrations below and above CMC into account as 
well as different protein states, folded vs. unfolded or partially unfolded. This study is 
one the few providing proof for direct interaction of protein drugs and surfactants. 
However, the fact that proteins and surfactants show direct interaction does not 
answer the question whether this phenomenon is beneficial for protein stability. The 
protein molecules may either be stabilized by shielding of the hydrophobic patches of 
the protein‟s surface or unfolding of the protein molecules may be induced by 
preferred interaction and stabilizing the unfolded state. But as surfactants already 
proved their suitability as stabilizers in protein formulations, the main stabilizing effect 
might not be derived from weak direct intermolecular contact, but from the surface 
competition between surface active proteins and the surfactant molecules. 
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6. Determination of the Interaction 
between Nonionic Surfactants and 
human Growth Hormone with the 
Help of Fluorescence Correlation 
Spectroscopy 
6.1. Introduction 
 
The technique of Fluorescence Correlation Spectroscopy (FCS) is already described 
in 1.2.2.4.3. Takakuwa et al. used the autocorrelation function and the resulting 
diffusion constants to characterize the interaction between a fluorescent labeled 
protein and liposomes similar (Takakuwa et al. 1999). In a similar way we tried to 
investigate the interaction between hGH and polysorbate 80 or two different sugar 
based surfactants. 
For this kind of experiments a low labeling degree was needed, i.e. one molecule of 
fluorescent dye per molecule protein would be desirable. For analysis of this system 
multicomponent fit was applied, fitted for two to four different species to differentiate 
between labeled protein, labeled aggregates, labeled protein surfactant complexes 
and to diminish background fitting also for free dye. An increase of diffusion times 
would give a hint of an interaction of nonionic surfactant micelles and proteins as 
described by Schellekens et al. in the context of immunogenicity of different 
erythropoietin (Epo) formulations (Berland 1997; Hermeling et al. 2003). Further 
sample properties like counts per particle (cpp) describing the brightness of the 
fluorescent conjugate and the total intensity of the sample were determined. Parallel 
to regular FCS measurements a scanning for intensively fluorescent targets (SIFT) 
was also performed (due to set-up of the machine, the first and last sample could not 
be scanned). During a SIFT experiment the focus moves throughout the cell which 
increases the odds of tracking extremely large and hence slowly diffusing entities 
(Bertsch et al. 2005). This technique has been applied e.g. to scan for large fibrils of 
labeled protein of alpha-synuclein plaques as marker for Parkinson‟s and Alzheimer‟s 
disease (Giese et al. 2005) and might show larger oligomers of hGH that would have 
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been not detected by FCS with a fixed focus. 
6.2. Material and Methods 
 
6.2.1. Material 
 
PS 80 of technical grade was obtained by Sigma-Aldrich (Darmstadt, Germany). The 
sugar based nonionic surfactants PC 818 and PC 2000 were kindly donated by 
Cognis KG (Düsseldorf, Germany). The water used in all experiments was deionized 
water from the university supply purified in a PURELAB Plus system (ELGA labwater, 
Celle, Germany) with a conductivity of <0.055 µS/cm. Buffer salts and other reagents 
were of analytical grade or higher. hGH was kindly donated by Pharmacia & Upjohn 
and processed as described below for the nuclear magnetic resonance experiments. 
hGH was dialyzed over a time period of 24 h against 100 mM PBS pH 7.4 at 4°C 
using a 3500 Da MWCO Slide-a-Lyzer dialysis cassette with a nominal volume from 
3-12ml (Thermo Scientific, Rockford, USA). The dialysis was performed to remove 
glycine, which is present in the orgininal formulation. The glycine would otherwise 
react with the fluorescent probes. After dialysis, the protein concentration was 
determined via size exclusion chromatography. The protein was adjusted to a 
concentration of 1.00 mg/ml. Fluoroprobe 488 was obtained as staining kit from KMF 
Laborchemie (Lohmar, Germany). And Alexa Fluor 488 dye was also obtained as a 
ready-to-use kit from Invitrogen (Carlsbad, USA). 
6.2.2. Methods 
6.2.2.1. Size Exclusion Chromatography 
 
The monomer content of the protein formulation as well as the dimer formation was 
investigated via SEC. A HP 1100 HPLC system (Agilent Technologies, Waldbronn, 
Germany) equipped with a diode array detector and a 3000 SWXL gel filtration 
column (Tosoh Bioscience, Tokyo, Japan) was used for this experiment. 50 µl of a 
centrifuged protein sample was injected into the HPLC. Within the HPLC a 0.2 µm 
online filter was used. The running buffer was composed of 50 mM NaH2PO4 and 
  
 
150 mM NaCl at a pH of 7.2. The analytics were performed at a flow-rate of 
0.5 ml/min with UV-detection at 216 nm. 
 
6.2.2.2. Optimization of the Binding Protocol 
 
At first 100 µl of Fluoroprobe 488 with 2 mg/ml in DMSO were mixed with 100 µl of a 
1 mg/ml hGH solution and 1 ml sodium carbonate buffer supplied with the labeling kit. 
After incubation and stopping the reaction with 10 µl hydroxylamine solution the dye 
was separated from the protein by centrifuging in Vivaspin columns with a nominal 
MWCO of 5000 Da (Sartorius Stedim biotech, Aubagne Cedex, France). 
Consequently, the purification step was changed to PD-10 gel sepharose separation 
columns (SephadexTM G-25M, GE Healthcare, Buckinghamshire, United Kingdom). 
The column was equilibrated with 25 ml PBS before adding the sample. The reaction 
solution was added on the column and 10 ml PBS buffer pH 7.2 was added as 
eluent. 500 ml fractions were collected. These fractions were separated then for a 
second time.  
When Alexa 488 was applied, the first labeling was performed according to the 
manual. For coupling reaction, 2 ml of the protein solution (1 mg/ml) were added to 
200 µl 1 M sodium carbonate and 10 µl dye solution. The sample was incubated 1 h 
at room temperature (200 rpm on a horizontal shaker). At the end of the incubation, 
the sample was purified with a PD-10 column. The eluate was collected in 12 
fractions of 500 µl. Only the fractions 2 to 6 were retained and combined. 
Concentrations were determined using SEC. The dye concentration was reduced to 
one fifth of the original concentration to reduce the amount of free dye and finally by 
changing the collected fractions after separation to the fractions 7 to 12 the protocol 
was finalized. 
 
6.2.2.3. Fluorescence Correlation Spectroscopy 
 
FCS and Fluorescence Intensity Data analysis (FIDA) measurements were carried 
out with an Insight Reader (Evotec Technologies, Düsseldorf, Germany) with the 
excitation wavelength set to 488 nm, using a 40X 1.2 NA microscope objective 
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(Olympus, Japan) and a pinhole diameter of 70 µm at FIDA setting. Excitation power 
was 100 µW. Each sample was measured in triplicate during 10 s at room 
temperature. FCS plate reader applicable NUNC 96-well plates (Nalgene, Denmark) 
were used with a sample volume of 20 µl. The fluorescence data were analyzed by 
autocorrelation analysis using the FCSPPEvaluation software version 2.0 from 
Evotec technologies. Fluorescence intensity data were acquired and summed over 
time intervals of constant length (bins) of 40 µs using the Insight Reader software. 
The frequency of specific combinations of resulting photon counts per bin of 
Alexa 488 or Fluoprobe 488 was recorded in a two dimensional intensity distribution 
histogram with intensity values from 0 - 255 photons/bin or in a one dimensional 
autocorrelation function applying one-, two- or three-species fits, respectively. 
The protein concentration for all experiments was set to 0.5 mg/ml protein. The ratio 
of labeled protein to native protein was 1 to 1000. Surfactant concentrations ranged 
from 1% to 0.00001%. All experiments were performed in triplicate.  
 
6.3. Results and Discussion 
 
6.3.1. Optimization of the Binding Protocol 
 
The results from this experiment are summarized in  
Table 10. When the Fluoroprobe 488 kit was used as described in the user‟s manual 
93.1% free dye was detected in the solution by FCS measurement. As this was far 
from acceptable the purification step was changed from Vivaspin centrifuge tubes to 
PD-10 columns. This reduced the amount of unbound dye to 35.5% which was still 
not acceptable. A second purification step resulted only in dilution of the protein as 
tested by SEC but not in a reduction of the amount of free dye. Adjusting the 
stoichiometry from 10:1 to 2:1 did not lead to significant reduction of free fluorophor, 
either. Interestingly, although the amount of labeled dye was decreased an additional 
increase in the counts per particle distribution could be detected. That means the 
ratio of labeled dye per molecule protein was increasing, which was also not desired. 
As the use of a size exclusion column as well as centrifugation should result in 
complete separation of dye and protein, the dye is probably non-covalently linked to 
  
 
the hydrophobic proteins surface and could not be removed. Hence we changed the 
fluorescent dye to Alexa Fluor 488. From the 500 µl fractions that were collected from 
the final separation step, only the fractions 2 to 6 were retained and combined. 
Concentrations were determined using SEC. The resulting amount of free dye was 
45.7 %.  
# Protocol Amount of free 
dye [%] 
Amount of 
labeled protein 
[%] 
Counts per 
particle 
1 Standard protocol  
Fluoroprobe 488 
93.1 6.9 24.8 
2 #1 + use of PD 10 
columns and change 
stoichiometry to 1:2 
35.5 64.5 32.6 
3 # 2 + 2nd purification step 35.5 64.5 32.6 
4 Alexa 488 and PD 10 
columns 
45.7 54.3 23.4 
5 #4 + different 
stoichiometry (1:2) 
38.3 61.7 23.3 
6 #5 + 2nd purification step; 
fractions 7-12 
11.7 88.3 29.8 
 
Table 10: Optimization of the ratio of free fluorescent dye to labeled dye and 
degree of labeling as described by particle intensity (counts per particle) 
 
As this protocol was adapted from an antibody labeling kit with the aim of a high 
degree of labeling to optimize the binding reaction the dye concentration was 
reduced to one fifth of the original concentration. This resulted in 38.3 % free dye. 
And by changing the collected fractions after separation to the fractions 7 to 12 the 
amount of free surfactant could be reduced to 11.7 % which was acceptable for 
further experiments. Although these fractions showed a higher count per particle rate 
(1 < labeling degree < 1.3), this was acceptable as the amount of free dye was 
decreased so drastically. A third purification step led not to significantly lower 
amounts of free dye but of strong dilution of the protein.  
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6.3.2. Fluorescence Correlation Spectroscopy 
 
In Figure 61 the diffusion times are plotted against the surfactant concentration. hGH 
in a concentration of 0.1 mg/ml after labeling and purification has a diffusion time 
539.4 µs. After mixing labeled and unlabeled protein to a concentration of 0.5 mg/ml 
the diffusion time increased by 10%, which is viscosity dependent. When 
concentrations of 0.00001% to 0.01% were applied the diffusion time for all 
surfactants was in a range of 700 µs. Increasing the concentration to higher values in 
the PS 80 and PC 818 containing formulations made the protein diffuse faster 
(611 µs and 656 µs, respectively for 1%). If there would have been an inclusion of 
protein aggregates into micelles the opposite would have been expected. 
 
Figure 61: Diffusion time of labeled hGH as a function of the surfactant 
concentration ( PC 2000, ■ PC 818, and  PS 80). 
 
It is generally possible to tell between small differences in the diffusion time and 
hence size as shown by Chattopadhyay (Ghosh et al. 2009) who could distinguish 
between the native, the molten globule and the unfolded state of bovine serum 
albumin using FCS. Takakuwa et al. could prove the interaction of phospholipid 
liposomes with the very hydrophobic membrane protein 4.1 (Takakuwa et al. 1999). 
Thus, it seems very unlikely that micelles protein complexes occur for this system 
with nonionic surfactants and hGH. In contrast, the total intensity of the sample 
decreases with higher amounts of surfactant as shown in Figure 62 from values of 
about 200 to 120 when surfactant concentrations of 0.00001% and 1% were 
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compared. A decrease in total intensity might come from quenching effects of the 
surfactant in the solution, but nothing indicates inclusion of the protein into micelles. 
On the other hand, the cpp rate, which remained unaltered for all concentrations, 
would represent the brightness of a fluorescent labeled protein or the inclusion 
complex of one or more protein molecules in a micellar “carrier” as these systems 
would appear as one particle through the laser beam (data not shown). 
 
 
Figure 62: Total intensity of surfactant samples ( PC 2000, ■ PC 81, and 
 PS 80) 
 
In additional SIFT experiments aggregates could be detected in some formulations 
as indicated as wider distributions in Figure 63, but no correlation to the type of 
surfactant present nor to SEC results could be made. 
For all measurements the fixed parameters for unlabeled dye were used in the 
multicomponent fit. No third fluorescent species could be detected, which also 
indicates that unlabeled dye did not interact with surfactant micelles. 
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6.4. Conclusions 
 
The results from FCS and SIFT measurements both direct into the direction of no 
interaction on a micellar level. Neither the diffusion times of the micellar solutions nor 
the diffusion times of surfactant formulations, containing surfactants below CMC, 
differ significantly from protein in buffer. The only detectable changes arising from 
surfactants are related to total intensity. These results are a hint that no micellar 
inclusion happens. A complex between aggregated proteins within a micellar 
construct must have about three times larger volume than hGH monomers. Assuming 
that a polysorbate micelle has a diameter of 3-5 nm (Croy and Kwon 2005) and the 
same holds true for a folded hGH molecule (5 nm) (Maa and Hsu 1996) a third 
species with a significantly larger diffusion time would have been expected. But no 
third species with a higher diffusion time could be found in all formulations with better 
correlation values as for two species (i.e. pure dye and labeled protein). Binding o 
protein into a micellar complex core could not be detected. Due to changes of the 
PS 80 PC 818 PC 2000 
0.00001
% 
1% 
Figure 63: SIFT measurements of hGH and surfactants.  
  
 
fluorescence intensity in the presence of surfactant one could argue interaction might 
occur. The mode of this possible interaction is not be due to inclusion of protein 
aggregates or completely unfolded monomers and micellar surfactant molecules, but 
due to interaction of monomeric surfactant with protein molecules or pure quenching 
effects from the surfactant itself as no changes in diffusion rates could be detected. 
We could not confirm the proposed interaction from Schellekens et al. between Epo 
and nonionic surfactants (Hermeling et al. 2003) to our applied system with hGH.  
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7. Summary of the thesis 
The aim of this thesis was to find alternative nonionic surface active substances that 
are able to protect pharmaceutical proteins as good as the already approved 
excipients. The search was focused on substances that on the one hand show similar 
behavior in regards to physico-chemical properties as the gold standards polysorbate 
20 and polysorbate 80. On the other hand the drawbacks of polyethylene glycol 
derived products, such as peroxide residues, should be circumvented. 
Sugar-based surfactants were hypothesized as promising alternatives. In this thesis, 
first a screen for suitable sugar-based surfactant products from pharmaceutical, 
cosmetical and food industry was performed. These substances were tested on their 
basic physico-chemical properties, such as critital micelle concentration, solubility, 
micelle size, viscosity. With the help of mass spectrometry composition of the 
products was analyzed. Testing for peroxide equivalents, even after UV-radiation, 
revealed that these products are not forming any oxidizing species. Additionally, 
trehalose fatty acid esters were synthesized and physico-chemically characterized. 
The most promising candidates were Plantacare 818, Plantacare 2000, Ryoto 
Monoester P and two of the trehalose esters (capril and lauryl monoester). In regards 
to critical micelle concentration, effect on surface tension, hemolytic activity and 
micelle size the substances were in comparable range with the polysorbates. 
With the most promising surfactants stress tests in pharmaceutical protein 
formulations were performed. Especially the trehalose esters and the Plantacare 
products showed quite similar behavior to the polysorbates. Different stress tests 
were performed, mainly aiming for mechanical stress. What was unexpected, was 
that also under thermal stress the sugar-based surfactants could not show superiority 
to the polysorbates. Although lacking peroxide residues in the sugar-based surfactant 
formulations, the formation of oxidized methionine of Interleukin 11 was almost 
unaffected compared to high peroxide containing polysorbates. But, when put under 
mechanical stress some of the sugar-based surfactants were better stabilizers, e.g. in 
shaking experiments of human Growth Hormone, than the approved polysorbates. 
Another question that should be answered in this thesis is whether pharmaceutical 
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proteins are stabilized due to interactions with the outer shell of the protein or simply 
by surface coverage of the interfaces between the aqueous protein formulation and 
e.g. container walls or the container head space. Three different biophysical methods 
have been applied for this. Isothermal Titration Calorimetry revealed a very small 
interaction enthalpy between surfactants and proteins. That interaction was 
unspecific, i.e. without a fixed binding ratio, and temperature dependent. Due to the 
experimental set-up this interaction could only be shown for sugar-based surfactants 
as for the polysorbates the demicellization enthalpy was too low at temperatures 
between 5 °C and 37 °C to be applied in this system. Nuclear Overhausen 
Enhancenement NMR revealed that the hydrophobic chains of the surfactants are in 
close spatial distance to the hydrophobic aromatic amino acids of the protein. This 
was proven at higher excipient and protein concentration than would normally be 
applied to overcome a high noise signal in the NMR. Fluorescence Correlation 
Spectroscopy revealed no increase in diffusion times when surfactant molecules are 
present in the formulation. Hence, it seems unlikely that proteins migrate into a 
micelle and unfold there as was hypothesized by others. The main outcome of these 
experiments was that the direct interaction between protein and surfactant is very 
low. It is very likely that competition at hydrophobic interfaces is the main stabilizing 
property of nonionic surfactants. 
Summarizing, trehalose fatty acid ester and Plantacare 818 and Plantacare 2000 are 
suitable alternatives to polysorbates in the applied field of low concentration protein 
formulations. The direct interaction between nonionic surfactants and pharmaceutical 
proteins is very low and unspecific. 
In future studies, one might have a look on higher concentrated formulations of e.g. 
monoclonal antibodies and gain a better knowledge if these surfactants are able to 
prevent protein oxidation that would appear in the presence of polysorbates. 
Furthermore, the application of biophysical methods on high concentrated 
formulations might be interesting, as the protein at some point needs enough space 
that direct interaction might also have an impact on the formulation stability. 
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